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Abstract
Variable selection is one of the most popular tools for analyzing high-dimensional genomic
data. It has been developed to accommodate complex data structures and lead to structured
sparse identification of important genomics features. We focus on the network and interaction
structure that commonly exist in genomic data, and develop novel variable selection methods
from both frequentist and Bayesian perspectives.
Network-based regularization has achieved success in variable selections for high-dimensional
cancer genomic data, due to its ability to incorporate the correlations among genomic fea-
tures. However, as survival time data usually follow skewed distributions, and are contami-
nated by outliers, network-constrained regularization that does not take the robustness into
account leads to false identifications of network structure and biased estimation of patients’
survival. In the first project, we develop a novel robust network-based variable selection
method under the accelerated failure time (AFT) model. Extensive simulation studies show
the advantage of the proposed method over the alternative methods. Promising findings
are made in two case studies of lung cancer datasets with high dimensional gene expression
measurements.
Gene-environment (G×E) interactions are important for the elucidation of disease eti-
ology beyond the main genetic and environmental effects. In the second project, a novel
and powerful semi-parametric Bayesian variable selection model has been proposed to in-
vestigate linear and nonlinear G×E interactions simultaneously. It can further conduct
structural identification by distinguishing nonlinear interactions from main-effects-only case
within the Bayesian framework. The proposed method conducts Bayesian variable selection
more efficiently and accurately than alternatives. Simulation shows that the proposed model
outperforms competing alternatives in terms of both identification and prediction. In the
case study, the proposed Bayesian method leads to the identification of effects with important
implications in a high-throughput profiling study with high-dimensional SNP data.
In the last project, a robust Bayesian variable selection method has been developed for
G×E interaction studies. The proposed robust Bayesian method can effectively accom-
modate heavy-tailed errors and outliers in the response variable while conducting variable
selection by accounting for structural sparsity. Spike and slab priors are incorporated on
both individual and group levels to identify the sparse main and interaction effects. Exten-
sive simulation studies and analysis of both the diabetes data with SNP measurements from
the Nurses’ Health Study and TCGA melanoma data with gene expression measurements
demonstrate the superior performance of the proposed method over multiple competing al-
ternatives.
To facilitate reproducible research and fast computation, we have developed open source
R packages for each project, which provide highly efficient C++ implementation for all the
proposed and alternative approaches. The R packages regnet and spinBayes, associated with
the first and second project correspondingly, are available on CRAN. For the third project,
the R package robin is available from GitHub and will be submitted to CRAN soon.
High-dimensional variable selection for genomics data, from both
frequentist and Bayesian perspectives
by
Jie Ren
M.S., Kansas State University, 2015
A DISSERTATION
submitted in partial fulfillment of the
requirements for the degree
DOCTOR OF PHILOSOPHY
Department of Statistics
College of Arts and Sciences
KANSAS STATE UNIVERSITY
Manhattan, Kansas
2020
Approved by:
Major Professor
Cen Wu
Copyright
c© Jie Ren 2020.
Abstract
Variable selection is one of the most popular tools for analyzing high-dimensional genomic
data. It has been developed to accommodate complex data structures and lead to structured
sparse identification of important genomics features. We focus on the network and interaction
structure that commonly exist in genomic data, and develop novel variable selection methods
from both frequentist and Bayesian perspectives.
Network-based regularization has achieved success in variable selections for high-dimensional
cancer genomic data, due to its ability to incorporate the correlations among genomic fea-
tures. However, as survival time data usually follow skewed distributions, and are contami-
nated by outliers, network-constrained regularization that does not take the robustness into
account leads to false identifications of network structure and biased estimation of patients’
survival. In the first project, we develop a novel robust network-based variable selection
method under the accelerated failure time (AFT) model. Extensive simulation studies show
the advantage of the proposed method over the alternative methods. Promising findings
are made in two case studies of lung cancer datasets with high dimensional gene expression
measurements.
Gene-environment (G×E) interactions are important for the elucidation of disease eti-
ology beyond the main genetic and environmental effects. In the second project, a novel
and powerful semi-parametric Bayesian variable selection model has been proposed to in-
vestigate linear and nonlinear G×E interactions simultaneously. It can further conduct
structural identification by distinguishing nonlinear interactions from main-effects-only case
within the Bayesian framework. The proposed method conducts Bayesian variable selection
more efficiently and accurately than alternatives. Simulation shows that the proposed model
outperforms competing alternatives in terms of both identification and prediction. In the
case study, the proposed Bayesian method leads to the identification of effects with important
implications in a high-throughput profiling study with high-dimensional SNP data.
In the last project, a robust Bayesian variable selection method has been developed for
G×E interaction studies. The proposed robust Bayesian method can effectively accom-
modate heavy-tailed errors and outliers in the response variable while conducting variable
selection by accounting for structural sparsity. Spike and slab priors are incorporated on
both individual and group levels to identify the sparse main and interaction effects. Exten-
sive simulation studies and analysis of both the diabetes data with SNP measurements from
the Nurses’ Health Study and TCGA melanoma data with gene expression measurements
demonstrate the superior performance of the proposed method over multiple competing al-
ternatives.
To facilitate reproducible research and fast computation, we have developed open source
R packages for each project, which provide highly efficient C++ implementation for all the
proposed and alternative approaches. The R packages regnet and spinBayes, associated with
the first and second project correspondingly, are available on CRAN. For the third project,
the R package robin is available from GitHub and will be submitted to CRAN soon.
Table of Contents
List of Figures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xii
List of Tables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xiii
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xv
1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1 Penalized Variable Selection . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
1.2 Bayesian Variable Selection . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
1.3 Other Variable Selection Methods . . . . . . . . . . . . . . . . . . . . . . . . 8
1.4 Works in this dissertation . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
2 Robust Network-Based Regularization and Variable Selection for High-Dimensional
Genomic Data in Cancer Prognosis . . . . . . . . . . . . . . . . . . . . . . . . . . 11
2.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
2.2 Statistical Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
2.2.1 The LAD Regression for Censored Data . . . . . . . . . . . . . . . . 15
2.2.2 Robust Network-based Penalized Identification . . . . . . . . . . . . . 16
2.2.3 Computation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
2.3 Simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
2.4 Real Data Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
2.4.1 Non-small cell lung cancer (NSCLC) data . . . . . . . . . . . . . . . 25
2.4.2 Lung squamous cell carcinoma (LUSC) data . . . . . . . . . . . . . . 28
2.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
viii
3 Semi-parametric Bayesian variable selection for gene-environment interactions . . 33
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
3.2 Data and Model Settings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
3.2.1 Partially linear varying coefficient model . . . . . . . . . . . . . . . . 37
3.2.2 Basis expansion for structure identification . . . . . . . . . . . . . . . 38
3.2.3 Semi-parametric Bayesian variable selection . . . . . . . . . . . . . . 39
3.2.4 Gibbs sampler . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
3.3 Simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
3.4 Real Data Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
3.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
4 Robust Bayesian variable selection for gene-environment interactions . . . . . . . 61
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
4.2 Data and Model Settings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
4.2.1 Bayesian LAD Regression . . . . . . . . . . . . . . . . . . . . . . . . 66
4.2.2 Bayesian sparse group variable selection for G×E interactions . . . . 68
4.2.3 Gibbs sampler . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
4.2.4 A summary of proposed and alternative methods . . . . . . . . . . . 73
4.3 Simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
4.4 Real Data Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
4.4.1 Nurses’ Health Study (NHS) data . . . . . . . . . . . . . . . . . . . . 80
4.4.2 TCGA skin cutaneous melanoma data . . . . . . . . . . . . . . . . . 83
4.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
Bibliography . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
A Appendices for Chapter 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
ix
A.1 Additional simulation results . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
A.2 Biological similarity analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
B Appendices for Chapter 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
B.1 Hyper-parameters sensitivity analysis . . . . . . . . . . . . . . . . . . . . . . 116
B.2 FDR-based variable selection . . . . . . . . . . . . . . . . . . . . . . . . . . . 119
B.3 Variable selection based on 95% credible interval . . . . . . . . . . . . . . . . 120
B.4 Sensitivity analysis on smoothness specification . . . . . . . . . . . . . . . . 121
B.5 Additional simulation results . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
B.6 Computational cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
B.7 The estimated varying coefficient functions . . . . . . . . . . . . . . . . . . . 126
B.8 Assessment of the convergence of MCMC chains . . . . . . . . . . . . . . . . 127
B.9 Additional results for real data analysis . . . . . . . . . . . . . . . . . . . . . 128
B.10 Posterior inference for the BSSVC-SI method . . . . . . . . . . . . . . . . . 129
B.10.1 Priors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
B.10.2 Gibbs Sampler . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130
B.11 Posterior inference for the BSSVC method . . . . . . . . . . . . . . . . . . . 139
B.11.1 Priors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139
B.11.2 Posterior distribution . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
B.12 Posterior inference for the BVC-SI method . . . . . . . . . . . . . . . . . . . 142
B.12.1 Priors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 142
B.12.2 Gibbs Sampler . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
B.13 Posterior inference for the BVC method . . . . . . . . . . . . . . . . . . . . 147
B.13.1 Priors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147
B.13.2 Gibbs Sampler . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 148
C Appendices for Chapter 4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150
C.1 Summary of methods. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150
x
C.2 Hyper-parameters sensitivity analysis . . . . . . . . . . . . . . . . . . . . . . 151
C.3 Assessment of the convergence of MCMC chains . . . . . . . . . . . . . . . . 152
C.4 Additional simulation results . . . . . . . . . . . . . . . . . . . . . . . . . . . 153
C.5 Estimation results for data analysis . . . . . . . . . . . . . . . . . . . . . . . 159
C.6 Biological similarity analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . 175
C.7 Posterior inference . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 177
C.7.1 RBG-SS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 177
C.7.2 RBL-SS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 179
C.7.3 RBSG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 181
C.7.4 RBG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 183
C.7.5 RBL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 185
C.7.6 BSG-SS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 187
C.7.7 BGL-SS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 189
C.7.8 BL-SS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 191
C.7.9 BSG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 193
C.7.10 BGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 195
C.7.11 BL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 196
xi
List of Figures
2.1 Distribution of log(survival time) in the TCGA LUSC dataset . . . . . . . . 13
2.2 Sub-network for PCLAF. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
2.3 Sub-network for IRS4. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
3.1 Non-linear G×E effect of SNP rs1106380 from the NHS data. . . . . . . . . . 34
4.1 Distribution of the outcome variables . . . . . . . . . . . . . . . . . . . . . . 63
A.1 Gene Ontology analysis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
B.1 The estimated varying coefficient functions. . . . . . . . . . . . . . . . . . . 126
B.2 Potential scale reduction factor (PSRF) against iterations . . . . . . . . . . . 127
B.3 Real data analysis for the proposed method. . . . . . . . . . . . . . . . . . . 128
C.1 Potential scale reduction factor against iterations . . . . . . . . . . . . . . . 152
C.2 Gene Ontology analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 176
xii
List of Tables
2.1 Coordinate descent for the robust penalized network-based regularization . . 20
2.2 Simulation for gene expression data under AR structure . . . . . . . . . . . . 23
3.1 Identification in simulation. . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
3.2 Simulation results in Example 1. . . . . . . . . . . . . . . . . . . . . . . . . . 55
3.3 Identification results for varying and constant effects. . . . . . . . . . . . . . 58
3.4 Identification results for nonzero effect corresponds to the discrete environ-
ment effect. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
4.1 Simulation results in Example 1. . . . . . . . . . . . . . . . . . . . . . . . . . 77
4.2 Simulation results in Example 1 (2). . . . . . . . . . . . . . . . . . . . . . . 78
4.3 Overlaps in NHS T2D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
A.1 Simulation for gene expression data under Banded.1 and Banded.2 structure 110
A.2 Simulation for gene expression data using correlations calculated from LUSC
data. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
A.3 Simulation for gene expression data using correlations calculated from NSCLC
data. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
A.4 Simulation for SNP data under AR structures. . . . . . . . . . . . . . . . . . 112
A.5 Simulation for SNP data under banded structures. . . . . . . . . . . . . . . . 113
A.6 Simulation for SNP data based on the linkage disequilibrium (LD) structure. 114
B.1 Sensitivity analysis on hyper-parameters for pi’s. . . . . . . . . . . . . . . . . 117
B.2 Sensitivity analysis on hyper-parameters for λ’s. . . . . . . . . . . . . . . . . 118
B.3 Simulation results for FDR-based variable selection. . . . . . . . . . . . . . . 119
xiii
B.4 Identification in simulation. . . . . . . . . . . . . . . . . . . . . . . . . . . . 120
B.5 Sensitivity analysis on smoothness specification. . . . . . . . . . . . . . . . . 121
B.6 Simulation results in Example 2. . . . . . . . . . . . . . . . . . . . . . . . . . 122
B.7 Simulation results in Example 3. . . . . . . . . . . . . . . . . . . . . . . . . . 123
B.8 Simulation results in Example 4. . . . . . . . . . . . . . . . . . . . . . . . . . 124
B.9 Computational cost. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
C.1 Summary of the proposed and alternative methods. . . . . . . . . . . . . . . 150
C.2 Sensitivity analysis on hyper-parameters. . . . . . . . . . . . . . . . . . . . . 151
C.3 Simulation results in Example 2. . . . . . . . . . . . . . . . . . . . . . . . . . 153
C.4 Simulation results in Example 2 (2). . . . . . . . . . . . . . . . . . . . . . . 154
C.5 Simulation results in Example 3. . . . . . . . . . . . . . . . . . . . . . . . . . 155
C.6 Simulation results in Example 3 (2). . . . . . . . . . . . . . . . . . . . . . . 156
C.7 Simulation results in Example 4. . . . . . . . . . . . . . . . . . . . . . . . . . 157
C.8 Simulation results in Example 4 (2). . . . . . . . . . . . . . . . . . . . . . . 158
C.9 Analysis of the NHS T2D data using RBSG-SS. . . . . . . . . . . . . . . . . 159
C.10 Analysis of the NHS T2D data using RBL-SS. . . . . . . . . . . . . . . . . . 161
C.11 Analysis of the NHS T2D data using BSG-SS. . . . . . . . . . . . . . . . . . 163
C.12 Analysis of the NHS T2D data using BL-SS. . . . . . . . . . . . . . . . . . . 166
C.13 Analysis of the TCGA SKCM data using RBSG-SS. . . . . . . . . . . . . . . 169
C.14 Analysis of the TCGA SKCM data using RBL-SS. . . . . . . . . . . . . . . . 170
C.15 Analysis of the TCGA SKCM data using BSG-SS. . . . . . . . . . . . . . . . 172
C.16 Analysis of the TCGA SKCM data using BL-SS. . . . . . . . . . . . . . . . . 173
xiv
Acknowledgments
I would like to express my sincere gratitude to my major advisor, Dr. Cen Wu, who
guided me throughout this project. I am extremely fortunate to have a caring major advisor
who helped me through my graduate years. He always responded to my questions and ideas
with patience. If it wasn’t for his enduring support and pressure in the right direction when
needed, I would not have finished this manuscript.
I want to extend my thanks to Dr. Christopher Vahl, Dr. Haiyan Wang, Dr. Weiqun
Wang and Dr. Mark Ungerer, for serving on my committee and for providing support
and advice through my study process. I would like to thank the families of Coyne, Fryer
and Siepman for providing scholarships to graduate students in the Department of Statistics.
Without this support, it would have been harder to complete my research in a timely manner.
I also want to thank the coauthors of the papers that went into this dissertation. Without
their collaboration and expertise, the papers would not have come together so neatly.
Finally, I want to express my deepest gratitude to my family for their unwavering support
and love. To my parents, thank you for always believing in me and wanting the best for
me. To my significant other, Pat, thank you for helping me going through all the ups and
downs in my master and Ph.D. journey with your unending love, patience, understanding
and encouragement. This accomplishment would not have been possible without them.
xv
Chapter 1
Introduction
Due to the rapid advance of high-throughput biotechnologies, enormous amounts of omics
data have been collected at various levels of biological systems. A representative example is
the genotyping analysis performed by microarray technologies. The data from genotyping
can be considered as a matrix with columns corresponding to variables, such as SNPs, and
rows corresponding to samples. This data matrix has the “large p, small n” nature, that
is, the number of genetic features measured is much larger than the sample size. This high-
dimensionality of the high-throughput data has brought new challenges to the statistical
modeling. Since only a small subset of the genetic features is associated with the clinic
outcome of interest, an important question to answer is “How to identify the important
features from a large-scale candidate pool?”. With genetic features treated as variables in
a statistical model, this question can be reformulated as a variable section problem. The
least absolute shrinkage and selection operator (LASSO) is one of the most popular variable
selection methods for analyzing high-dimensional data (Tibshirani, 1996). By shrinking
the coefficients towards zero, the LASSO can effectively exclude irrelevant variables from
the model and produce sparse estimation of the coefficients. The term sparsity refers to
the phenomena of 0’s among the estimated coefficients. Over the past decades, plenty of
variants of LASSO, along with other variable selection methods have been developed for high-
dimensional data. Here we provide a brief overview for popular variable selection methods
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in omics studies from both frequentist and Bayesian perspectives.
1.1 Penalized Variable Selection
Penalization or regularization has become one of the most popular frameworks for selecting
important features in omics studies. Let Y be a vector of the disease outcome, where Y can
be a continuous disease phenotype (e.g. body weight in obesity studies), categorical disease
status (e.g. cancer stages) or survival time of patients. Let X be the design matrix of
the p-dimensional genomics features. X can be various omics measurements such as SNPs,
DNA methylation and gene expressions, among others. The penalized regression model can
be expressed as
L(β;Y,X) +
p∑
j=1
pλ(|βj|) (1.1)
where L(β;Y,X) is the loss function that measures the lack of fit of the model, and pλ(·) is
a penalty function indexed by the regularization parameters λ ≥ 0. The penalty function
imposes shrinkage on the coefficient vector β = (β1, . . . , βp)
>. βj is the coefficient correspond-
ing to the jth feature in the high-dimensional genomics data. By minimizing the penalized
loss function (1.1), variable selection can be achieved with penalized estimation simultane-
ously. In other words, variables whose regression coefficients are shrunk to zero (βj = 0) are
automatically excluded from the model. The well-known LASSO (Tibshirani (1996)) is a
penalized least square regression with `1 penalty, which adopts the form as follows
‖Y −Xβ‖22 + λ
p∑
j=1
|βj| (1.2)
Fan and Li (2001) proposes three criteria for a good penalty function. In brief, a desired
penalty function should result in a estimator that is continuous (continuity), while setting
small estimated coefficients to zero (sparsity) and maintaining nearly unbiased estimates for
large coefficients (unbiasedness). While LASSO meets the sparsity and continuity criteria,
it leads to biased estimates, especially for the large coefficients, therefore fails to achieve
2
unbiasedness. This leads to developments of penalties for nearly unbiased variable selection,
including the smoothly clipped absolute deviation (SCAD) (Fan and Li, 2001), the minimax
concave penalty (MCP) (Zhang, 2010) and adaptive LASSO (Zou, 2006). The penalties are
defined as follows
SCAD: pλ,γ(βj) =

λ|βj| |βj |≤λ
−β2j−2γλ|βj |+λ2
2(γ−1) λ<|βj |≤γλ
1
2
(γ + 1)λ2 |βj |>γλ
MCP: pλ,γ(βj) =

λ|βj| − (2γ)−1β2j |βj |≤γλ
1
2
γλ2 |βj |>γλ
Adaptive LASSO: pλ,γ(βj) = λ(|β(0)j |−γ)|βj|
where γ > 2 for SCAD, γ > 1 for MCP and γ > 0 for adaptive LASSO. β
(0)
j is the
initial estimate of β. These penalties have been demonstrated to have attractive properties
theoretically and practically. Together with LASSO, they are considered as the family of
baseline penalization methods.
In order to take complex data structures into consideration, more advanced penalty
functions have been developed. For example, grouping structures exist in many statistical
modeling problems, such as a group of dummy variables for a categorical factor or a set of
basis functions in nonparametric modeling. For selecting grouped variables, Yuan and Lin
(2006) proposes the group LASSO method, with the penalty defined as
pλ(β) = λ
G∑
g=1
√
Lg‖βg‖2 (1.3)
where βg is a coefficient vector of length Lg (β = (β
>
1 , ..., β
>
G)
>). The term
√
Lg ad-
justs the penalty for the varying group sizes, and ‖·‖2 is the euclidean norm. Following
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Yuan and Lin (2006), other baseline penalization methods have also been extended to the
group setting (Huang et al., 2012). Another example of complex data structure is the high
correlation among genetic features in omics data, which have been widely observed and
reported. The elastic net (Zou and Hastie (2005)) and the fused-lasso (Tibshirani et al.
(2005)) are two popular choices for analyzing correlated genomic features. The elastic net
uses a combination of the `1 and `2 penalties (λ1‖β‖22 + λ2|β|), which encourages a group-
ing effect and tends to drop or select highly correlated predictors together. The fused-lasso
(λ1
∑p
j=1 |βj|+ λ2
∑p
j=2 |βj − βj−1|) induces smoothness among the coefficients of neighbor-
ing features. An application example of the fused-lasso is the DNA copy number variations
(CNVs) data. The CNVs form block structures along their gemonic location, and the fused-
lasso can promote this type of block structure on the penalized estimates. In order to utilize
the correlation information in a more efficient and flexible way, the network-constrained
regularization approaches have been developed, such as Li and Li (2008) and Huang et al.
(2011), among many others. In particular, Huang et al. (2011) develops the sparse Laplacian
shrinkage (SLS) penalty, which is built upon the combination of MCP (Zhang, 2010) and
Laplacian quadratic that is associated with a graph. The SLS penalty takes the form
p∑
j=1
pλ1,γ(βj) + λ2
∑
1≤j<k≤p
|ajk|(βj − sgn(ajk)βk)2 (1.4)
where pλ1,γ(βj) is the MCP penalty with tuning parameter λ1, and regularization parameter
γ (Zhang, 2010), and |ajk| is the measure of connection intensity between variables xj and xk.
The MCP penalty in (1.4) promotes sparsity in the model, and the second term encourages
smoothness among the coefficient profiles of the related covariates. As shown in Huang
et al. (2011), the penalty in (1.4) is capable of taking correlation structure into account
without introducing extra bias. They also show that in high dimension settings with p n
under certain assumptions, SLS is selection consistent and equivalent to the oracle Laplacian
shrinkage estimator with high probability. Recently, as multi-layer high-dimensional omics
data has become available, these popular penalization methods have also been adopted to
integrate multi-omics data (Du et al. (2020); Jiang et al. (2019); Li et al. (2020)).
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In the analysis of omics data, it is not uncommon to encounter model mis-specification
and heterogeneity problems, like heavy-tailed errors and outliers in response variables and the
contamination in predictors. Such challenges demand the development of robust methods
that can accommodate data contamination and can be insensitive to model specification.
For penalized regression, a practical way to obtain robustness is to adopt the “robust loss
function + penalty” form. Wu and Ma (2015) surveys some broadly adopted robust loss
functions, including check loss function, the least absolute deviation (LAD) loss function,
rank-based loss function and their variants. The high computational burden resulting from
the nonsmoothness of the loss functions is a major limitation of robust methods, especially
when it comes to the analysis of high-dimensional data. The LAD loss function, as a special
case of quantile-based loss functions, is especially appealing for omics studies due to its
computational convenience (Wu and Ma (2015); Huang et al. (2007); Wu et al. (2018a)).
The LAD-based penalization can be expressed as
n∑
i=1
|yi − x>i β|+
p∑
j=1
pλ(|βj|) (1.5)
For a contaminated observation with yi significantly deviating from x
>
i βˆ, the predicted value
from model (2.1), the `1 based loss down-weighs such a deviation, while the non-robust loss,
for example, least square based loss, results in a much larger deviation.
1.2 Bayesian Variable Selection
O’Hara and Sillanpa¨a¨ (2009) classifies different Bayesian variable selection approaches into
four categories (1) adaptive shrinkage (2) indicator model selection (3) stochastic search
variable selection (SSVS) and (4) model space approach. In particular, the first category,
adaptive shrinkage, has a tight connection with the frequentist variable selection methods.
From a Bayesian perspective, the LASSO estimates can be interpreted as posterior mode
estimates when the regression parameters have independent and identical Laplace priors
pi(β) =
∏p
j=1
λ
2
exp
{
− λ |βj|
}
(Tibshirani (1996)). Specifically, with a independent priori
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pi(σ2) on σ2, the posterior distribution can be expressed as
pi(β, σ2|y) = pi(σ2)(σ2)−(n−1)2 exp(− 1
2σ2
‖Y −Xβ‖22 − λ
p∑
j=1
|βj|)
The maximum a posteriori probability (MAP) estimate for β is equivalent to the LASSO
estimate in (1.2), for any fixed value of σ2. Park and Casella (2008) proposes a fully Bayesian
analysis for lasso regression, the Bayesian LASSO, by adopting a conditional Laplace prior
on β
pi(β|σ2) =
p∏
j=1
λ
2σ
exp
{
− λ
σ
|βj|
}
They also demonstrate that this conditional Laplace prior guarantees the unimodality of
the posterior distribution. Although this fully Bayesian analysis produces similar shrinkage
on individual coefficients as the LASSO, it cannot set a posterior estimate to zero exactly.
Kyung et al. (2010) extends this fully Bayesian framework to a more general form that can
accommodate the group LASSO (Yuan and Lin, 2006), the fused LASSO (Tibshirani et al.,
2005) and the elastic net (Zou and Hastie, 2005). In particular, the group lasso can be
represented by adopting a multivariate Laplace prior
pi(βg|σ2) ∝ exp
{
−
√
Lgλ
σ
‖βg‖2
}
(1.6)
where βg and Lg are defined at the same way as in (1.3) and
√
Lgλv
σ
is the scale parameter of
the multivariate Laplace. These methods share the same drawback as the Bayesian LASSO
in the lack of the model selection property. This difficulty can be overcome by borrowing
strength from the spike-and-slab priors (Mitchell and Beauchamp, 1988) that have been
widely used in other Bayesian variable selection methods, such as indicator model selection
and SSVS. The spike-and-slab priors on βj(j = 1, . . . , p) can be expressed in a general form
βj|φj ind∼ φjpi1(βj) + (1− φj)pi0(βj)
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where pi1(·) is a flat “slab distribution” for modeling large effects, pi0(·) is a “spike distribu-
tion” either exactly at or concentrated around zero for modeling negligibly small effects, and
φj ∈ {0, 1} is a auxiliary indicator variable. If φj = 1, βj∼pi1(βj) indicates the presence of
the jth genetic effect in the model. The opposite occurs when φj = 0. Conventionally, pi1(·)
is set to a normal distribution with large variance. The choices of pi0(·) leads to the different
variable selection methods. The SSVS method proposed by George and McCulloch (1993)
adopts a mixture prior of two normal distributions (φjN(0, cjτ
2
j ) + (1− φj)N(0, τ 2j )), where
the spike part (the second density) has a small variance τ 2j and centers around zero. Kuo
and Mallick (1998) adopts a point mass mixture prior where the pi0 is defined as δ0(βj), so
that coefficients of unimportant effects can be set to zero in the spike part.
Many methods have been developed to combine the point mass mixture prior and Laplace
shrinkage for variable selection. Yuan and Lin (2005) proposes an empirical Bayesian vari-
able selection method with prior βj|φj ind∼ φj λ2 exp(−λ|βj|) + (1 − φj)δ0(βj). Zhang et al.
(2014a) generalizes this strategy to group variable selection. Xu and Ghosh (2015) proposes
a sparse group selection method to select variables both at the group level and (within group)
individual level. In Zhang et al. (2014a) and Xu and Ghosh (2015), a multivariate Laplace
distribution is used as the slab part for imposing shrinkage at the group level:
βg|φg, σ2 ∼ φg M-Laplace(0, σ√
Lgλ
) + (1− φg)δ0(βg)
where the density function of a L-dimensional multivariate Laplace distribution is
M-Laplace(x|0, C−1) ∝ CL exp(−C‖x‖2)
Roc˘kova´ and George (2018) adopts a mixture prior of two Laplace distributions in SSVS
method. Specifically, they defines pi0(βj) =
λ1
2
exp(−λ1|βj|) with λ1 small and pi0(βj) =
λ0
2
exp(−λ0|βj|) with λ0 large. It is worth noting that there are other priors that can be
incorporated within the spike and slab form, such as the Zellner’s g-prior (Zhang et al.
(2016)). They can also be used for variable selection purposes.
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To tackle the challenges of heterogeneity, robust Bayesian variable selection methods have
also been developed. Sha et al. (2006) proposes a Bayesian variable selection approach for
censored survival data under the accelerated failure time (AFT) models. The robustness of
the model is obtained by adopting a log-t distribution for the failure time (survival time).
Another example of leveraging the heavy-tailed t distribution for robustness is the study
in Yi and Xu (2008). They develop a variant of Bayesian LASSO for quantitative trait
loci (QTL) mapping by assigning t distribution priors on β. Ren et al. (2020b) adopts a
Bayesian formulation of the least absolute deviation (LAD) regression to accommodate data
contamination and long-tailed distributions in the phenotype in Gene-environment studies.
1.3 Other Variable Selection Methods
We focus on penalization and Bayesian variable selection here since the two are the foci of this
dissertation. It is worth noting that there exists a diversity of variable selection methods that
are also applicable in analyzing omics data. For example, boosting and random forest are
popular machine learning techniques for feature selection. In random forest, the importance
measures of variables can guide the decision of whether a variable should be included in
the model or not (Breiman, 2001). Boosting is an ensemble procedure that combines the
outputs of many weak learners to produce a powerful strong learner. In omics study, weak
learners can be individual SNP, gene expression and other genetic features. In each iteration,
boosting selects the variables having the largest correlation with residuals corresponding to
the current active set of selected predictors (the weak learners), and then fits the new model
to recompute the residuals. Variable selection in boosting is achieved because the algorithm
largely ignores non-informative predictors when fitting the models. The prediction power
has improved significantly in boosting through aggregating multiple weak learners (Friedman
(2001)).
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1.4 Works in this dissertation
In Chapter 2, we develop a novel robust network-based variable selection method under
the accelerated failure time (AFT) model for survival time in cancer genomic studies. We
consider a least absolute deviation (LAD) loss function, where the `1 form introduces robust-
ness by down weighing the deviation of the outlier. The computational cost of the proposed
methods is much lower compared to other high dimensional variable selection methods for
survival outcomes. To identify important genomic signatures while accommodating corre-
lations under survival outcomes, we develop robust network-based penalization under the
AFT model with Kaplan-Meier weights. The proposed penalty function is of an “MCP +
L1” form, where MCP encourages sparsity and the L1 term incorporate network structures by
promoting the smoothness among pairwise coefficient profiles of correlated gene expressions.
We develop an effective algorithm that borrows strength from majorization-minimization
(MM) within the coordinate descent (CD) framework. Extensive simulation studies show
the advantage of the proposed method over the alternative methods. Two case studies of
lung cancer datasets with high dimensional gene expression measurements demonstrate that
the proposed approach has identified markers with important implications.
In Chapter 3, we explore Bayesian variable selection for Gene-Environment (G×E) inter-
actions. We propose a novel and powerful semi-parametric Bayesian variable selection model
that can investigate linear and nonlinear G×E interactions simultaneously. To accommodate
possible nonlinear effects of environment factor, we first consider a partially linear varying
coefficient model where the varying coefficient functions capture the possible non-linear G×E
interaction, and the linear part models the G×E interactions with linear assumptions. The
changing of basis with B splines is adopted to separate the coefficient functions with vary-
ing, non-zero constant and zero forms, corresponding to cases of nonlinear interaction, main
effect only (no interaction) and no genetic interaction at all. Instead of using conventional
Bayesian Lasso and Bayesian Group Lasso to impose penalty on individual and group levels,
we adopt spike-and-slab priors with the slab parts coming from Laplace distributions, to
shrink coefficients of irrelevant covariates to zero. Highly efficient Gibbs sampler has been
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developed to carry out the computation. Simulation shows that the proposed model out-
performs competing alternatives in terms of both identification and prediction. In the case
study, the proposed Bayesian method leads to the identification of effects with important
implications in a high-throughput profiling study with high-dimensional genetic variants.
Built upon our existing work in both robust network-constrained variable selection (Chap-
ter 2) and robust penalization for G×E interactions (Wu et al., 2018a), we develop a novel
robust Bayesian variable selection method to dissect G×E interactions in Chapter 4. Out-
liers and data contamination in disease phenotypes of G×E studies have been commonly
encountered, leading to the development of a broad spectrum of robust penalization meth-
ods. Nevertheless, within the Bayesian framework, the issue has not been taken care of in
existing studies. In this study, we propose a Bayesian method that can effectively accom-
modate heavy–tailed errors and outliers in the response variable while conducting variable
selection by accounting for structural sparsity. In particular, the spike–and–slab priors have
been imposed on both individual and group levels to identify important main and interaction
effects. An efficient Gibbs sampler has been developed to facilitate fast computation. Exten-
sive simulation studies and analysis of both the diabetes data with SNP measurements from
the Nurses Health Study and TCGA melanoma data with gene expression measurements
demonstrate the superior performance of the proposed method over multiple competing al-
ternatives.
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Chapter 2
Robust Network-Based
Regularization and Variable Selection
for High-Dimensional Genomic Data
in Cancer Prognosis
2.1 Introduction
In cancer research, profiling studies have been extensively conducted to identify prognos-
tic markers that may contribute to the development and progression of cancer. Important
prognostic markers have the potential to shed deep insight in elucidating the genetic basis
of cancer, and provide assistance in cancer prevention, diagnosis and treatment selection.
The generation of unprecedented amount of high dimensional genomics data from the high-
throughput profiling studies has led to the development of extensive regularized variable
selection methods (Fan and Lv (2010)). The genomics features, such as gene expressions
and single nucleotide polymorphism (SNPs), are treated as variables within the regulariza-
tion (or penalization) framework. As the correlations among genomics features have been
widely recognized, multiple studies have developed network based regularization methods to
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accommodate interconnections among these features, including gene expressions (Li and Li
(2008)), SNPs (Ren et al. (2017)), copy number variations (Peng et al. (2012)) and DNA
methylations (Sun and Wang (2012)). Recently, network based penalization has also been
adopted to integrate multi-omics data (Jiang et al. (2019)).
The network based methods have unique strength to effectively capture correlations by
incorporating prior biological information via the network (or graph) structure, where the
vertices of networks are the genomic features and the edges of the networks denote certain
regulatory relationship among the features. Incorporation of the network structure in regu-
larized variable selection has led to significant improvement in both identification accuracy
and predictive performance, as demonstrated in aforementioned studies, as well as many
other studies. Nevertheless, these methods have limitations. First, network–constrained reg-
ularization methods under survival outcomes have not received much attention. As mark-
ers identified under patients’ survival have important implications in cancer prognosis, the
network–based regularized variable selection will improve accuracy in both identifying prog-
nostic markers and predicting patients’ survival. However, the disease outcome investigated
from published studies are mainly continuous (Li and Li (2008); Peng et al. (2012)), binary
(Huang et al. (2018); Min et al. (2018); Ren et al. (2017); Sun and Wang (2012, 2013))
and multi-nomial (Tian et al. (2014)). Markers identified from these studies, though impor-
tant, cannot be treated as potential prognostic markers directly. Second, existing network
(or graph) based methods lack robust properties, which are critical to accommodate data
contamination and long-tailed distributions. In studies that investigate the regulations of be-
tween CNVs and gene expressions (Peng et al. (2012)), as gene expressions may have heavy
tailed distributions (especially at high expression levels) or be contaminated, inference of
gene regulatory relationship based on non-robust methods might be biased.
We use the lung squamous cell carcinoma (LUSC) data collected by The Cancer Genome
Atlas (TCGA) as a motivating example. For the 461 subjects analyzed in this study, five
subjects have survival time 150.13, 151.15, 154.20, 156.54 and 173.69 months, respectively,
while the rest 456 subjects have survival times ranging from 0.03 to 139.98 months. Figure
2.1 shows the plots of both empirical density function of the log survival time as well as the
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corresponding best-fitted normal density. The deviation from normal is observed. Moreover,
the Kolmogorov-Smirnov test yields a pvalue less than 0.01, which suggests a significant
difference from normal distribution. Such a pattern may happen for multiple reasons. For
example, when multiple cancer subtypes exist, the largest subtype can be viewed as be-
ing “contaminated” by small subtypes. Contamination of survival can also be caused by
misclassification of causes of death (Rampatige et al. (2013)) and unreliable extraction of
survival times from medical records (Fall et al. (2008)). Without taking robustness into
consideration, non-robust network based methods will lead to biased estimation and thus
false identification of network structure, even in the presence of only one contaminated ob-
servation. As shown in Wu and Ma (2015), for high-dimensional genomic data, the robust
variable selection methods are still not well developed, which is particularly true for the
network–constrained approaches, possibly due to the extra complexity from incorporating
network structure to accommodate interconnections among genomic features.
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Figure 2.1: Distribution of log(survival time) in the TCGA LUSC dataset.
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In this study, we propose a robust network–based regularization and variable selection
method for high-dimensional genomics data in cancer prognosis. Our method has the follow-
ing novel features to distinguish itself from existing ones. First, we adopt the least absolute
deviation (LAD) loss function to accommodate heavy-tailed distribution and data contam-
ination. Although no robust loss function universally outperforms the rest, the LAD loss
function, as a special case of quantile-based loss functions, is especially appealing for high-
dimensional data due to its L1 form (Wu and Ma (2015); Huang et al. (2007); Wu et al.
(2018a)). Other robust loss functions, including exponential square loss (Wang et al. (2013b))
and rank based loss (Wu et al. (2015)), do not enjoy such a computational convenience for
data with high-dimensionality. Second, as our goal is to robustly identify important ge-
nomic signatures while accommodating correlations under survival outcomes, we develop
robust network based penalization under the accelerated failure time (AFT) model with
Kaplan-Meier weights. The proposed penalty function is of an “MCP + L1” form, where
MCP, the Minimax Concave Penalty, encourages sparsity (Zhang (2010)) and the L1 term
promotes network structure. Besides, although the weighted LAD estimator has been in-
vestigated in Huang et al. (2007), the strength of its regularized counterpart has not been
fully explored, especially for network structure estimation and identification. Third, we de-
velop an effective algorithm within the coordinate descent framework. On the contrary, the
computational cost for many robust variable selection methods are prohibitively high under
complicated data and model settings (Wu and Ma (2015)). The advantage of our method
over alternatives has been convincingly demonstrated in both simulation studies and two
case studies. To the best of our knowledge, identifying important genomic features in cancer
prognostic studies through robust penalization by incorporating network structures has not
been reported before. It is also noting that our method is not restricted to cancer survival
only. Instead, it can be readily extended to other types of response, such as the continuous
disease phenotypes.
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2.2 Statistical Methods
We consider the AFT model for cancer prognosis. For high-dimensional genomics data,
the AFT model is adopted over the Cox model and other alternatives due to its lower
computational cost. From now on, we use gene expression as a representative example of
genomics features.
2.2.1 The LAD Regression for Censored Data
Denote the ith subject by using the subscript i. Let (Ti, Xi, Zi) (i = 1, . . . , n) be n in-
dependent and identically distributed random vectors, where Ti is the logarithm of sur-
vival time, Xi = (xi1, xi2 . . . , xip)
T is the p–dimensional vector of gene expressions, and
Zi = (zi0, zi1 . . . , ziq)
T is the (q+ 1)–dimensional vector of which the first component zi0 = 1
and the last q components are clinical/environmental covariates. Usually, q and p are of low
and high dimensionality, respectively. The AFT model postulates that
Ti = Ziα +Xiβ + εi
α = (α0, α1, . . . , αq)
T where α0 is the intercept and the last q components are the regression
coefficients for the clinical covariates. β = (β1, . . . , βp)
T is the regression coefficient vector
for the gene expressions, and εi is the error term with an unspecified distribution. Denote
Ci as the logarithm of the censoring time. Under right censoring, we observe (Yi, δi, Zi, Xi),
where Yi = min(Ti, Ci), and δi = I(Ti ≤ Ci) is the indicator of event. Without loss of
generality, we assume that {(Yi, δi, Zi, Xi), i = 1, . . . , n} have been sorted with respect to Yi
in an ascending order.
We adopt the Kaplan-Meier weights for censoring. Let Fˆn be the Kaplan–Meier estimator
of the distribution function F of T . Then by following Stute and Wang (1993), we have
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Fˆn(y) =
∑n
i=1 vi1{Yi ≤ y}, where the Kaplan–Meier weights vi (i = 1, . . . , n.) are defined as
v1 =
δ1
n
, vi =
δi
n− i+ 1
i−1∏
j=1
(
n− j
n− j + 1)
δj , i = 2, . . . , n.
To accommodate data contamination, consider the weighted LAD loss function
L(α, β) =
1
n
n∑
i=1
vi|Yi − Ziα−Xiβ | (2.1)
The robustness comes from the L1 form of the loss function. For a contaminated observation
with Yi significantly deviating from Ziαˆ + Xiβˆ, the predicted value from model (2.1), the
L1 based loss down-weighs such a deviation, while the non-robust loss, for example, least
square based loss, results in a much larger deviation.
2.2.2 Robust Network-based Penalized Identification
As only a small subset of gene expressions is associated with cancer prognosis, and the total
number of gene expressions is much larger than the sample size, identification of important
prognostic markers is of a “large p, small n” nature, and can be achieved through regularized
variable selection. Consider the regularized loss function:
Q(α, β) = L(α, β) + P (β;λ, γ), (2.2)
where λ and γ are tuning parameters. A nonzero component of regularized estimate βˆ
indicates that the corresponding gene expression is associated with cancer prognosis. One
possible choice for the penalty function is
P (β;λ, γ) =
p∑
m=1
ρλ1,γ(|βm|),
where ρλ1,γ(t) = λ1
∫ |t|
0
(1 − x
γλ1
)+dx is the Minimax Concave Penalty (MCP) with tuning
parameter λ1 and regularization parameter γ (Zhang (2010)).
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The effects of gene expressions are represented by β, the vector of regression coefficients.
We impose MCP on β, and components of non-zero regularized estimate suggests that the
corresponding gene expressions are associated with cancer prognosis. A major disadvantage
of this penalty is that correlations among gene expressions are not considered. Multiple
studies, including aforementioned ones, have shown that failure to accommodate correlations
results in biased estimation and false identification of important effects. To overcome this
issue, we use a network structure to describe the interconnections among gene expressions.
In the gene expression network, a node corresponds to a gene expression, and two nodes
are connected by the edge if corresponding gene expressions are associated statistically or
biologically. We propose the following penalty function to incorporate network information:
P (β;λ, γ) =
p∑
m=1
ρλ1,γ(|βm|) + λ2
∑
1≤m<k≤p
|amk||βm − sgn(amk)βk|, (2.3)
where ρλ1,γ(·) is the MCP defined above, βm is the coefficient corresponding to the m-th
gene expression and amk measures the strength of connection between the m-th and k-
th gene expression. The first term of (2.3) imposes MCP on all the p components of β,
thus it encourages sparsity in the regularized estimate. The second term promotes the
smoothness among pairwise coefficient profiles of correlated gene expressions. It encourages
their regression coefficients to be of similar magnitude. The extent of “encouragement” is
adjusted by amk. The penalty shares certain similarity with the sparse Laplacian penalty
(Huang et al. (2011)). However, it also has remarkable difference due to the L1 form, which
is adopted for the “consistency” purposes with the weighted LAD loss function.
In (2.3), |amk| is the network adjacency which plays a critical role in quantifying the
strength of connection between two nodes. We consider the approach from Zhang and Hor-
vath (2005) to specify adjacency. Denote rmk as the Pearson correlation coefficient between
the mth and kth gene expression. Let A = (amk, 1 ≤ m, k ≤ p) be the adjacency matrix,
where amk = r
α
mk · I{|rmk| > r} with α = 5. A properly defined network adjacency mea-
sure can keep the sign of rmk, retain strong correlations and tune down weak ones (that are
possibly noises). We choose the power transformation and the value of α following existing
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studies (Huang et al. (2011); Zhang and Horvath (2005)). We calculate the cutoff r based
on Fisher transformation zmk = 0.5log((1 + rmk)/(1 − rmk)). If the correlation between
mth and kth gene expressions is 0,
√
n− 3zmk approximately follows N(0, 1), which can
then be adopted to calculate a threshold δ for
√
n− 3zmk. Then the threshold for rmk is
r = exp(2δ/
√
n− 3)−1)/(exp(2δ/√n− 3)+1). The network is weighted and sparse. Please
refer to Huang et al. (2011) and Zhang and Horvath (2005) for more details. There are al-
ternative ways of constructing network adjacency. For instance, biological information (like
pathway) is used to define adjacency in some studies. We conjecture that they are equally
applicable. As our objective is not to compare different network constructions, we focus on
this specific network structure.
2.2.3 Computation
Consider the following iterative algorithm:(a) initialize αˆ and βˆ; (b) update αˆ as the mini-
mizer of (2.1) with β fixed at βˆ; (c) update βˆ as the minimizer of (2.2) with α fixed at αˆ;
(d) iterate step (b) and (c) until convergence. The non-convexity of MCP in the penalty
function (2.3) makes that computation of step (c) particularly challenging. Here, we develop
an effective algorithm that borrows strength from MM (majorization-minimization) within
the coordinate descent (CD) framework. More specifically, the nonconvex MCP in (2.3) is
replaced by its majorization function to create a surrogate regularized loss function first,
then optimization is conducted over the surrogate loss function with respect to one predictor
at a time, and cycled through all predictors untill convergence.
We define a majorization function for the MCP function ρλ1,γ(|β|) at the d-th iteration
(d = 1, 2, ...) as
φ
β
(d−1)
m
(|βm|) = ρλ1,γ(|β(d−1)m |) + ρ′λ1,γ(|β(d−1)m |+)(|βm| − |β(d−1)m |), m = 1, . . . , p
where β
(d−1)
m is the value of βm at the end of the (d-1)-th iteration, and ρ
′
λ1,γ
(|βm|+) is the
limit of ρ′λ1,γ(t) as t→ |βm| from the above. ρ′λ1,γ(|βm|+) exists for all βm due to the piecewise
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differentiability of MCP. We can see that
φ
β
(d−1)
m
(|βm|) ≥ ρλ1,γ(|βm|) for all m
where the equality holds when βm = β
(d−1)
m . Hence, φβ(d−1)m , m = 1, ..., p majorizes the MCP
function ρλ1,γ(|β|). Subsequently, the regularized loss function in (2.2) is majorized at the
d-th iteration by
Qβ(d−1)(α, β) = L(α, β) +
p∑
m=1
φ
β
(d−1)
m
(|βm|) + λ2
∑
1≤m<k≤p
|amk||βm − sgn(amk)βk|
Next, we update the value of β at the d-th iteration by minimizing the surrogate regularized
loss function:
β(d) = argmin
β
Qβ(d−1)(α, β) (2.4)
This minimization can be conducted within the coordinate descent framework. With α and
β−m held fixed at the current estimate, we have
β(d)m = argmin
βm
{ 1
n
n∑
i=1
vi|Yi − Ziα−
∑
j 6=m
Xijβj −Ximβm |
+
∑
j 6=m
φ
β
(d−1)
j
(|βj|) + φβ(d−1)m (|βm|)
+ λ2
∑
j 6=m
∑
j<k≤p
|ajk||βj − sgn(ajk)βk|+ λ2
∑
m<k≤p
|amk||βm − sgn(amk)βk|
}
= argmin
βm
{ 1
n
n∑
i=1
vi|Yi − Ziα−
∑
j 6=m
Xijβj −Ximβm |+ ρ′λ1,γ(|β(d−1)m |+)|βm|
+ λ2
∑
m<k≤p
|amk||βm − sgn(amk)βk|
}
Therefore, (2.4) can be equivalently expressed as a minimization problem for weighted me-
dian regression. We re-write (2.4) as
β(d)m = argmin
βm
{
1
n+1+p−m
∑n+1+p−m
i=1 wim|uim|
}
(2.5)
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where
u
(d)
im =

Yi−Ziα−
∑p
j 6=mXijβ
(d−1)
j
Xim
− βm i=1,2,...,n
0− βm i=n+1
sgn(amk)βk − βm i=n+2,...,n+1+p−m
(2.6)
and
w
(d)
im =

1
n
vi|Xim| i=1,2,...,n
ρ
′
λ1,γ
(|β(d−1)m |+) i=n+1
λ2|amk| i=n+2,...,n+1+p−m
(2.7)
where m and k follow the same definition as in (2.3). The minimizer of (2.5) is the
weighted median of (n + 1 + p − m) pseudo observations. Similarly, we can update the
(q + 1)–dimensional vector α(d) component-wisely by minimizing the loss function (2.1) us-
ing weighted median regression. Specifically, for each l = 0, . . . , q, update α
(d)
l using the
weighted median in (2.1) with β and α−l held fixed. With fixed tuning parameters, the
coordinate descent algorithm is described in Table 2.1
Table 2.1: Coordinate descent algorithm.
Algorithm Coordinate descent for the robust penalized network–based regularization
Initialize d = 0, α(0) and β(0)
Repeat
update α(d+1) component-wisely using weighted median regression
for m = 1, 2, . . . , p
compute um and wm via (2.6) and (2.7)
update β
(d+1)
m using the weighted median in (2.5)
m← m+ 1
end for
d← d+ 1
until convergence
Selection of proper tuning parameters is crucial to the proposed method. Here, we have
tuning parameters λ1 and λ2, as well as a regularization parameter γ. In MCP, γ balances
between the concavity and unbiasedness. As suggested by Zhang (2010) and other studies,
in our numerical study, we experiment γ with a sequence of values, including 1.5, 3, 5, 7 and
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10, and find that the results not sensitive to the choice of γ. Therefore, we set γ=5. We
choose the optimal pair of tuning parameters (λ1, λ2) via a two-dimensional grid search on
independent testing data sets. That is, we first obtain regularized estimates from training
data, then evaluate prediction performance over independently generated testing data. In
simulation, the tunings determined from V-fold cross validation are very close to those based
on independent testing data, but computationally more intensive. In real data analysis, we
use cross validation to choose optimal tuning parameters since independent testing data
sets are not available. In both simulation study and case study, convergence has been
achieved in a small to moderate number of iterations. We compute the CPU time of running
100 replicates of simulated 300 × 500 gene expression data with AR structure and fixed
tuning parameters on a regular laptop. The CPU time in seconds are 53.0 (LAD Network),
36.1 (LAD MCP), 34.9 (LAD LASSO), 39.1 (Network), 24.3 (MCP) and 24.7 (LASSO),
respectively.
To facilitate computation, we implement the proposed method, as well as the alternatives
in C++ and provide the R package regnet with detailed documentation and examples (Ren
et al. (2019b)).
2.3 Simulation
To demonstrate the utility of the proposed approach, we evaluate the performance through
simulation study. In particular, we consider right censored survival data under the acceler-
ated failure time (AFT) model. We generate datasets for different correlation structures and
correlation levels, each with 300 subjects. For each subject, we simulate 5 clinical covariates
and the expression of 500 genes, from multivariate normal distributions with marginal means
equal to zero and variances equal to one. Among the 500 genes, there are 100 clusters with 5
genes per cluster. For the gene expression, we consider three correlation structures. (1) the
auto-regression (AR) structure, in which gene i and j within the same cluster have correlation
coefficients ρ|i−j|, and they are independent cluster–wisely. We consider ρ = 0.2, 0.5 and 0.8,
representing weak, moderate and strong correlation respectively. (2) banded correlation
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structure where the ith and jth genes have ρ = 0.5 if |i− j| = 1 and ρ = 0 otherwise. Gene
expressions in different clusters are independent. (3) banded correlation structure where the
ith and jth genes have correlation coefficient 0.5 if |i− j| = 1, 0.25 if |i− j| = 2 and 0 other-
wise. 10% of clusters are randomly selected to have nonzero regression coefficients generated
from Unif[0.2, 0.8]. For the clinical covariates, we simply use a multivariate normal distribu-
tion with ρ = 0.7 in all scenarios. All clinical covariates have non-zero coefficients generated
independently from Unif[0.2, 0.8]. The log event times are generated under the AFT model
with random errors from N(0, 1) (Error1), T(1) (Error2), 85%N(0,1) + 15%Cauchy(0, 1)
(Error3) or 75%N(0,1) + 25%Cauchy(0, 1) (Error4). The log censoring times are generated
from uniform distribution. The average censoring rate is about 30%. We choose the tun-
ing parameters based upon the prediction performance of the corresponding model in an
independently simulated validation dataset.
For comparison, besides the developed robust network-constrained approach (LAD Network),
we also consider two robust approaches, robust MCP (LAD MCP) and robust LASSO
(LAD LASSO), as well as three non-robust approaches, Network (Huang et al. (2011)),
MCP and LASSO. All the robust methods adopt the weighted LAD loss function, while
non-robust methods adopt the weighted least square loss. In particular, robust MCP is
equivalent to the proposed approach when λ2 = 0 in (2.3). Similarly, Network reduces to
MCP when the tuning parameter corresponding to the Laplacian term is 0. Comparison
between robust and non-robust methods has fully demonstrated the advantage of not only
robustness in accommodating data contamination in survival response, but also the net-
work based penalty from LAD Network in accommodating interconnections among genetic
measurements. Simulation results for the gene expression data under AR structure are tab-
ulated in Table 2.2. We can observe that from the upper panel of Table 2.2 where ρ = 0.5,
LAD Network has better performance than LAD MCP and LAD LASSO for all four error
types. For example, under Error2, LAD Network identifies 31.63(sd 13.55) out of the 50
true positives, with a relatively small number of false positives 14.93(sd 9.85). LAD MCP
identifies a lower number of true positives 23.1(sd 9.64) with a higher number of false pos-
itives 56.17(sd 81.31). LAD LASSO has a true positives 30.33(sd 6.57), but a much higher
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Table 2.2: Simulation for gene expression data (n, p) = (300, 505). 50 genes have nonzero
regression coefficients. 5 clinical covariates are not subject to selection. The gene expressions
have AR structure with ρ = 0.5 (upper panel) and ρ = 0.8 (lower panel). mean(sd) of true
positives (TP) and false positives (FP) based on 100 replicates.
LAD Network LAD MCP LAD LASSO Network MCP LASSO
AR ρ = 0.5
Error1 TP 44.90(5.65) 40.67(4.59) 38.90(5.19) 40.07(4.70) 28.53(3.92) 48.27(1.20)
FP 9.77(7.59) 8.63(8.16) 121.93(36.26) 8.13(5.37) 7.67(3.96) 75.57(10.64)
Error2 TP 31.63(13.55) 23.10(9.64) 30.33(6.57) 1.57(2.84) 1.50(2.76) 4.07(6.35)
FP 14.93(9.85) 56.17(81.31) 103.17(49.89) 3.37(7.73) 3.27(7.94) 11.40(19.09)
Error3 TP 43.68( 7.64) 36.28( 5.79) 34.88( 7.74) 20.03(12.84) 15.42(9.45) 31.83(16.71)
FP 16.05(29.77) 12.64(20.27) 114.35(57.49) 9.81( 6.57) 7.97(5.47) 60.73(33.39)
Error4 TP 39.03(10.15) 31.57(4.70) 34.10(6.26) 11.83(10.91) 9.73(8.51) 20.57(16.26)
FP 14.33(11.20) 13.50(19.47) 109.87(40.55) 8.93(8.02) 7.67(7.77) 38.83(30.69)
AR ρ = 0.8
Error1 TP 46.93(5.77) 41.00(6.36) 43.70(4.94) 49.60(0.62) 23.93(2.97) 48.27(1.14)
FP 5.27(6.35) 2.43(2.58) 94.20(38.45) 12.00(8.39) 7.70(5.38) 61.67(15.77)
Error2 TP 43.80(12.34) 23.93(5.46) 38.57(5.9) 10.97(15.16) 4.77(7.68) 9.47(10.68)
FP 15.07(13.55) 14.20(22.23) 101.42(41.99) 18.50(33.77) 16.07(64.74) 21.82(25.00)
Error3 TP 47.23(7.11) 37.07(5.93) 43.90(4.37) 33.33(20.10) 15.47(10.68) 30.60(18.05)
FP 4.53(5.06) 11.87(35.83) 91.37(24.94) 27.93(40.69) 19.07(66.48) 49.33(27.36)
Error4 TP 44.37(10.23) 32.30(5.03) 44.30(3.28) 32.57(19.21) 13.63(8.72) 28.27(14.97)
FP 10.17(9.43) 6.03(8.22) 105.00(32.13) 26.90(20.39) 10.73(6.20) 47.60(26.05)
false positives 103.17(sd 49.89). Compared with non-robust methods, the proposed method
has significant advantage when heterogeneity exists in the data (Error2, Error3 and Error4).
When there is no heterogeneity (Error1), performance of the proposed method is comparable
to that of the non-robust Network method and outperforms MCP and LASSO.
As correlation increases, the proposed one outperform other alternatives more signifi-
cantly. As what we can observe from the lower panel of Table 2.2 where ρ = 0.8 under AR
structure, LAD Network achieves ideal true positives and satisfactory false positives. For
example, LAD Network has a TP 43.8(sd 12.34) and a FP 15.07(sd 13.55) for Error 2 and a
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TP 47.23(sd 7.11) and a FP 4.53(sd 5.05) for Error 3, outperforming all other alternatives.
To further examine the performance of the proposed approach, we also conduct simulation
under banded structures. Results are summarized in Table A.1 in the Appendix A. The pro-
posed LAD Network delivers a consistent performance under different covariance structures:
it outperforms robust alternatives when moderate to strong correlation exists among genetic
variants, and it has significant advantage over non-robust methods when heterogeneity exists
in the data.
In the second set of simulation, we consider more realistic correlation structures. Specif-
ically, We generate gene expression datasets based on correlation structure extracted from
real data in cancer studies. 500 genes are selected from Non-small cell lung cancer (NSCLC)
data and Lung squamous cell carcinoma (LUSC) data, respectively. Two gene expression
datasets, each with 300 subjects, are simulated with a multivariate normal distribution with
marginal means zero and correlation matrix computed from genes selected from NSCLC
data and LUSC data, respectively. 10% of genes are assigned to have nonzero regression
coefficients generated from Unif[0.2, 0.8]. The 500 genes from real data are selected in a
way that they form group-wise correlation structure. Unlike the first set of simulation where
there are 5 genes per cluster, the clusters in this setting form more closely to real data based
upon the calculated correlation coefficient. Results are shown in Table A.2 and A.3 in the
Appendix A. In Table A.2, under Error 3, LAD Network has the highest TP, 43.00(6.79),
and the lowest FP, 3.14(3.91), among all the six approaches. The superior performance has
also been observed under other heavy-tailed distributions. With standard normal error (Er-
ror 1), LAD Network is comparable with the non-robust Network method, and outperforms
the other two non-robust methods. Similar patterns have also been observed from Table
A.3. The conclusions from the simulations based on real gene expression data are consistent
with the ones we have from the first setting.
In the third set of simulation, we examine whether the proposed one demonstrates supe-
rior performance over the alternatives on simulated single-nucleotide polymorphism (SNP)
data. We consider two schemes to simulate SNP data. With the first SNP generating
scheme, the SNP data are simulated by dichotomizing expression values of each gene at
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the 1st and 3rd quartiles, with the 3–level (2,1,0) for genotypes (AA,Aa,aa) respectively,
where the gene expresison values are generated under the first set of simulation. Results
are given in Table A.4 and A.5 under AR structure and banded structure respectively in
the Appendix A. Under the second approach, the SNP genotype data are simulated based
on a pairwise linkage disequilibrium (LD) structure. Let q1 and q2 be the minor allele fre-
quencies (MAFs) of two alleles A and B for two adjacent SNPs. We denote LD as δ, and
the frequencies of four haplotypes are calculated as pAB = q1q2 + δ, pAb = q1(1 − q2) − δ,
paB = (1−q1)q2−δ, and pab = (1−q1)(1−q2)+δ. Under Hardy-Weinberg equilibrium, SNP
genotype (AA, Aa, aa) at locus 1 can be generated from a multinomial distribution with
frequencies (q21, 2q1(1− q1), (1− q1)2). Based on the conditional genotype probability matrix
( Cui et al. (2008)), we can simulate the genotypes for locus 2. With MAFs 0.3 and pairwise
correlation r = 0.6, we have δ = r
√
q1(1− q1)q2(1− q2). The simulation results based on LD
structure are given in Table A.6 in the Appendix A. Under both SNP generating schemes,
the patterns are similar as those observed from the gene expression data.
2.4 Real Data Analysis
We analyze lung cancer data with gene expression measurements from two studies, separately.
The first dataset is from the study of Xie et al. (2011), and the second one is the Lung
squamous cell carcinoma (LUSC) data from TCGA (https://cancergenome.nih.gov/).
2.4.1 Non-small cell lung cancer (NSCLC) data
In the USA, lung cancer is the most common cause of cancer death. About 80% to 85% of
lung cancers are non-small cell lung cancer (NSCLC). To identify genetic markers associated
with the prognosis of NSCLC, gene profiling studies have been extensively conducted. As
individual studies usually have small sample sizes, we follow the study of Xie et al. (2011)
and collect data from four independent studies with gene expression measurements. After
matching clinical variables and gene expression data, we have total 348 subjects and 22,283
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gene expressions. Among the 348 subjects, 180 died during follow up, with survival times
ranging from 0.03 to 204 months (median 26.19 months). To reduce the computational cost,
we rank the probes by their variations and select the top 700 for downstream analysis. We
include five clinical covariates, age, gender, smoking history, tumor stage and chemotherapy.
Age is a normalized continuous variable, and dummy variables are created for categorical
variables: smoking history, tumor stage and chemotherapy.
We apply all the methods to the lung cancer dataset. First, we conduct the logrank test
to evaluate the prediction performance after splitting the patient group into training and
testing sets. By dichotomizing the patients according to the median risk scores from the
testing set, two risk groups can be created. Larger log rank test statistic indicates more sig-
nificant survival difference between the low-risk and high-risk groups, thus better prediction
performance. The log-rank statistics are 206.5 (LAD Network), 130.7 (LAD MCP), 132.7
(LAD LASSO), 77.0 (Network), 11.1 (MCP) and 133.0 (LASSO), respectively. The proposed
method has the best predictive performance, as indicated by the log-rank test statistic.
As a representative example, we examine the sub-network of gene PCLAF, PCNA Clamp
Associated Factor. PCLAF is identified by five methods (all methods except MCP) as one
of the most important genes. PCLAF encodes a PCNA-binding protein and is a regulator
of DNA repair during DNA replication. It has been found to be overexpressed in various
tumors, including lung tumor tissues (Hosokawa et al. (2007); Kato et al. (2012b); Yu et al.
(2001)). Figure 2.2 shows the sub-network of PCLAF, where the red nodes indicate the
probe of PCLAF. Thickness of the edges denotes the strength of correlation between genes.
Comparing different methods, it can be clearly observed that the proposed approach has
identified much more highly correlated prognostic genes, since the interconnections among
genes have been accommodated by the approach that incorporates the network structure
information. Eight genes are directly connected to PCLAF in the sub-network identified by
the proposed approach. They are TOP2A, ASPM, SELENBP1, MAD2L1, CDC20, PRC1,
TYMS and DLGAP5. All of them are positively correlated to PCLAF, except SELENBP1.
PRC1 (Protein regulator of Cytokinesis 1) has the highest correlation with PCLAF (r=0.83).
It is interesting that PCLAF and PRC1 are located closely on Chromosome 15. Similar as
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Figure 2.2: Sub-network for PCLAF.
PCLAF, PRC1 is overexpressed in lung cancer cells. Higher level of PRC1 is found to
be associated with poor survival of lung cancer patients (Hanselmann et al. (2017); Zhan
et al. (2017)).However, none of the alternative methods capture this important prognostic
marker in the PCLAF network. In addition, TOP2A (DNA Topoisomerase II Alpha) (Hou
et al. (2017); Huang et al. (2015)), CDC20 (Cell Division Cycle 20) (Kato et al. (2012a);
Wang et al. (2013c)), DLGAP5 (DLG Associated Protein 5) (Schneider et al. (2017); Shi
et al. (2017)) and MAD2L1 (MAD2 mitotic arrest deficient-like 1) (Shi et al. (2016)) have
been identified as negative prognostic markers in NSCLC by recent studies. Studies report
that the over-expression of TYMS (thymidylate synthase) (Chamizo et al. (2015); Wang
et al. (2013a)) and ASPM (Kuo et al. (2015)) are related to drug-resistance in advanced
NSCLC. Among the genes, SELENBP1 (selenium-binding protein 1) is negatively correlated
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with PCLAF and other genes in the network. Selenium-binding proteins are known to play
important roles in cancer prevention effects of selenium. Down-regulation of SELENBP1 is
associated with poor prognosis in NSCLC patients (Tan et al. (2016); Zeng et al. (2013)).
Overall, the proposed approach identifies more informative prognostic markers.
We also examine the biological similarity of the identified genes by the Gene Ontology
(GO) analysis. An obvious difference between the proposed method and the alternatives is
observed. The GO analysis results are provided in Figure A.1 in the Appendix.
2.4.2 Lung squamous cell carcinoma (LUSC) data
Lung squamous cell carcinoma (LUSC) is one of the most common types of NSCLC. It
comprises 25–30% of all lung cancer cases (Zappa and Mousa (2016)). LUSC is more strongly
correlated with cigarette smoking history than most other subtypes of NSCLC (Kenfield et al.
(2008)). We analyze TCGA (The Cancer Genome Atlas) data on the prognosis of LUSC
(The Cancer Genome Atlas Research Network (2012)). We consider four clinical covariates:
age at diagnosis, gender, smoking history and tumor stage. The total number of genes is
20,499 and the sample size is 461. 203 died during follow-up among all the subjects. The
survival times range from 0.03 to 173.69 months, with a median of 17.84 months. Similar as
the NSCLC study, we select the top 700 genes for further analysis.
We applied the six methods to the working dataset. The log-rank statistics are 155.0
(LAD Network), 116.9 (LAD MCP), 102.8 (LAD LASSO), 76.4 (Network), 40.6 (MCP) and
96.1 (LASSO), respectively. The proposed method has the largest log-rank statistic and thus
superior prediction performance.
We use the sub-network of gene IRS4 (Insulin receptor substrate 4) as a representative
example. IRS4 is identified by five methods (all expect Network) as a prognostic gene. IRS4
plays a tumor-promoting role in NSCLC (Hoxhaj et al. (2013); Weischenfeldt et al. (2017)).
The proposed method identifies 13 genes in the sub-network of IRS4 (Figure 2.3). Ten genes
are uniquely identified by the proposed method, and the rest three (PSMD10, CMTX5 and
LOC158602) are also identified by other methods. Both PSMD10 (Proteasome 26S Subunit,
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Figure 2.3: Sub-network for IRS4.
Non-ATPase 10) and CMTX5 (also known as PRPS1, phosphoribosyl pyrophosphate syn-
thetase 1) are positively correlated with IRS4 and have been reported as oncogenes (He et al.
(2017); Luo et al. (2016)). Among the 13 genes in IRS sub-network, three of them (PSMD10,
CMTX5, PHEX) are located on chromosome X, the same as IRS4. LOC158602 is a gene
with unknown function, but highly correlated with both PSMD10 and CMTX5. DRG1 (De-
velopmentally regulated GTP binding protein 1) is only identified by the proposed method.
DRG1 plays important roles in regulating cell growth. Overexpression of DRG1 leads to
chromosome missegregation and promotes tumor progression in NSCLC (Lu et al. (2016)).
GSR (glutathione reductase) is one of enzymes in the glutathione (GSH) metabolism sys-
tem, which is a major redox regulatory systems in mammals that support increased tumor
growth (Tobe et al. (2015)). It has been reported that GSH levels in cells, regulated by
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GSH-synthesising enzymes such as GSR, is associated with resistance to epidermal growth
factor receptor (EGFR) inhibitors in NSCLC (Li et al. (2016)). In this network, GSR has
a strong correlation with RIT1 (Ras Like Without CAAX 1) (r=0.69). RIT1 encodes a
RAS-family small GTPase. It has been reported as an oncogene. Mutations in RIT1 may
also induce resistance to EGFR inhibition, but in a MEK-dependent manner (Berger et al.
(2014)).
To further investigate the biological similarity of the identified genes, the GO analysis
is conducted for the LUSC data. The results are provided in Figure A.1, which suggests
moderate similarity.
2.5 Discussion
In cancer genomics studies, much effort has been devoted to developing variable selection
methods to identify important genomics features associated with survival outcomes (Tib-
shirani (1997); Huang and Ma (2010); Sha et al. (2006)). In recent decades, it has been
recognized that network (or graph) based regularization methods are particularly effective
in accommodating the correlation among genomic variants in a number of studies, neverthe-
less, their development and application in cancer survival studies are quite limited. Besides,
although the lack of robustness might lead to biased estimation and false identification of
sparse network structures, robust network–based variable selection has not received much
attention in cancer prognosis studies. Motivated by the limitations of existing studies and
analysis of the cancer genetic data, we have proposed a robust network constrained regular-
ization and variable selection method to accommodate correlations among gene expressions
in the search of important prognostic markers. The proposed method outperforms alterna-
tives, both robust and non-robust, under a diversity of simulation setups. In the analysis
of cancer prognosis data with high-dimensional gene expression measurements, it leads to
biologically sensible findings and improved prediction.
Our method significantly distinguishes from and complements existing ones in the fol-
lowing aspects. We adopt a weighted LAD objective function to accommodate data con-
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tamination, with Kaplan-Meier weights for censoring. To incorporate the interconnections
among gene expressions, we propose a network-constrained penalty of the “MCP+L1” form,
and develop an efficient algorithm within the coordinate descent framework. The MM step
is critical for the formulation of the convex surrogate objective function, which naturally
leads to a weighted median regression problem. The effectiveness of smoothing the non-
convex penalty function has been demonstrated in Peng and Wang (2015) and studies alike.
To achieve high computational efficiency, we adopt AFT model for cancer prognosis in this
study. Cox proportional hazard model can also be used in cancer genomic studies (Huang
and Liang (2018, 2019)), but has higher computational cost than AFT model in general.
Here we describe the correlation among genomic variants through network structures. We
acknowledge that, first, different network structures can be constructed (Huang et al. (2011))
and, second, there exists a variety of ways to incorporate correlations in penalized estimation
and identification, not necessarily through network based penalty functions. For example,
the spatial correlation among CNVs can be taken into account by using the adaptive fused
LASSO penalty (Gao and Huang (2010a)). Also, in addition to the data-driven approach,
network structures can be constructed based on prior biological knowledge (Jiang et al.
(2017); Li and Li (2008); Min et al. (2018); Sun and Wang (2012)). Comparisons to other
network structures and structures other than networks are not the focus of this project, thus
not pursued. We also acknowledge that Bayesian methods can be robust depending on the
prior distribution assumptions. For example, Sha et al. (2006) consider AFT models with the
t prior distribution. Note that the robustness of our proposed method is not only restricted
to certain type of heavy–tailed distribution or data contamination, and Sha et al. (2006) will
not lead to networks among genomic variants. Moreover, comparisons between frequentist
and Bayesian methods is beyond of the scope of this project, and will be postponed to the
future.
The proposed algorithm for LAD Network under survival response is essentially a first or-
der method. The first order method, such as gradient descent and proximal gradient descent,
can enjoy a linear convergence rate when the objective function has strong convexity (Boyd
and Vandenberghe (2004)). The LAD Network loss function is, however, not differentiable
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and not strongly convex, which poses challenge on establishing the rate of convergence. We
conjecture that the rate of convergence of LAD Network can be shown by following that
of the subgradient method (Bertsekas (2010)). It is also worth noting that Wu and Lange
(2008) has given a detailed discussion of LASSO in LAD regression, although the rate of
convergence has not been provided. The iteration cost of our algorithm is not cheap, due to
the MM step and the sorting step for solving weighted median regression. From a practical
point of view, the fast convergence of our algorithm is guaranteed by the C++ core module
of R package regnet. In addition, Gao and Huang (2010b) has investigated estimation and
selection consistency of LAD LASSO, which is important for developing consistency prop-
erties of LAD Network case. In this project, we focused on the development of statistical
methodology. Investigations on the theoretical properties will be conducted in future studies.
Regularized objective function of robust penalization methods share a common structure
of “robust objective function + penalty function” (Wu and Ma (2015)). The computational
advantage of the proposed method roots in the L1 form of the objective function. It is
conjectured that the robustness can be achieved by coupling the penalty function with other
robust loss functions, such as the exponential squared loss (Wang et al. (2013b)) and rank
based loss (Wu et al. (2015)). However, since additional tunings and smoothing are demanded
for these loss functions, the computational expenses are even high under low dimensional
settings.
In this study, we focus on prognostic outcomes. Extension of our method to continuous
disease phenotypes can be made readily by changing Kaplan-Meier weights to equal weights.
In addition, the proposed method is not limited to the analysis of gene expression measure-
ment. The network structure has been widely adopted to describe correlations among other
genomics features, such as SNPs (Ren et al. (2017)), CNVs (Peng et al. (2012)) and DNA
methylations (Sun and Wang (2012)), where robust network based penalization is also of
great interest.
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Chapter 3
Semi-parametric Bayesian variable
selection for gene-environment
interactions
3.1 Introduction
It has been widely recognized that the genetic and environmental main effects alone are
not sufficient to decipher an overall picture of the genetic basis of complex diseases. The
Gene-Environment (G×E) interactions also play vital roles in dissecting and understanding
complex diseases beyond the main effects (Hunter (2005); Hutter et al. (2013)). Significant
amount of efforts have been made to conducting analysis for the investigation of the asso-
ciations between disease phenotypes and interaction effects marginally, especially in GWAS
(Mukherjee et al. (2011)). As the disease etiology and prognosis are generally attributable
to the coordinated effects of multiple genetic and environment factors, as well as the G×E
interactions, joint analysis has provided a powerful alternative to dissect G×E interactions.
From the statistical modeling perspective, the interactions can be described as the prod-
uct of variables corresponding to genetic and environmental factors. With the main G and E
effects, as well as their interactions, the contribution of genetic variants to disease phenotype
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Figure 3.1: Non-linear G×E effect of SNP rs1106380 from the Nurses’ Health Study (NHS)
data. The blue dashed lines represent the 95% credible region.
can be expressed as a linear function of the environmental factor. Such a linear interaction
assumption does not necessarily hold true in practice. Taking the Nurses’ Health Study
(NHS) data analyzed in this article as an example, we are interested in examining how the
SNP effects on weight are mediated by age as the environmental factor. The range of sub-
jects’ age in the NHS data is from 41 to 68. As reported, for type 2 diabetes, the average
age for the onset is 45 years (Centers for Disease Control and Prevention (2020)). Therefore,
the presence of rs1106380×age interaction is roughly within such a range. We fit a Bayesian
marginal model to SNP rs1106380 by using a non-parametric method to model the G×E
interaction while accounting for effects from clinical covariates. A 95% credible region has
also been provided. Figure 3.1 clearly suggests that the linear interaction assumption is vio-
lated. Mis–specifying the form of interactions will lead to biased identification of important
effects and inferior prediction performance.
The non-linear G×E interactions have been first conducted in marginal analysis, including
Ma et al. (2011) and Wu and Cui (2013a). Motivated by the set based association analysis,
the modeling strategy has been adopted to investigate how genetic variants in a set, such as
the gene set, pathways or networks, are mediated by one or multiple types of environmental
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exposures to influence disease risk. The set–based modeling incorporating the nonlinear
G×E interactions is essentially a joint analysis with high-dimensional covariates. Recently,
penalized variable selection methods have emerged as a promising tool to capture G×E
interactions that might be only weak or moderate individually, but that are strong collectively
(Du et al. (2020); Wu et al. (2013, 2014, 2015, 2018c); Zhou et al. (2020b)).
Penalization methods have been first coined in Tibshirani (1996), which has also pointed
out the connection between penalization and the corresponding Bayesian variable selection
methods. In particular, the LASSO estimate can be interpreted as the posterior mode
estimate when identical and independent Laplace prior has been imposed on each component
of the coefficient vector under penalized least square loss. Park and Casella (2008) has
further refined the prior as a conditional Laplace prior within the fully Bayesian framework
to guarantee the unimodality of the posterior distribution. As LASSO belongs to the family
of penalized estimate induced by the `q norm penalty with q=1, the Bayesian counterpart of
penalization methods have been generalized to accommodate more complex data structure
with other penalty functions, such as elastic net, fused LASSO and group LASSO. These
extensions can also be formulated within the Bayesian framework with a similar rationale of
specifying priors (Kyung et al. (2010)).
As penalization is tightly connected to Bayesian methods, the development of novel
Bayesian variable selection will significantly broaden the scope of variable selection methods
for G×E interaction studies, which will provide us fresh perspectives and promising results
not offered by the existing studies. However, our limited literature review indicates that
Bayesian variable selection has not been thoroughly conducted in existing G×E studies, es-
pecially for nonlinear interactions. For example, Liu et al. (2015) has developed a Bayesian
mixture model to identify important G×E and G×G interaction effects through indicator
model selection. Variable selection has been achieved by examining the posterior inclusion
probability. However, this study cannot handle nonlinear interactions. More pertinent to
the penalization, Li et al. (2015) has developed a Bayesian group LASSO for non-parametric
varying coefficient models, where the non-linear interaction is expressed as a linear combi-
nations of Legendre polynomials, and the identification of G×E interactions amounts to the
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shrinkage selection of polynomials on the group level using multivariate Laplace priors. Li
et al. (2015) has been built upon the Laplace prior adopted in Bayesian LASSO, therefore
the coefficients cannot be shrunken to zero exactly in order to achieve the ”real” sparsity,
Accounting for nonlinear effects in G×E studies has deeply rooted in structured variable
selection for high dimensional data (Zhang et al. (2011)). An efficient selection procedure
is expected to not only accurately pinpoint the form of nonlinear interactions, but also
avoid modeling the main-effect-only case (corresponding to the non-zero constant effects) as
nonparametric ones, since this type of misspecification may over–fit the data and result in
loss of efficiency. To the best of our knowledge, automatic structure identification involv-
ing nonlinear effects has not been conducted in Bayesian G×E studies. To overcome the
aforementioned limitations, we develop a novel semi-parametric Bayesian variable selection
method for G×E interactions. We consider both linear and nonlinear interactions simulta-
neously. The interactions between a genetic factor and a discrete environmental factor are
modeled parametrically, while the nonlinear interactions are modeled using varying coeffi-
cient functions. In particular, we conduct automatic structure identification via Bayesian
regularization to separate the cases of G×E interactions, main-effect-only and no genetic ef-
fects at all, which more flexibly captures the main and interaction effects. Besides, to shrink
the coefficients of unimportant linear and nonlinear effects to zero exactly, we adopt the
spike-and-slab priors in our model. The spike-and-slab priors have recently been shown as
effective when being incorporated in Bayesian hierarchical framework for penalization meth-
ods, including the spike–and–slab LASSO (Roc˘kova´ and George (2018); Tang et al. (2017)),
Bayesian fused LASSO (Zhang et al. (2014a)) and Bayesian sparse group LASSO (Xu and
Ghosh (2015)). It leads to sparsity in the sense of exact 0 posterior estimates which are not
available in Bayesian LASSO type of Bayesian shrinkage methods including Li et al. (2015).
Motivated by the pressing need to conduct efficient Bayesian G×E interaction studies
accounting for the nonlinear interaction effects, the proposed semi-parametric model sig-
nificantly advances from existing Bayesian variable selection methods for G×E interactions
in the following aspects. First, compared to studies that solely focus on linear (Liu et al.
(2015)) or non-linear effects (Li et al. (2015)), the proposed one can accommodate both
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types of effects concurrently, thus more comprehensively describe the overall genetic archi-
tecture of complex diseases. Second, to the best of our knowledge, for G×E interactions,
automatic structure discovery has been considered in the Bayesian framework for the first
time. Compared to Li et al. (2015), one of the very few (or perhaps the only) literature
in Bayesian variable selection for non-linear effects, our method is more fine tuned for the
structured sparsity by distinguishing whether the genetic variants have nonlinear interac-
tion, main effects only and no genetic effects at all, with the forms of coefficient functions
being varying, non-zero constant and zero respectively. Third, borrowing strength from the
spike–and–slab priors, we efficiently perform Bayesian shrinkage on the individual and group
level simultaneously. In particular, with B–spline basis expansion, the identification of non-
linear interaction is equivalent to the selection of a group of basis functions. We develop
an efficient MCMC algorithm for semi–parametric Bayesian hierarchical model. We show in
both simulations and a case study that the exact sparsity significantly improves accuracy in
identification of relevant main and interaction effects, as well as prediction. For fast com-
putation and reproducible research, we implement the proposed and alternative methods in
C++ and encapsulate them in a publicly available R package spinBayes (Ren et al. (2019c)).
The rest of the article is organized as follows. In Section 3.2, we formulate the semi-
parametric Bayesian variable selection model and derive a Gibbs sampler to compute the
posterior estimates of the coefficients. We carry out the simulation studies to demonstrate
the utility of our method in Section 3.3. A case study of Nurses’ Health Study (NHS) data
is conducted in Section 3.4.
3.2 Data and Model Settings
3.2.1 Partially linear varying coefficient model
We denote the ith subject using subscript i. Let (Xi, Yi, Zi, Ei,Wi), i = 1, . . . , n be inde-
pendent and identically distributed random vectors. Yi is the response variable. Xi is the
p-dimensional design vector of genetic factors, and Zi and Ei are the continuous and dis-
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crete environment factors, respectively. The clinical covariates are denoted by q-dimensional
vector Wi. In the NHS data, the response variable is weight, and Xi represents SNPs. We
consider age and the indicator of history of hypertension for Zi and Ei, correspondingly.
Height and total physical activity are used as clinical covariates, so q is 2. Now consider the
following partially linear varying coefficient model
Yi = β0(Zi) +
p∑
j=1
βj(Zi)Xij +
q∑
t=1
αtWit + ζ0Ei +
p∑
j=1
ζjEiXij + i (3.1)
where βj(·) is a smoothing varying coefficient function, αt is the coefficient of the tth clin-
ical covariates, ζ0 is the coefficient of the discrete E factor, and ζj is the coefficient of the
interaction between the jth G factor Xj = (X1j, . . . , Xnj)
> and Ei. The random error
i ∼ N(0, σ2).
Here only two environmental factors, Zi and Ei, are considered for the simplicity of
notation. Their interactions with the G factor are modeled as non–linear and linear forms,
respectively. The model can be readily extended to accommodate multiple E factors.
3.2.2 Basis expansion for structure identification
As we discussed, distinguishing the case of main-effect-only from nonlinear G×E interac-
tion is necessary since mis-specification of the effects cause over-fitting. The following basis
expansion is necessary for the separation of different types of effects. We approximate the
varying coefficient function βj(Zi) via basis expansion. Let qn be the number of basis func-
tions
βj(Zi) ≈
qn∑
k=1
B˜jk(Zi)γ˜jk = B˜j(Zi)
>γ˜j
where B˜j(Zi) = (B˜j1(Zi), . . . , B˜jqn(Zi))
> is a set of normalized B spline basis, and γ˜j =
(γ˜j1, . . . , γ˜jqn)
> is the coefficient vector. By changing of basis, the aforementioned basis
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expansion is equivalent to
βj(·) ≈
qn∑
k=1
B˜jk(·)γ˜jk .= γj1 + B˜j∗(·)>γj∗
where B˜j∗(Zi) = (B˜j2(Zi), . . . , B˜jqn(Zi))
>. γj1 and γj∗ = (γj2, . . . , γjqn)
> correspond to the
constant and varying components of βj(·), respectively. The intercept function can be ap-
proximated similarly as β0(·) ≈
∑qn
k=1 B˜0k(·)η˜k .= η1 + B˜0∗(·)>η∗. Define γj = (γj1, (γj∗)>)>,
η = (η1, (η∗)>)>, Bj(Zi) = (1, (B˜j∗(Zi))>)>
.
= (Bj1(Zi), . . . , Bjqn(Zi))
> and B0(Zi) =
(1, (B˜0∗(Zi))>)>. Collectively, model (3.1) can be rewritten as
Yi = B0(Zi)
>η +
p∑
j=1
Bj(Zi)
>γjXij +
q∑
t=1
αtWit + ζ0Ei +
p∑
j=1
ζjEiXij + i
= B0(Zi)
>η +
p∑
j=1
(Xijγj1 + U
>
ij γj∗) +W
>
i α + E
>
i ζ0 + T
>
i ζ + i
where Uij = (Bj2(Zi)Xij, . . . , Bjqn(Zi)Xij)
>, α = (α1, . . . , αq)>, Ti = (Xi1Ei, . . . , XipEi)>,
and ζ = (ζ1, . . . , ζp)
>. Note that basis functions have been widely adopted for modeling
the functional type of coefficient in general semi-parametric models, as well as functional
regression analysis (Huang et al. (2002, 2004); Zhu et al. (2010)). For a comprehensive
review of literature in this area, please refer to Morris (Morris et al. (2007)).
3.2.3 Semi-parametric Bayesian variable selection
The proposed semi-parametric model is of “large p, small n” nature. First, not all the
main and interaction effects are associated with the phenotype. Second, we need to further
determine for the genetic variants, whether they have nonlinear interactions, or main effect
merely, or no genetic contribution to the phenotype at all. Therefore, variable selection is
demanded.
From the Bayesian perspective, variable selection falls into the following four categories:
(1) indicator model selection, (2) stochastic search variable selection, (3) adaptive shrinkage
and (4) model space method (O’Hara and Sillanpa¨a¨ (2009)). Among them, adaptive shrink-
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age methods solicit priors based on penalized loss function, which leads to sparsity in the
Bayesian shrinkage estimates. For example, within the Bayesian framework, LASSO and
group LASSO estimates can be understood as the posterior mode estimates when univariate
and multivariate independent and identical Laplace priors are placed on the individual and
group level of regression coefficients, respectively (Li et al. (2015); Park and Casella (2008)).
The proposed one belongs to the family of adaptive shrinkage Bayesian variable selection.
For convenience of notation, we first define the approximated least square loss function as
follows:
L˜(η, γ, α, ζ0, ζ) = ‖Y −B0η −
p∑
j=1
Xjγj1 −
p∑
j=1
Ujγj∗ −Wα− Eζ0 − Tζ‖2
where Y = (Y1, . . . , Yn)
>, B0 = (B0(Z1), . . . , B0(Zn))>, Uj = (U1j, . . . , Unj)>, W = (W1, . . . ,Wn)>
and T = (T1, . . . , Tn)
>. Let θ = (η>, γ>, α>, ζ0, ζ>)> be the vector of all the parameters.
Then the corresponding penalized loss function is
L˜(η, γ, α, ζ0, ζ) + λe
p∑
j=1
|ζj|+ λc
p∑
j=1
|γj1|+ λv
p∑
j=1
‖γj∗‖2 (3.2)
The formulation of (3.2) has been primarily driven by the need to accommodate linear
and nonlinear G×E interaction while avoiding mis-specification of the main-effect-only as
nonlinear interactions. Here γj1 is the coefficient for the main effect of the jth genetic factor
Xj, and the `2 norm of the spline coefficients ‖γj∗‖2 is corresponding to the varying parts of
βj(·). If ‖γj∗‖2 = 0, then there is no nonlinear interaction between Xj and continuous envi-
ronment factor Z. Furthermore, if γj1 = 0, then Xj has no main effect and is not associated
with the phenotype. Similarly, the linear interaction between Xj and the discrete environ-
ment factor E is determined by ζj. ζj=0 indicates that there is no linear interaction. Overall,
the penalty functions in (3.2) provide us the flexibility to achieve identification of structured
sparsity through variable selection. Note that the main effects of environmental exposures
Z and E are of low dimensionality, thus they are not subject to selection. Therefore, for the
current G×E interaction study, we are particular interested in conducting Bayesian variable
40
selection on both the individual level of γj1 and ζj (j = 1, . . . , p), and the group level of
γj∗ (j = 1, . . . , p).
Laplacian shrinkage on individual level effects. Following the fully Bayesian analy-
sis for LASSO proposed in Park and Casella (2008), we impose the individual-level shrinkage
on genetic main effects and linear G×E interactions by adopting i.i.d. conditional Laplace
prior on γj1 and ζj (j = 1, . . . , p)
pi(γ11, . . . , γp1|σ2) =
p∏
j=1
λc
2σ
exp
{
− λc
σ
|γj1|
}
pi(ζ1, . . . , ζp|σ2) =
p∏
j=1
λe
2σ
exp
{
− λe
σ
|ζj|
} (3.3)
The above Laplace priors can be expressed as scale mixture of normals (Andrews and Mallows
(1974))
pi(γj1|τ 2cj, σ2) ind∼ N(0, σ2τ 2cj)
τ 2cj
ind∼
λ2c
2
exp
{
− λ
2
c
2
τ 2cj
}
pi(ζj|τ 2ej, σ2) ind∼ N(0, σ2τ 2ej)
τ 2ej
ind∼
λ2e
2
exp
{
− λ
2
e
2
τ 2ej
}
(3.4)
It is easy to show that, after integrating out τ 2cj and τ
2
ej, (3.4) leads to the same priors in
(3.3).
Laplacian shrinkage on group level effects. Kyung et al. (2010) extended the
Bayesian LASSO to a more general form that can represent the group LASSO by adopting
a multivariate Laplace prior. We follow the strategy and let the prior for γj∗ (j = 1, . . . , p)
be
pi(γj∗|σ2) ∝ exp
{
−
√
Lλv
σ
‖γj∗‖2
}
(3.5)
where L = qn−1 is the size of the group, (
√
Lλv
σ
)−1 is the scale parameter of the multivariate
Laplace and
√
L terms adjusts the penalty for the group size.
√
L can be dropped from the
formula when all the groups have the same size. In this study, we use the same number of
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basis functions for all parameters, and thus L is the same for all groups. For completeness,
we still include
√
L in (3.5) for possible extension to varying group sizes in the future. Similar
to the (3.4), this prior can be expressed as a gamma mixture of normals
pi(γj∗|τ 2vj, σ2) ind∼ NL(0, σ2τ 2vjIL)
τ 2vj
ind∼ Gamma
(L+ 1
2
,
Lλ2v
2
) (3.6)
where L+1
2
is the shape parameter and Lλ
2
2
is the rate parameter of the Gamma distribution.
After integrating out τ 2vj in (3.6), the conditional prior on γj∗ has the desired form in (3.5).
Priors in (3.4) and (3.6) can lead to a similar performance as the general LASSO model
in (3.2), by imposing individual shrinkage on γj1 and ζj and group level shrinkage on γj∗,
respectively.
Spike-and-slab priors on both individual and group level effects. Compared
with (3.2), priors in (3.4) and (3.6) cannot shrink the posterior estimates to exact 0. Li et al.
(2015) has such a limitation since multivariate Laplace priors have been imposed on the
group level effects. One of the significant advancements of our study over existing Bayesian
G×E interaction studies, including Li et al. (2015), is the incorporation of spike–and–slab
priors to achieve sparsity. For γj∗, we have
γj∗|φvj, τ 2vj, σ2 ind∼ φvjNL(0, diag(σ2τ 2vj, . . . , σ2τ 2vj)) + (1− φvj)δ0(γj∗)
φvj|piv ind∼ Bernoulli(piv)
τ 2vj|λv ind∼ Gamma(
L+ 1
2
,
Lλ2v
2
)
(3.7)
where δ0(γj∗) denotes a point mass at 0L×1 and piv ∈ [0, 1]. We introduce a latent binary
indicator variable φvj for each group j, (j = 1, . . . , p). φvj facilitates the variable selection
by indicating whether or not the jth group is included in the final model. Specifically, when
φvj = 0, the coefficient vector γj∗ has a point mass density at zero which implies all predictors
in the jth group are excluded from the final model. This is equivalent to concluding that
the jth G factor Xj does not have an interaction effect with the environment factor Z. On
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the other hand, when φvj = 1, the prior in (3.7) reduces to the prior in (3.6) and induces the
same behavior as Bayesian group LASSO. Thus, the coefficients in vector γj∗ have non-zero
values and the jth group is included in the final model. Note that, after integrating out φvj
and τ 2vj in (3.7), the marginal prior on γj∗ is a mixture of a multivariate Laplace and a point
mass at 0L×1 as follows
pi(γj∗|σ2) ∼ piv M-Laplace(0, σ√
Lλv
) + (1− piv)δ0(γj∗) (3.8)
When piv = 1, (3.8) is equivalent to (3.5). Fixing piv = 0.5 makes the prior essentially non-
informative since it gives the equal prior probabilities to all sub-models. Instead of fixing
piv, we assign it a conjugate beta prior piv ∼ Beta(rv, wv) with fixed parameters rv and wv.
The value of λv controls the shape of the slab part of (3.8) and determines the amount of
shrinkage on the γj∗. For computation convenience, we assign a conjugate Gamma hyperprior
λ2v ∼ Gamma(av, bv) which can automatically accounts for the uncertainty in choosing λv
and ensure it is positive. We set av and bv to small values so that the priors are essentially
non-informative.
Remark : The form in (3.8) shows that our prior combines the strength of the Laplacian
shrinkage and the spike–and–slab prior. The Laplacian shrinkage is used as the slab part of
the prior, which captures the signal in the data and provides the estimation for large effects.
Compared with (3.5), the additional spike part (point mass at zero) in (3.8) shrinks the
negligibly small effects to zeros and achieve the variable selection.
Likewise, for γj1 and ζj (j = 1, . . . , p) corresponding to the individual level effects, the
spike-and-slab priors can be written as
γj1|φcj, τ 2cj, σ2 ind∼ φcjN(0, σ2τ 2cj) + (1− φcj)δ0(γj1)
φcj|pic ind∼ Bernoulli(pic)
τ 2cj|λc ind∼ Gamma(1,
λ2c
2
)
(3.9)
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and
ζj|φej, τ 2ej, σ2 ind∼ φejN(0, σ2τ 2ej) + (1− φej)δ0(ζj)
φej|pie ind∼ Bernoulli(pie)
τ 2ej|λe ind∼ Gamma(1,
λ2e
2
)
(3.10)
We assign conjugate beta prior pic ∼ Beta(rc, wc) and pie ∼ Beta(re, we), and Gamma priors
λ2c ∼ Gamma(ac, bc) and λ2e ∼ Gamma(ae, be). An inverted gamma prior for σ2 can maintain
conjugacy. The limiting improper prior pi(σ2) = 1/σ2 is another popular choice. Parameters
η, α and ζ0 may be given independent flat priors.
3.2.4 Gibbs sampler
The binary indicator variables can cause an absorbing state in the MCMC algorithm which
violates the convergence condition (Carlin and Chib (1995)). To avoid this problem, we
integrate out the indicator variables φc, φv and φe in (3.7), (3.9) and (3.10). We will show
that, even though φc, φv and φe are not part of the MCMC chain, their values still can be
easily computed at every iterations. Let µ = E(Y ), the joint posterior distribution of all the
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unknown parameters conditional on data can be expressed as
pi(η, α, ζ0, γj1,τ
2
c , pic, λc, γj∗, τ
2
v , piv, λv, ζj, pie, λe, τ
2
e , σ
2|Y )
∝(σ2)−n2 exp
{
− 1
2σ2
(Y − µ)>(Y − µ)
}
× exp
(
− 1
2
η>Σ−1η0 η
)
exp
(
− 1
2
α>Σ−1α0α
)
exp
(
− 1
2σ2ζ0
ζ20
)
×
p∏
j=1
(
piv(2piσ
2τ 2vj)
−L
2 exp
(
− 1
2σ2τ 2vj
γ>j∗γj∗
)
I{γj∗ 6=0} + (1− piv)δ0(γj∗)
)
× (λ2v)av−1 exp(−bvλ2v)
p∏
j=1
(
Lλ2v
2
)L+1
2
(τ 2vj)
L+1
2
−1 exp
(
− Lλ
2
v
2
τ 2vj
)
× piγv−1v (1− piv)wv−1
×
p∏
j=1
(
pic(2piσ
2τ 2cj)
− 1
2 exp
(
− 1
2σ2τ 2cj
γ2j1
)
I{γj1 6=0} + (1− pic)δ0(γj1)
)
× (λ2c)ac−1 exp(−bcλ2c)
p∏
j=1
λ2c
2
exp
(
− λ
2
c
2
τ 2cj
)
× piγc−1c (1− pic)wc−1
×
p∏
j=1
(
pie(2piσ
2τ 2ej)
− 1
2 exp
(
− 1
2σ2τ 2ej
ζ2j
)
I{ζj 6=0} + (1− pie)δ0(ζj)
)
× (λ2e)ae−1 exp(−beλ2e)
p∏
j=1
λ2e
2
exp
(
− λ
2
e
2
τ 2ej
)
× piγe−1e (1− pie)we−1
× (σ2)−s−1 exp(− h
σ2
)
Let µ(−η) = E(Y )−B0η, representing the mean effect without the contribution of β0(Zi).
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The posterior distribution of η conditional on all other parameters can be expressed as
pi(η|rest)
∝ pi(η)pi(y|·)
∝ exp
(
− 1
2
η>Σ−1η0 η
)
exp
(
− 1
2σ2
(Y − µ)>(Y − µ)
)
∝ exp
(
− 1
2
η>Σ−1η0 η −
1
2σ2
(Y −B0η − µ(−η))>(Y −B0η − µ(−η))
)
∝ exp
(
η>(Σ−1η0 +
1
σ2
B>0 B0)η −
2
σ2
(Y − µ(−η))>B0η
)
Hence, the full conditional distribution of m is multivariate normal N(µη,Ση) with mean
µη =
(
Σ−1η0 +
1
σ2
B>0 B0
)−1( 1
σ2
(Y − µ(−η))>B0
)>
and variance
Ση =
(
Σ−1η0 +
1
σ2
B>0 B0
)−1
The full conditional distribution of α and ζ0 can be obtained in similar way.
α|rest ∼ Nq(µα, Σα)
where µα = Σα(
1
σ2
(Y − µ(−α))>W )> and Σα = (Σ−1α0 + 1σ2W>W )−1
ζ0|rest ∼ N(µζ0 ,Σζ0)
where µζ0 = Σζ0(
1
σ2
(Y − µ(−ζ0))>E) and Σζ0 = (1/σ2ζ0 +
∑n
i=1 E
2
i
σ2
)−1.
Denote µ(−γj∗) = E(Y ) − Ujγj∗ and lvj = pi(γj∗ 6= 0|rest), the conditional posterior
distribution of γj∗ is a multivariate spike-and-slab distribution:
γj∗|rest ∼ lvjN(µγj∗ , σ2Σγj∗) + (1− lvj)δ0(γj∗) (3.11)
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where µγj∗ = Σγj∗U
>
j (Y − µ(−γj∗)) and Σγj∗ = (U>j Uj + 1τ2vj IL)
−1. It is easy to compute that
lvj is equal to
lvj =
piv
piv + (1− piv)(τ 2vj)
L
2 |Σγj∗|−
1
2 exp
(
− 1
2σ2
‖Σ
1
2
γj∗U
>
j (Y − µ(−γj∗))‖22
)
The posterior distribution (4.10) is a mixture of a multivariate normal and a point mass at 0.
Specifically, at the gth iteration of MCMC, γ
(g)
j∗ is drawn from N(µγj∗ , Σγj∗) with probability
lvj and is set to 0 with probability 1 − lvj. If γ(g)j∗ is set to 0, we have φ(g)vj = 0. Otherwise
φ
(g)
vj = 1.
Likewise, the conditional posterior distributions of γj1 and ζj are also spike-and-slab
distributions. Let µγj1 = Σγj1X
>
j (Y −µ(−γj1)) and Σγj1 = (X>j Xj+ 1τ2cj )
−1, the full conditional
distribution of γj1 is
γj1|rest ∼ lcjN(µγj1 , σ2Σγj1) + (1− lcj)δ0(γj1)
where
lcj = pi(γj1 6= 0|rest)
=
pic
pic + (1− pic)(τ 2cj)
1
2 (Σγj1)
− 1
2 exp
(
− 1
2σ2
Σγj1‖(Y − µ(−γj1))>Xj‖22
)
Let µζj = Σζj(Y − µ(−ζj))>Tj and Σζj = (T>j Tj + 1τ2ej )
−1, the full conditional distribution of
ζj is
ζj|rest ∼ lejN(µζj , σ2Σζj) + (1− lej)δ0(ζj)
where
lej = pi(ζj 6= 0|rest)
=
pie
pie + (1− pie)(τ 2ej)
1
2 (Σζj)
− 1
2 exp
(
− 1
2σ2
Σζj‖(Y − µ(−ζj))>Tj‖22
)
At the gth iteration, the values of φ
(g)
cj and φ
(g)
ej can be determined by whether the γ
(g)
j1 and
ζ
(g)
j are set to 0 or not, respectively. We list the conditional posterior distributions of other
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unknown parameters here. The details can be found in the Supplementary Materials.
(τ 2vj)
−1|rest ∼

Inverse-Gamma(L+1
2
, Lλ
2
v
2
) if γj∗ = 0
Inverse-Gaussian(Lλ2v,
√
Lλ2vσ
2
‖γj∗‖22 ) if γj∗ 6= 0
(τ 2cj)
−1|rest ∼

Inverse-Gamma(1, λ
2
c
2
) if γj1 = 0
Inverse-Gaussian(λ2c ,
√
λ2cσ
2
γ2j1
) if γj1 6= 0
(τ 2ej)
−1|rest ∼

Inverse-Gamma(1, λ
2
e
2
) if ζj = 0
Inverse-Gaussian(λ2e,
√
λ2eσ
2
ζ2j
) if ζj 6= 0
λ2v, λ
2
c and λ
2
e all have Gamma posterior distributions
λ2v|rest ∼ Gamma(av +
p(L+ 1)
2
, bv +
L
∑p
j=1 τ
2
vj
2
)
λ2c |rest ∼ Gamma(ac + p, bc +
∑p
j=1 τ
2
cj
2
)
λ2e|rest ∼ Gamma(ae + p, be +
∑p
j=1 τ
2
ej
2
)
piv, pic and pie have beta posterior distributions
piv|rest ∼ Beta(rv +
p∑
j=1
I{γj∗ 6=0}, wv +
p∑
j=1
I{γj∗=0})
pic|rest ∼ Beta(rc +
p∑
j=1
I{γj1 6=0}, wc +
p∑
j=1
I{γj1=0})
pie|rest ∼ Beta(re +
p∑
j=1
I{ζj 6=0}, we +
p∑
j=1
I{ζj=0})
Last, the full conditional distribution for σ2 the posterior distribution for σ2 is Inverse-
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Gamma(µσ2 , Σσ2) where
µσ2 = s+
n+
∑
I{γj1 6=0} + L
∑
I{γj∗ 6=0} +
∑
I{ζj 6=0}
2
Σσ2 = h+
(Y − µ)>(Y − µ) +∑pj=1 ((τ 2cj)−1γ2j1 + (τ 2vj)−1γ>j∗γj∗ + (τ 2ej)−1ζ2j )
2
Under our priors setting, conditional posterior distributions of all unknown parameters have
closed forms by conjugacy. Therefore, efficient Gibbs sampler can be used to simulate from
the posterior distribution.
To facilitate fast computation and reproducible research, we have implemented the pro-
posed and all the alternative methods in C++ from the R package spinBayes (Ren et al.
(2019c)) on CRAN.
3.3 Simulation
We compare the performance of the proposed method, Bayesian spike and slab variable
selection with structural identification, termed as BSSVC-SI, to four alternatives termed as
BSSVC, BVC-SI, BVC and BL, respectively. BSSVC is the proposed method but without
implementing structural identification. It does not distinguish the nonzero constant effect
from the nonlinear effect. Specifically, in BSSVC, coefficients of qn basis functions of βj are
treated as one group and are subject to selection at the group level. Comparison of BSSVC-
SI with BSSVC demonstrate the importance of structural identification in the detection
of interaction effects. BVC-SI is similar to the proposed method, except that it does not
adopt the spike-and-slab prior. BVC does not use the spike-and-slab prior and does not
distinguish the constant and varying effects. All these three alternative methods, BSSVC,
BVC-SI and BVC, are different variations of the proposed BSSVC-SI, aiming to evaluate
the strength of using the spike-and-slab prior and demonstrate the necessity of including
structural identification. The last alternative BL is the well-known Bayesian LASSO (Park
and Casella (2008)). BL assumes all interactions are linear. Details of the alternatives,
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including the prior and posterior distributions, are available in the Supplementary Materials.
We consider four examples in our simulations. Under all four settings, the responses are
generated from model (3.1) with n = 500, p = 100 and q = 2. Note that, the dimension of
regression coefficients to be estimated after basis expansion is larger than the sample size
(n = 500). For example, when the number of basis function qn = 5, the effective dimension
of regression coefficient is 604. In each example, we assess the performance in terms of
identification, estimation, and prediction accuracy. We use the integrated mean squared
error (IMSE) to evaluate estimation accuracy on the nonlinear effects. Let βˆj(z) be the
estimate of a nonparametric function βj(z), and {zm}ngridm=1 be the grid points where βj is
assessed. The IMSE of βˆj(z) is defined as IMSE (βˆj(z)) =
1
ngrid
∑ngrid
m=1
{
βˆj(zm)− βj(zm)
}2
.
Note that IMSE(βˆj) reduces to MSE(βˆj) when βj is a constant. Identification accuracy is
assessed by the number of true/false positives. Prediction performance is evaluated using
the mean prediction errors on an independently generated testing dataset under the same
settings.
Example 1
We first generate a n × p matrix of gene expressions, where n = 500 and p = 100, from
a multivariate normal distribution with zero mean vector. We consider an auto-regression
(AR) correlation structure for gene expression data, in which gene j and k have correlation
coefficient ρ|j−k|, with ρ = 0.5. For each observation, we simulate two clinical covariates from
a multivariate normal distribution with ρ = 0.5. The continuous and discrete environment
factors Zi and Ei are simulated from a Unif[0, 1] distribution and a binomial distribution,
respectively. The random error  ∼ N(0, 1).
The coefficients are set as µ(z) = 2 sin(2piz), β1(z) = 2 exp(2z − 1), β2(z) = −6z(1− z),
β3(z) = −4z3, β4(z) = 0.5, β5(z) = 0.8, β6(z) = −1.2, β7(z) = 0.7, β8(z) = −1.1, α1 = −0.5,
α2 = 1, ζ0 = 1.5, ζ1 = 0.6, ζ2 = 1.5, ζ3 = −1.3, ζ4 = 1, ζ5 = −0.8. We set all the rest of the
coefficients to 0.
Example 2
We examine whether the proposed method demonstrates superior performance over the
alternatives on simulated single-nucleotide polymorphism (SNP) data. The SNP genotype
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data Xi are simulated by dichotomizing expression values of each gene at the 1st and 3rd
quartiles, with the 3–level (2,1,0) for genotypes (AA,Aa,aa) respectively, where the gene
expression values are generated from Example 1.
Example 3
In the third example, we consider a different scheme to simulate SNP data. The SNP
genotype data are simulated based on a pairwise linkage disequilibrium (LD) structure.
For the two minor alleles A and B of two adjacent SNPs, let q1 and q2 be the minor allele
frequencies (MAFs), respectively. The frequencies of four haplotypes are calculated as pAB =
q1q2 + δ, pab = (1− q1)(1− q2) + δ, pAb = q1(1− q2)− δ, and paB = (1− q1)q2 − δ, where δ
denotes the LD. Under Hardy-Weinberg equilibrium, SNP genotype (AA, Aa, aa) at locus 1
can be generated from a multinomial distribution with frequencies (q21, 2q1(1− q1), (1− q1)2).
Based on the conditional genotype probability matrix (Cui et al. (2008)), we can simulate
the genotypes for locus 2. With MAFs 0.3 and pairwise correlation r = 0.6, we have
δ = r
√
q1(1− q1)q2(1− q2).
Example 4
In the last example, we consider more realistic correlation structures. Specifically, we use
the real data analyzed in the next section. To reduce the computational cost, we use the
first 100 SNPs from the case study. For each simulation replicate, we randomly sample 500
subjects from the dataset. The same coefficients and error distribution are adopted.
Posterior samples are collected from a Gibbs Sampler running 10,000 iterations in which
the first 5,000 are burn-ins. The Bayesian estimates are the posterior medians. To estimate
the prediction errors, we compute the mean squared error in 100 simulations. For both
BSSVC-SI and BSSVC, we consider the median probability model (MPM) (Barbieri and
Berger (2004); Xu and Ghosh (2015)) to identify predictors that are significantly associated
with the response variable. Suppose we collect G posterior samples from MCMC after burn-
ins. The jth predictor is included in the regression model at the gth MCMC iterations if the
indicator φ
(g)
j = 1. Thus, the posterior probability of including the jth predictor in the final
51
model is defined as
pj = pˆi(φj = 1|y) = 1
G
G∑
g=1
φ
(g)
j , j = 1, . . . , p (3.12)
A higher posterior inclusion probability pj can be interpreted as a stronger empirical
evidence that the jth predictor has a non-zero coefficient and therefore is associated with
the response variable. The MPM model is defined as the model consisting of predictors
that have posterior inclusion probability at least 1
2
. When the goal is to select a single
model, Barbieri and Berger (2004) recommends using MPM due to its optimal prediction
performance.
Table 3.1: Simulation results. (n, p, q) = (500, 100, 2). mean(sd) of true positives (TP)
and false positives (FP) based on 100 replicates.
BSSVC-SI BSSVC
Varying Constant Nonzero Varying Constant Nonzero
Example 1 TP 3.00(0.00) 4.93(0.25) 5.00(0.00) 3.00(0.00) 0.00(0.00) 5.00(0.00)
FP 0.20(0.41) 0.00(0.00) 0.00(0.00) 5.00(0.26) 0.00(0.00) 0.10(0.31)
Example 2 TP 3.00(0.00) 5.00(0.00) 5.00(0.00) 3.00(0.00) 0.00(0.00) 5.00(0.00)
FP 0.20(0.41) 0.00(0.00) 0.03(0.18) 5.00(0.26) 0.00(0.00) 0.03(0.18)
Example 3 TP 3.00(0.00) 4.97(0.18) 5.00(0.00) 3.00(0.00) 0.00(0.00) 5.00(0.00)
FP 0.03(0.18) 0.07(0.37) 0.00(0.00) 5.03(0.18) 0.00(0.00) 0.10(0.31)
Example 4 TP 3.00(0.00) 4.97(0.18) 5.00(0.00) 3.00(0.00) 0.00(0.00) 5.00(0.00)
FP 0.17(0.38) 0.03(0.18) 0.00(0.00) 5.10(0.31) 0.00(0.00) 0.13(0.35)
Table 3.1 summarized the results on model selection accuracy. The identification perfor-
mance for the varying and nonzero constant effects corresponding to the continuous environ-
ment factor, and nonzero effect (linear interaction) corresponding to the discrete environment
factor are evaluated separately. We can observe that the proposed model has superior perfor-
mance over BSSVC. BSSVC fails to identify any nonzero constant effect and has high false
positive for identifying varying effect since it lacks structural identification to separate main-
effect-only case from the varying effects. On the other hand, BSSVC-SI identifies most of the
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true effects with very lower false positives. For example, considering the MPM in Example
1, BSSVC-SI identifies all 3 true varying effects in every iteration, with a small number of
false positives 0.20(sd 0.41). It also identifies 4.93(sd 0.25) out of the 5 true constant effects
without false positives. Besides, all the 5 true nonzero effects are identified without any
false positives. We demonstrate the sensitivity of BSSVC-SI for variable selection to the
choice of the hyper-parameters for piv, pic and pie and the the choice of the hyper-parameters
for λv, λc and λe in the Appendix. The results are tabulated in Table C.2 and Table B.2,
respectively. Both tables show that the MPM model is insensitive to different specification
of the hyper-parameters. An alternative way for selecting variables with posterior inclusion
probability is to use a FDR-based method (Morris et al. (2007); Storey (2003)), which con-
trol the overall average Bayesian FDR rate by selecting variables with marginal inclusion
probability larger than certain threshold. The results of FDR-based variable selection is
summarized in (Table B.3). Overall the MPM and FDR models have very similar results in
all four examples. The alternatives BVC-SI and BVC are not included here due to the lack
of variable selection property. Li et al. (2015) adopts a method that is based on 95% credible
interval (95%CI) for selecting important varying effects. In the Appendix, we show that,
even adopting the 95%CI-based selection method, the identification performance of BVC-SI
and BVC are unsatisfied, especially in terms of selecting a large number of false positives
(Table B.4).
We also examine the estimation performance. We show the results from Example 1
(Table 3.2) here. The IMSE for all true varying effects, MSE for constant and nonzero
effects, as well as the total squared errors for all coefficient estimates and prediction errors
are provided in the Table. We observe that, across all the settings, the proposed method
has the smallest prediction errors and total squared errors of coefficients estimates than all
alternatives. For example, in Table 3.2, the BSSVC-SI has the smallest total squared errors
0.268(sd 0.080) and prediction error 1.159(0.066) among all the approaches. The key of the
superior performance lies in (1) accurate modeling of different types of main and interaction
effects, and (2) the spike and slab priors for achieving sparsity. Compared with BVC-SI
which has (1) but does not spike and slab prior, BSSVC-SI performs better when estimating
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both varying and constant coefficients. For example, the IMSE and MSE on β0(Z) and α1
are 0.049 (sd 0.017) and 0.004 (sd 0.004), respectively. While BVC-SI yields 0.067(sd 0.030)
and 0.008(0.010), correspondingly. Besides, compared with BSSVC which adopts the spike
and slab priors without considering structured Bayesian variable selection, BSSVC-SI has
comparable estimation performance on coefficients even though BSSVC overfits the data.
In addition, similar patterns have been observed in Table B.6, Table B.7 and Table B.8 for
Examples 2, 3 and 4 respectively, in the Appendix.
As a demonstrating example, Figure B.1 shows the estimated varying coefficients of the
proposed model for the gene expression data in Example 1. Results from the proposed
method fit the underlying trend of varying effects reasonably well. Following Li et al. Li
et al. (2015), we assess the convergence of the MCMC chains by the potential scale reduction
factor (PSRF) (Brooks and Gelman (1998); Gelman and Rubin (1992)). PSRF values close
to 1 indicate that chains converge to the stationary distribution. Gelman et al. (2004)
recommend using PSRF≤ 1.1 as the cutoff for convergence, which has been adopted in our
study. We compute the PSRF for each parameter and find all chains converge after the
burn-ins. For the purpose of demonstration, Figure C.1 shows the pattern of PSRF after
burn-ins for each parameter in Figure B.1. The figure clearly shows the convergence of the
proposed Gibbs sampler.
We conduct sensitivity analysis on how the smoothness specification of the parameters in
the B spline affects variable selection. The results summarized in Table B.5 in the Appendix
shows that the proposed model is insensitive to the smoothness specification as long as the
choices on number of spline basis are sensible. In simulation, we set the degree of B spline
basis O = 2 and the number of interior knots K = 2, which makes qn = 5.
Computation feasibility is an important practical consideration for high-dimensional
Bayesian variable selection methods. We examine the computational cost of the proposed
method for finishing 10,000 MCMC iterations under different combinations of sample sizes
and SNP numbers. We focus on SNP numbers since the increase is computationally more
challenging than that of the covariate numbers due to basis expansion. The results summa-
rized in Table B.9 show that the proposed method is highly computationally efficient. For
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Table 3.2: Simulation results in Example 1. Gene expression data (n, p, q) = (500, 100,
2). mean(sd) of the integrated mean squared error (IMSE), mean squared error (MSE), total
squared errors for all estimates and prediction errors based on 100 replicates.
BSSVC-SI BSSVC BVC-SI BVC BL
IMSE
β0(Z) 0.049(0.017) 0.050(0.017) 0.067(0.030) 0.066(0.028) 0.806(0.039)
β1(Z) 0.052(0.028) 0.027(0.019) 0.090(0.051) 0.107(0.051) 0.139(0.060)
β2(Z) 0.035(0.020) 0.026(0.014) 0.045(0.023) 0.050(0.021) 0.252(0.049)
β3(Z) 0.033(0.025) 0.024(0.019) 0.081(0.057) 0.106(0.062) 0.256(0.062)
MSE
α1 0.004(0.004) 0.004(0.005) 0.008(0.010) 0.008(0.011) 0.012(0.015)
α2 0.004(0.005) 0.004(269) 0.009(0.013) 0.009(0.013) 0.011(0.012)
ζ0 0.033(0.025) 0.024(0.019) 0.081(0.057) 0.106(0.062) 0.032(0.045)
ζ1 0.004(0.005) 0.003(0.004) 0.007(0.008) 0.006(0.007) 0.026(0.043)
ζ2 0.011(0.014) 0.009(0.011) 0.017(0.016) 0.017(0.016) 0.055(0.067)
ζ3 0.008(0.011) 0.008(0.010) 0.017(0.024) 0.017(0.022) 0.055(0.052)
ζ4 0.014(0.017) 0.019(0.028) 0.020(0.025) 0.020(0.023) 0.042(0.052)
ζ5 0.009(0.013) 0.010(0.016) 0.020(0.030) 0.024(0.032) 0.048(0.052)
Total 0.268(0.080) 0.304(0.132) 2.181(0.373) 2.119(0.363) 4.916(0.564)
Pred.
Error 1.159(0.066) 1.167(0.067) 2.112(0.175) 2.075(0.170) 9.417(0.914)
example, when sample size n = 1500 and the number of gene p = 300, the CPU time for
10,000 iterations is approximately 121 seconds. Please note that the number of regression
coefficients to be estimated after basis expansion is on the order of qnp + p, where qn is the
number of basis functions. The term qnp gives the number of spline coefficients of nonlinear
G×E interactions and p is the number of linear G×E interactions. In this example, the
number of regression coefficients to be estimated is approximately 1800, higher than the
sample size n = 1500. The efficient C++ implementation of the Gibbs sampler is an impor-
tant guarantee for the computational scalability. The proposed method can be potentially
applied to larger datasets with a reasonable computation time.
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3.4 Real Data Analysis
We analyze the data from Nurses’ Health Study (NHS). We use weight as the response and
focus on SNPs on chromosome 10. We consider two environment factors. The first is age
which is continuous and is known to be related to the variations in the obesity level. The
second is the binary indicator of whether an individual has a history of hypertension (hbp),
which is a sensible candidate for a discrete environment factor. In addition, we consider
two clinical covariates: height and total physical activity. In NHS study, about half of the
subjects are diagnosed of type 2 diabetes (T2D) and the other half are controls without the
disease. We only use health subjects in this study. After cleaning the data through matching
phenotypes and genotypes, removing SNPs with minor allele frequency (MAF) less than 0.05
or deviation from Hardy–Weinberg equilibrium, the working dataset contains 1716 subjects
with 35099 SNPs.
For computational convenience prescreening can be conducted to reduce the feature space
to a more attainable size for variable selection. For example, Li et al. (2015) use the single
SNP analysis to filter SNPs in a GWA study before downstream analysis. Machine learning
has also being used for screening important genetic variants in T2D studies (Jung et al.
(2020)). In this study, we follow the procedure described in Ma et al. (2011) and Wu and
Cui (2013a) to screen SNPs. Specifically, we use three likelihood ratio tests with weight as
the response variable to evaluate the penetrance effect of a variant under the environmental
exposure. The three likelihood ratio tests have been developed to test whether the interaction
effects are nonlinear, linear, constant or zero, respectively. The SNPs with p-values less than
a certain cutoff (0.005) from any of the tests are kept. 269 SNPs pass the screening.
We analyze the data by using the proposed method as well as BSSVC, the alternative
without structural identification. As methods BVC-SI, BVC and BL show inferior perfor-
mance in simulation, they are not considered in real data analysis. The proposed method
identifies three SNPs with constant effects only, eleven SNPs with varying effects and six-
teen SNPs with interactions with the hbp indicator. The BSSVC identifies twelve SNPs
with varying effects and 10 SNPs with interactions with the hbp indicator. The Identifi-
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cation results for varying and constant effects are summarized in Table 3.3. In this table,
we can see that the three SNPs (rs11014290, rs2368945 and rs10787374) that are identified
as constant effects only by BSSVC-SI are also selected by BSSVC. However, due to lack of
structural identification, BSSVC identified them as SNPs with varying effects. The proposed
method identifies rs1816002, a SNP located within gene ADAMTS14 as an important SNP
with varying effect. ADAMTS14 is a member of ADAMTS metalloprotease family. Stud-
ies have shown that two members in the family, ADAMTS1 and ADAMTS13 are related
to the development of obesity (Liu et al. (2012); Porter et al. (2005)), which suggests that
ADAMTS14 may also have implications in obesity. The alternative method BSSCV fails
to identify this important gene. The varying effect of the DIP2C gene SNP rs4880704 is
identified by both BSSVC-SI and BSSVC. DIP2C (disco interacting protein 2 homolog C)
has been found a potential epigenetic mark associated with obesity in children (Fradin et al.
(2017)) and plays an important role in the association between obesity and hyperuricemia
(Li et al. (2013)). The identification results for nonzero effects (representing the interactions
with the binary indicator of a history of hypertension (hbp)) are summarized in Table 3.4.
The interaction between rs593572 in gene KCNMA1 and hbp is identified by the proposed
method. KCNMA1 (potassium calcium-activated channel subfamily M alpha 1) has been
reported as an obesity gene that contributes to excessive accumulation of adipose tissue
in obesity (Jiao et al. (2011)). Interestingly, the main effect of KCNMA1 is not identified,
which suggests that KCNMA1 only has effect in the hypertension patients group. This result
could be partially explained by the observation of significant association between the genetic
variation in the KCNMA1 and hypertension (Toma´s et al. (2008)).
The eleven varying coefficients of age that are identified by BSSVC-SI and the intercept
are shown in Figure B.3 in the Appendix. All estimates have clear curvature and cannot be
appropriately approximated by a model assuming linear effects. It is difficult to objectively
evaluate the selection performance with real data. The prediction performance may provide
partial information on the relative performance of different methods. Following Yan and
Huang (2012) and Li et al. (2015), we refit the models selected by BSSVC-SI and BSSVC
by Bayesian LASSO. The prediction mean squared errors (PMSE) based on the posterior
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Table 3.3: Identification results for varying and constant effects.
BSSVC-SI BSSVC
SNP Gene V(Age) C V(Age)
rs11014290 PRTFDC1 -1.864 Varying
rs2368945 RPL21P93 1.494 Varying
rs4880704 DIP2C Varying Varying
rs1106380 CACNB2 Varying Varying
rs2245456 MALRD1 Varying
rs17775990 OGDHL Varying Varying
rs7922576 ZNF365 Varying Varying
rs1816002 ADAMTS14 Varying
rs2784761 RPL22P18 Varying Varying
rs181652 AC005871.1 Varying
rs10765108 DOCK1 Varying
rs2764375 LINC00959 Varying Varying
rs10787374 RPS6P15 2.020 Varying
rs11006525 MRPL50P4 Varying
rs1698417 AC026884.1 Varying
rs7084791 PPP1R3C Varying
rs12354542 BTF3P15 Varying
median estimates are computed. The PMSEs are 90.66 and 95.21 for BSSVC-SI and BSSVC,
respectively. We also compute the prediction performance of BVC-SI, BVC and BL, based
on the models selected by the 95% CI-based method. The PMSE is 106.26 for BVC-SI,
110.19 for BVC and 107.82 for BL. The proposed method outperforms all the competitors.
3.5 Discussion
The importance of G×E interactions in deciphering the genetic architecture of complex dis-
eases have been increasingly recognized. A considerable amount of effort has been developed
to dissect the G×E interactions. In marginal analysis, statistical testing of G×E interactions
prevails, which spans from the classical linear model with interactions in a wide range of stud-
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Table 3.4: Identification results for nonzero effect corresponds to the discrete environment
effect.
BSSVC-SI BSSVC
rs10740217 CTNNA3 -1.06 -1.18
rs10787374 RPS6P15 -1.56 -1.42
rs10795690 AC044784.1 1.23
rs10829152 ANKRD26 1.29 1.73
rs10999234 PRKG1 1.97
rs11187761 PIPSL 1.04
rs11245023 C10orf90 -0.92
rs11250578 ADARB2 -1.62
rs12267702 LYZL1 1.30 0.96
rs17767748 BTRC 1.18 1.15
rs2495763 PAX2 -1.33 -1.12
rs4565799 MCM10 -0.84 -0.98
rs593572 KCNMA1 1.70
rs685578 AL353149.1 -1.13
rs7075347 AL357037.1 1.00
rs7911264 HHEX -1.30
rs796945 RNLS 1.89
rs9419280 LINC01168 1.57
rs997064 PCDH15 1.31
ies, such as case-control study, case only study and the two-stage screening study, to more
sophisticated models, such as empirical Bayesian models, non- and semi-parametric models
(Cornelis et al. (2011)). On the other hand, the joint methods, especially the penalized vari-
able selection methods, for G×E interactions, have been motivated by the success of gene set
based association analysis over marginal analysis, as demonstrated in Wu and Cui (2013b),
Wu et al. (2012) and Schaid et al. (2012). Recently, multiple penalization methods have
been proposed to identify important G×E interactions under parametric, semi-parametric
and non-parametric models recently (Wu et al. (2014, 2015, 2018a,c)).
Within the Bayesian framework, non-linear interaction has not been sufficiently consid-
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ered for G×E interactions. Furthermore, incorporation of the structured identification to
determine whether the genetic variants have non-linear interaction, or main-effect-only, or no
genetic influences at all is particularly challenging. In this study, we have proposed a novel
semi-parametric Bayesian variable selection method to simultaneously pinpoint important
G×E interactions in both linear and nonlinear forms while conducting automatic structure
discovery. We approximate the nonlinear interaction effects using B splines, and develop a
Bayesian hierarchical model to accommodate the selection of linear and nonlinear G×E in-
teractions. For the nonlinear effects, we achieve the separation of varying, non-zero constant
and zero coefficient functions through changing of spline basis, corresponding to cases of G×E
interactions, main effects only (no G×E interactions) and no genetic effects. This automatic
separation of different effects, together with the identification of linear interaction, lead to
selection of important coefficients on both individual and group levels. Within our Bayesian
hierarchical model, the group and individual level shrinkage are induced through assigning
spike-and-slab priors with the slab parts coming from a multivariate Laplace distribution
on the group of spline coefficients and univariate Laplace distribution on the individual co-
efficient, correspondingly. We have developed an efficient Gibbs sampler and implemented
in R with core modules developed in C++, which guarantees fast computation in MCMC
estimation. The superior performance of the proposed method over multiple alternatives has
been demonstrated through extensive simulation studies and a case study.
The cumulative evidence has indicated the effectiveness of penalized variable selection
methods to pinpoint important G×E interactions. Bayesian variable selection methods, how-
ever, have not been widely adopted in existing G×E studies. The proposed semi-parametric
Bayesian variable selection method has the potential to be extended to accommodate a di-
versity forms of complex interaction structures under the varying index coefficient models
and models alike, as summarized in Ma and Song (2015). Other possible extensions in-
clude Bayesian semi-parametric interaction analysis for integrating multiple genetic datasets
(Li et al. (2019)). Investigations of all the aforementioned extensions are postponed to the
future.
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Chapter 4
Robust Bayesian variable selection for
gene-environment interactions
4.1 Introduction
Deciphering the genetic architecture of complex diseases is a challenging task, as it demands
the elucidation of the coordinated function of multiple genetic factors, their interactions, as
well as gene-environment interactions. How the genetic contributions to influence the varia-
tions in the disease phenotypes are mediated by the environmental factors reveals a unique
perspective of the disease etiology beyond the main genetic effects and their interactions (or
epistasis) (Hunter (2005); Simonds et al. (2016)). Till now, G×E interaction analyses have
been extensively conducted, especially within the framework of genetic association studies,
to search for the important main and interaction effects that are associated with the disease
trait (Mukherjee et al. (2011)).
With the availability of a large amount of genetic factors, such as SNPs or gene expres-
sions, G×E interactions are of high dimensionality even though the preselected environmen-
tal factors are usually low dimensional. Therefore, the genetic association studies essentially
aim to “find a needle from a haystack”. Such a “large dimensionality, small sample size”
problem can also be effectively addressed using penalization and Bayesian variable selection
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methods (Fan and Lv (2010); Wu and Ma (2015)), and a surging amount of G×E studies
have recently been conducted along this line (Zhou et al. (2020a)).
A prominent trend among these studies is to incorporate robustness in penalized identifi-
cation of main and interaction in order to accommodate data contamination and heavy-tailed
distributions in the disease phenotypes. Take the datasets analyzed in this article for exam-
ple. The disease outcomes of interest are weight from the Nurses Health Study (NHS) and
(log-transformed) Breslows depth from The Cancer Genome Atlas (TCGA) Skin Cutaneous
Melanoma (SKCM) data. We plot the two in Figure 4.1, where the long tails can be clearly
observed. In practice, such a heavy-tailed distribution is frequently encountered and arise
due to multiple reasons. For instance, some phenotypes have skewness in nature. For the
subjects recruited for the NHS, their ages are in the range from 41 to 68 as the average age
for the onset of type 2 diabetes is 45 (Centers for Disease Control and Prevention (2020)).
The subjects weight among this age group does have a right-skewed tendency. In addition,
in the study of complex diseases such as cancer, even patients of similar profiles may have
different subtypes as rigorous accrual of patients is usually not affordable. The data from
the major disease subtype can be viewed as being contaminated by other subtypes or out-
liers. As nonrobust approaches cannot efficiently accommodate data contamination and long
tailed distributions, which inevitably leads to biased estimates and false identifications, the
robust penalization methods have thus been extensively developed for G×E studies (Wu and
Ma (2015); Zhou et al. (2020a)).
Note that the interconnections between penalization and Bayesian methods has already
been established in literature. For instance, it has been pointed out in Park and Casella
(2008) that within the Bayesian framework, regularized estimate under LASSO is equivalent
to the posterior mode of regression coefficients when the same conditional Laplace prior is
placed on each regression coefficient independently. Such an interconnection can be further
generalized to the Bayesian counterparts of group LASSO, fused LASSO and elastic net
(Kyung et al. (2010)). Despite such a deep connection and remarkable successes of robust
penalization-based analysis, robust Bayesian methods have not been investigated for gene-
environment interactions by far. In fact, our literature search indicates that only limited
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Figure 4.1: Distribution of the outcome variables for the NHS (left) and SKCM (right)
data.
number of Bayesian variable selection methods have been developed for G×E studies, and
none of them is robust (Zhou et al. (2020a)).
Driven by the urgent need to conduct robust Bayesian analysis for gene-environment
interactions, we propose robust Bayesian variable selection methods tailored for interaction
analysis. To illustrate, before we discuss the proposed joint study, let us first consider a
marginal conceptual model: Outcome ∼ Es + G + G×(Es), where G and Es denote one
G factor and several E factors, respectively. The term G×(Es) represents the interaction
between the G factor and all the environmental variables. With a slight abuse of notation,
the last two terms in the conceptual model can be rewritten as G×(1, Es), which is a group
of main genetic and G×E interaction effects with respect to the G factor. Therefore, to
determine whether the genetic factor is associated with the phenotype, and if so, to further
examine which effects from the group are associated with the phenotype, essentially amount
to a sparse group (or bi-level) variable selection problem. The sparse group selection remains
and becomes even more challenging for our G×E study when a large number of G factors are
jointly analyzed. Therefore, within the Bayesian framework, the proposed method should
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aim to incorporate robustness and bi-level selection simultaneously.
We adopt a Bayesian formulation of the least absolute deviation (LAD) regression to
accommodate data contamination and long-tailed distributions in the phenotype. Such a
formulation is a special case of the Bayesian quantile regression (Yu and Moyeed (2001)).
The LAD loss has been a very popular choice for developing robust penalization methods due
to computational simplicity when being coupled with complex penalty functions, including
the network-constrained penalty (Ren et al. (2019a); Wu et al. (2018b)) and sparse group
penalty (Wu et al. (2018a)). Interestingly, its computational convenience has also been
revealed within the Bayesian framework as efficient Gibbs sampler can be constructed when
the loss is combined with LASSO, group LASSO and elastic net penalties (Li et al. (2010)).
Furthermore, following the strategy of eliciting the prior for bilevel selection from a nonrobust
Bayesian method (Xu and Ghosh (2015)), we have developed the Bayesian LAD sparse
group LASSO for robust G×E interaction studies. The spike-and-slab priors have been
imposed on both the individual and group level to ensure the shrinkage of posterior estimates
corresponding to unimportant main and interaction effects to zero exactly. Such a prior lead
to the real sparsity and is superior over Laplacian shrinkage in terms of identification and
prediction results (George and McCulloch (1993); Roc˘kova´ and George (2018); Tang et al.
(2017)).
In this study, our objective is to conduct robust Bayesian variable selection for G×E
interactions, which has been well motivated from the success of penalization methods (espe-
cially those robust ones) in G×E studies and a lack of robust interaction analysis within the
Bayesian framework. The significance of the proposed study lies in the following aspects.
First, it advances from existing Bayesian G×E studies by incorporating robustness to accom-
modate data contamination and heavy-tailed distributions in the disease phenotype. Second,
on a broader scope, although robust Bayesian quantile regression based variable selection has
been proposed under LASSO, group LASSO and elastic net, the more complicated sparse
group (or bi-level) structure, which is of particular importance in high dimensional data
analysis in general (Breheny and Huang (2009)), has not been examined by far. We are
among the first to develop robust Bayesian sparse group LASSO for bi-level variable selec-
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tion. Third, unlike existing Bayesian regularized quantile regression methods which build
upon the priors under Laplacian type of shrinkage, we conduct efficient Bayesian regulariza-
tion on both the individual and group levels by borrowing strength from the spike-and-slab
priors, thus leading to better identification and prediction performance over the competing
alternatives, as demonstrated in extensive simulation studies and case studies of NHS data
with SNP measurements and TCGA melanoma data with gene expression measurements.
To facilitate reproducible research and fast computation using our MCMC algorithm, we
implement the proposed and alternative approaches in C++, which are available from an
open source R package robin that will be available at CRAN soon.
4.2 Data and Model Settings
Use subscript i to denote the ith subject. Let (Xi, Yi, Ei,Wi), (i = 1, . . . , n) be independent
and identically distributed random vectors. Yi is a continuous response variable representing
the disease phenotype. Xi is the p–dimensional vector of G factors. The environmental fac-
tors and clinical covariates are denoted as the k-dimensional vector Ei and the q-dimensional
vector Wi, respectively. Considering the following model:
Yi =
q∑
t=1
αtWit +
k∑
m=1
θmEim +
p∑
j=1
γjXij +
p∑
j=1
k∑
m=1
ζjmEimXij + i
=
q∑
t=1
αtWit +
k∑
m=1
θmEim +
p∑
j=1
(
γjXij +
k∑
m=1
ζjmEimXij
)
+ i
=
q∑
t=1
αtWit +
k∑
m=1
θmEim +
p∑
j=1
(
U>ij βj
)
+ i,
(4.1)
where αt’s, θm’s, γj’s and ζjm’s are the regression coefficients for the clinical covariates,
environmental factors, genetic factors and G×E interactions, respectively. We define βj =
(γj, ζj1, . . . , ζjk)
> ≡ (βj1, . . . , βjL)> and Uij = (Xij, XijEi1 . . . , XijEik)> ≡ (Uij1, . . . , UijL)>,
where L = k + 1. The coefficient vector βj represents all the main and interaction effects
corresponding to the jth genetic measurement. The i’s are random errors. Without loss
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of generality, we assume that the data have been properly normalized so that the intercept
can be omitted. Denote Ui = (U
>
i1 , . . . , U
>
ip)
>, α = (α1, . . . , αq)>, θ = (θ1, . . . , θk)> and
β = (β>1 , . . . , β
>
p )
>. The vector β is of length p × L. Then model (4.1) can be written in a
more concise form as
Yi = W
>
i α + E
>
i θ + U
>
i β + i (4.2)
4.2.1 Bayesian LAD Regression
The least absolute deviation (LAD) regression is well known for its robustness to heavy-
tailed errors or outliers in response. To construct a Bayesian formulation of LAD regression,
we assume that i’s are i.i.d random variables from the Laplace distribution with density
f(i|ν) = ν
2
exp {−ν|i|} i = 1, . . . , n, (4.3)
where ν−1 is the scale parameter of the Laplace distribution. Let Y = (Y1, . . . , Yn)>. With
clinical covariates W = (W1, . . . ,Wn)
>, environment factors E = (E1, . . . , En)>, and ge-
netic main effects and G×E interactions U = (U1, . . . , Un)>, the likelihood function can be
expressed as
f(Y |W,E,U, α, θ, β, ν) =
n∏
i=1
ν
2
exp {−ν |Yi − µi|} , (4.4)
where µi = W
>
i α + E
>
i θ + U
>
i β.
Based on Kozumi and Kobayashi (2011), the Laplace distribution is equivalent to the
mixture of an exponential and a scaled normal distribution. Specifically, let z and u˜ be
the standard normal and exponential random variables, respectively. If a random variable 
follows the Laplace distribution with parameter ν, then it can be represented as follows
 = ν−1κ
√
u˜z, (4.5)
where κ =
√
8 is a constant. Therefore, the response Yi can be rewritten as Yi = µi +
ν−1κ
√
u˜izi, where zi ∼ N(0, 1) and u˜i ∼ Exp(1). Let u = ν−1u˜. Then u follows the
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exponential distribution Exp(ν−1). We thus have the following hierarchical representation
of the Laplace likelihood:
Yi = µi + ν
− 1
2κ
√
uizi,
ui|ν ind∼ ν exp (−νui) ,
zi
ind∼ N(0, 1).
This hierarchical representation allows us to express the likelihood function as a multivariate
normal distribution, which is critical to construct a Gibbs sampler for efficient sampling of
the regression coefficients corresponding to main and interaction effects robustly.
Remark : The Laplace distribution in Bayesian LAD regression can be treated as a special
case of the asymmetric Laplace distribution (ALD) in Bayesian quantile regression (Yu and
Moyeed (2001); Yu and Zhang (2005)). In Bayesian quantile regression, we assume that i
follows the asymmetric Laplace distribution with density
f(i|τ, ν) = τ(1− τ)ν exp {−νρτ (i)} i = 1, . . . , n, (4.6)
where the check loss function is ρτ (i) = i {τ − I(i < 0)} for the τth quantile (0 < τ < 1).
Note that, when τ = 0.5, the ALD in (4.6) reduces to a symmetric Laplace distribution
defined in (4.3). Yu and Moyeed (Yu and Moyeed (2001)) have shown that maximizing
a likelihood function under the asymmetric Laplace error distribution (4.6) is equivalent to
minimizing the check loss function in quantile regression. Kozumi and Kobayashi (2011) have
proposed a Gibbs sampling algorithm for Bayesian quantile regression based on a location-
scale mixture representation of the ALD. Specifically, with u˜ and z defined as above, the
asymmetric Laplace error in (4.6) can be represented as
 = ν−1ψz + ν−1κ
√
u˜z, (4.7)
where
ψ =
1− 2τ
τ(1− τ) and κ =
√
2
τ(1− τ) .
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When τ = 0.5, we have ψ = 0 and κ =
√
8, and equation (4.7) reduces to the Laplace error
in (4.5).
4.2.2 Bayesian sparse group variable selection for G×E interac-
tions
The proposed Bayesian sparse group variable selection method is motivated by the following
considerations. In model (4.1), the coefficient vector βj corresponds to the main and interac-
tion effects with respect to the jth genetic variant. Whether the genetic variant is associated
with the phenotype or not can be determined by whether βj = 0. A zero coefficient vector
suggests that the variant does not have any effect on the disease outcome. If βj 6= 0, then
a further investigation on the presence of the main effect, or the interaction or both is of
interest, which can be facilitated by examining the nonzero component in βj. Therefore,
a tailored robust Bayesian variable selection method for G×E studies should accommodate
the selection on both group (the entire vector of βj) and individual (each component of βj)
levels at the same time.
In order to impose sparsity on both group and individual level to identify important main
and interaction effects, we conduct the decomposition of βj by following the reparmetrization
from Xu and Ghosh (2015). Specifically, βj is defined as
βj = V
1
2
j bj,
where bj = (bj1, . . . , bjL)
> and V
1
2
j = diag {ωj1, . . . , ωjL} , ωjl ≥ 0 (l = 1, ..., L). To determine
whether the jth genetic variant has any effect at all, we conduct group-level selection on bj
by adopting the following multivariate spike–and–slab priors
bj|φbj ind∼ φbj NL (0, IL) + (1− φbj)δ0(bj),
φbj|pi0 ind∼ Bernoulli(pi0),
(4.8)
where IL is an identity matrix, δ0(bj) denotes a point mass at 0L×1 and pi0 ∈ [0, 1]. We
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introduce a latent binary indicator variable φbj for each group j(j = 1, . . . , p) to tackle the
group–level selection. In particular, when φbj = 0, the coefficient vector bj has a point mass
density at zero and all predictors representing the main and interaction effects in the jth
group are excluded from the model, indicating that the jth genetic variant is not associated
with the phenotype. On the other hand, when φbj = 1, the components in coefficient vector
bj have non-zero values.
To further determine whether there is an important main genetic effect, G×E interaction
or both, we impose sparsity within the group j by assigning the following spike–and–slab
priors on each ωjl (j = 1, . . . , p and l = 1, . . . , L)
ωjl|φwjl ind∼ φwjl N+
(
0, s2
)
+ (1− φwjl)δ0(ωjl),
φwjl|pi1 ind∼ Bernoulli(pi1),
(4.9)
where N+ (0, s2) denotes a normal distribution, N (0, s2), truncated below at 0. When the
binary indicator variable φwjl = 0, ωjl is set to zero by the point mass function δ0(ωjl). Within
the jth group, when the component ωjl = 0, we have βjl = 0 and the corresponding Ujl is
excluded from the model, even when bj 6= 0. This implies that the jth genetic variant does
not have the main effect (if l=1) or the interaction effect with the (l − 1)th environment
factor (if l > 1). The βjl is non-zero if and only if the vector bj 6= 0 and the individual
element ωjl 6= 0.
In (4.8) and (4.9), pi0 and pi1 control the sparsity on the group and individual level,
respectively. Their values should be carefully tuned. Fixing their values at 0.5 makes the
prior essentially non-informative since equal prior probabilities are given to all the sub-
models. Instead of fixing pi0 and pi1, we assign conjugate beta priors pi0 ∼ Beta(a0, b0) and
pi1 ∼ Beta(a1, b1), which can automatically account for the uncertainty in choosing pi0 and pi1.
We fixed parameters a0 = b0 = a1 = b1 = 1, so that the priors are essentially non-informative.
For computation convenience, we assign a conjugate Inverse–Gamma hyperprior on s2
s2 ∼ Inv-Gamma(1, η)
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η is estimated with the Monte Carlo EM algorithm (Park and Casella (2008); Xu and Ghosh
(2015)). For the gth EM update,
η(g) =
1
Eη(g−1)
[
1
s2
|Y ] ,
where the posterior expectation of 1
s2
is estimated from the MCMC samples based on t(g−1).
To maintain conjugacy, we place a Gamma prior on ν,
ν ∼ Gamma(c, d).
We set c and d to small values.
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4.2.3 Gibbs sampler
The joint posterior distribution of all the unknown parameters conditional on data can be
expressed as
pi(α, θ, bj, ωjl,ν, ui, pi0, pi1, s
2|Y )
∝
n∏
i=1
(2piκ2ν−1ui)−
1
2 exp
−
(
Yi −W>i α− E>i θ −
∑p
j=1
(
U>ij βj
))2
2κ2ν−1ui

×
n∏
i=1
ν exp(−νui) νc−1 exp {−dν}
× exp
(
− 1
2
θ>Σ−1θ0 θ
)
exp
(
− 1
2
α>Σ−1α0α
)
×
p∏
j=1
(
pi0(2pi)
−L
2 exp
{
−1
2
b>j bj
}
I{bj 6=0} + (1− pi0)δ0(bj)
)
×
p∏
j=1
L∏
l=1
(
pi12(2pis
2)−
1
2 exp
{
−ω
2
jl
2s2
}
I{ωjl>0} + (1− pi1)δ0(ωjl)
)
× pia0−10 (1− pi0)b0−1
× pia1−11 (1− pi1)b1−1
× (s2)−2 exp(− η
s2
).
Define the coefficient vector without the jth group as β(j) = (β
>
1 , . . . , β
>
j−1, β
>
j+1, . . . , β
>
p ) and
the corresponding part of the design matrix as U(j). Likewise, define the coefficient vector
without the lth element in the jth group as β(jl) and the corresponding design matrix as
U(jl). Let l
b
j = p(bj 6= 0|rest), then the conditional posterior distribution of bj is a multivariate
spike–and–slab distribution:
bj|rest ∼ lbj NL(µbj , Σbj) + (1− lbj) δ0(bj), (4.10)
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where Σbj =
(
νκ−2
∑n
i=1 u
−1
i V
1
2
j UijU
>
ijV
1
2
j + IL
)−1
, µbj = Σbjνκ
−2∑n
i=1 u
−1
i V
1
2
j Uij y˜ij and
y˜ij = yi −W>i α− E>i θ − U>(j)β(j). The lbj can be derived as
lbj =
pi0
pi0 + (1− pi0)|Σbj |−
1
2 exp
{
−1
2
‖Σ
1
2
bj
νκ−2
∑n
i=1 u
−1
i V
1
2
j Uij y˜ij‖22
} .
The posterior distribution (4.10) is a mixture of a multivariate normal and a point mass at 0.
Specifically, at the gth iteration of MCMC, b
(g)
j is drawn from N(µbj , Σbj) with probability l
b
j
and is set to 0 with probability 1− lbj. If b(g)j is set to 0, we have φb(g)j = 0, which suggests that
the jth genetic variant is not associated with the phenotype at the gth iteration. Otherwise,
φ
b(g)
j = 1.
In addition to the multivariate spike–and–slab distribution on the group level, on the
individual level, the conditional posterior distribution of ωjl is also spike-and-slab. Let
lwjl = p(ωjl 6= 0|rest), we have
ωjl|rest ∼ lwjl N+(µωjl , σ2ωjl) + (1− lwjl)δ0(ωjl),
where σ2ωjl =
(
1
s2
+ νκ−2
∑n
i=1 u
−1
i U
2
ijlb
2
jl
)−1
, µωjl = σ
2
ωjl
νκ−2
∑n
i=1 u
−1
i bjlUijly˜ijl and y˜ijl =
yi −W>i α− E>i θ − U>(jl)β(jl). It can be shown that
lwjl =
pi1
pi1 + (1− pi1)12s(σ2ωjl)−
1
2 exp
{
−1
2
σ2ωjl
(
νκ−2
∑n
i=1 u
−1
i bjlUijly˜ijl
)2}[
Φ
(
µωjl
σωjl
)]−1 ,
where Φ(·) is the cumulative distribution function of the standard normal random variable.
At the gth iteration, the value of φ
w(g)
jl can be determined by whether the ω
(g)
jl is set to 0 or
not. Recall that φ
w(g)
jl = 0 implies that the jth genetic variant does not have the main effect
(if l=1) or the interaction effect with the (l − 1)th E factor (if l > 1).
The full conditional distribution for ui is Inverse-Gaussian:
ui|rest ∼ Inverse-Gaussian(µui , λui),
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where the shape parameter λui = 2ν, mean parameter µui =
√
2κ2
(Yi−y˜i)2 and y˜i = Yi−W>i α−
E>i θ − U>i β.
With the conjugate Inverse–Gamma prior, the posteriors of s2 is still an Inverse–Gamma
distribution
s2|rest ∼ Inv-Gamma
(
1 +
1
2
∑
j,l
I{ωjl 6=0}, η +
1
2
∑
j,l
ω2jl
)
.
With conjugate Beta priors, pi0 and pi1 have beta posterior distributions
pi0|rest ∼ Beta
(
a0 +
p∑
j=1
I{bj 6=0}, b0 +
p∑
j=1
I{bj=0}
)
,
pi1|rest ∼ Beta
(
a1 +
∑
j,l
I{ωjl 6=0}, b1 +
∑
j,l
I{ωjl=0}
)
.
Last, the full conditional distribution for ν is Gamma distribution
ν|rest ∼ Gamma (sν , rν) ,
where the shape parameter sν = c +
3n
2
and the rate parameter rν = d +
∑n
i=1 ui +
(2κ2)−1
∑n
i=1 u
−1
i y˜i
2. Under our prior setting, conditional posterior distributions of all un-
known parameters have closed forms by conjugacy. Therefore, efficient Gibbs sampler can
be constructed for the posterior distribution.
To facilitate fast computation and reproducible research, we have implemented the pro-
posed and all the alternative methods in C++
4.2.4 A summary of proposed and alternative methods
All the methods under comparison can be grouped according to three criteria: with or with-
out robustness, with or without spike-and-slab priors, and the types of structured sparsity
(individual-, group- and bi-level) accommodated through variable selection. We first de-
scribe the robust Bayesian methods with spike-and-slab priors: RBSG–SS, RBG–SS and
RBL–SS, which have all been proposed for the first time. Among them, RBSG–SS is the
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golden method developed for conducting robust sparse group variable selection for G×E
interactions with spike-and-slab priors on both the group and individual levels. Besides,
RBG–SS and RBL–SS are robust Bayesian group level and individual level selection with
spike–and–slab priors, respectively. The spike–and–slab prior has only been imposed on the
group level in RBG–SS. Compared to RBSG–SS, it does not induce within group sparsity.
On the other hand, RBL–SS conducts individual-level selection without accounting for group
structure. An immediate family of robust methods related to the three are RBSG, RBG and
RBL, which do not adopt spike–and–slab priors and cannot shrink coefficients corresponding
to the main and interaction effects to zero exactly. While RBG and RBL can be directly
derived based on Li et al. (2010), RBSG, robust Bayesian sparse group selection, has not
been investigated in existing studies so far.
We have also included six non-robust methods for comparison. Among them, BSG–SS,
BG–SS and BL–SS are the non–robust counterparts of RBSG–SS, RBG–SS and RBL–SS,
respectively. In particular, the BSG–SS conducts (non–robust) Bayesian sparse group selec-
tion with spike-and-slab priors on group and individual level simultaneously, while variable
selection has only been conducted on group (individual) level through RBG–SS (RBL–SS)
under the spike–and–slab priors. In addition, BSG, BG and BL can be viewed as the bench-
marks without incorporating spike–and–slab priors corresponding to BSG–SS, BG–SS and
BL–SS. They can also be considered as the non–robust counterpart corresponding to RBSG,
RBG and RBL. All the six non–robust alternatives can be readily derived based on existing
studies.
For clarification, we list all the methods under comparison in Table C.1 in the Appendix.
Our contribution includes developing the 4 robust Bayesian variable selection approaches,
RBSG–SS, RBG–SS, RBL–SS and RBSG among the first time. For all the rest of the
approaches, a modification to the methods from the references provided in Table C.1 by
including clinical covariates is necessary. Otherwise, these methods cannot be adopted for a
direct comparison with the four newly developed ones.
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4.3 Simulation
We comprehensively evaluate the proposed and alternative methods through simulation stud-
ies. Under all the settings, the responses are generated from model (4.1) with n = 500, q =
3, p = 100 and k = 5, which leads to a total of 105 main effects, 500 interactions and 3
additional clinical covariates. Thus, the actual dimension of coefficient vector is 608, higher
than the sample size (n = 500). The genetic main effects and G×E interactions form 100
groups with group size L = 6. Within each one of the following examples, we consider six
different error distributions for i’s: N(0, 1)(Error 1), Laplace(µ,b) with the mean µ = 0
and the scale parameter b = 2 (Error 2), 10%Laplace(0,1) + 90%Laplace(0,
√
5) (Error 3),
90%N(0,1) + 10%Cauchy(0, 1) (Error 4), t-distribution with 2 degrees of freedom (t(2))
(Error 4), LogNormal(0,1) (Error 5). All of them are heavy-tailed distributions except the
first one.
We assess the performance in terms of identification and prediction accuracy. For meth-
ods incorporating spike–and–slab priors, we consider the median probability model (MPM)
(Barbieri and Berger (2004); Xu and Ghosh (2015)) to identify important effects. In partic-
ular, for the proposed RBSG–SS, we define φjl = φ
b
jφ
w
jl for the lth predictor in the jth group.
At the gth MCMC iterations, this predictor is included in the model if the indicator φ
(g)
jl is
1. Suppose we have collected G posterior samples from the MCMC after burn-ins, then the
posterior probability of including the lth predictor from the jth group in the final model is
pjl = pˆi(φjl = 1|y) = 1
G
G∑
g=1
φ
(g)
jl , j = 1, . . . , p and l = 1, . . . , L. (4.11)
A higher posterior inclusion probability pjl can be interpreted as a stronger empirical ev-
idence that the corresponding predictor has a non-zero coefficient and is associated with
the phenotype. The MPM model is defined as the model consisting of predictors with at
least 1
2
posterior inclusion probability. When the goal is to select a single model, Barbieri
and Berger (Barbieri and Berger (2004)) recommends using MPM because of its optimal
prediction performance. Meanwhile, the 95% credible interval (95%CI) (Li et al. (2015)) is
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adopted for methods without spike–and–slab priors.
Prediction performance is evaluated using the mean prediction errors on an independently
generated testing dataset under the same data generating model over 100 replicates. For all
robust approaches, the prediction error is defined as mean absolute deviations (MAD). MAD
can be computed as 1
n
∑n
i=1 |yi − yˆi|. The prediction error for non–robust ones is defined as
the mean squared error (MSE), i.e., 1
n
∑n
i=1 (yi − yˆi)2.
Example 1
We generate a n × p matrix of gene expressions with n = 500 and p = 100, from
a multivariate normal distribution with marginal mean 0 and marginal variance 1. We
consider an auto-regression (AR) correlation structure for gene expression data, in which
gene j and h have correlation coefficient ρ|j−h|, with ρ = 0.3 (1 6 j, h 6 p). For E factors,
five continuous variables are generated from a multivariate normal distribution with marginal
mean 0, marginal variance 1 and AR correlation structure with ρ = 0.5. We then dichotomize
one of them at 0 to create a binary variable. Thus, there are four continuous and one binary E
factor. At last, we simulate three clinical covariates from a multivariate normal distribution
and AR correlation structure with ρ = 0.5, and dichotomize one of them at 0 to create a
binary clinical covariate.
For the clinical covariates and environmental main effects, their coefficients αt’s and
θm’s are generated from Uniform[0.8, 1.5]. For genetic main effect and G×E interactions,
we randomly selected 25 βjl’s in 9 groups to have non-zero values that are generated from
Uniform[0.3, 0.9]. All other βjl’s are set to zeros.
Example 2
We assess the performance under single-nucleotide polymorphism (SNP) data. The SNPs
are obtained by dichotomizing the gene expression values at the 1st and 3rd quartiles, with
the 3–level (0,1,2) for genotypes (aa,Aa,AA) respectively. Here, the gene expressions are
generated from Example 1.
Example 3
Consider simulating the SNP data under a pairwise linkage disequilibrium (LD) structure.
Let the minor allele frequencies (MAFs) of two neighboring SNPs with risk alleles A and
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B be r1 and r2, respectively. The frequencies of four haplotypes are as pAB = r1r2 + δ,
pab = (1 − r1)(1 − r2) + δ, pAb = r1(1 − r2) − δ, and paB = (1 − r1)r2 − δ, where δ denotes
the LD. Assuming Hardy-Weinberg equilibrium and given the allele frequency for A at
locus 1, we can generate the SNP genotype (AA, Aa, aa) from a multinomial distribution
with frequencies (r21, 2r1(1 − r1), (1 − r1)2). The genotypes at locus 2 can be simulated
according to the conditional genotype probability matrix in Cui et al. (2008). We have
δ = rp
√
r1(1− r1)r2(1− r2) with MAFs 0.3 and pairwise correlation rp = 0.6.
Example 4
A more practical correlation structure is adopted in this example. We extract the first
100 SNPs from the NHS data analyzed in the case study, so the correlation is based on the
real data. For each simulation replicate, we randomly sample 500 subjects from the dataset.
The same coefficients and error distributions from the first 3 examples are adopted.
Table 4.1: Simulation results in Example 1. (n, q, k, p) = (500, 2, 5, 100). mean(sd) of
true positives (TP), false positives (FP) and prediction errors (Pred) based on 100 replicates.
RBSG–SS RBG–SS RBL–SS BSG–SS BG–SS BL–SS
Error 1 TP 24.97(0.18) 25.00(0.00) 24.93(0.25) 24.97(0.18) 25.00(0.00) 24.93(0.25)
N FP 1.30(1.24) 29.60(2.42) 1.30(1.44) 0.47(0.68) 29.00(0.00) 0.43(0.73)
Pred 0.83(0.03) 0.86(0.03) 0.84(0.04) 1.07(0.07) 1.13(0.07) 1.08(0.08)
Error 2 TP 21.66(1.72) 24.84(0.55) 18.58(2.14) 19.98(1.95) 24.58(0.86) 15.54(2.04)
L FP 1.32(1.33) 30.96(4.27) 1.62(1.64) 1.82(1.53) 30.98(4.83) 0.92(0.94)
Pred 2.15(0.10) 2.17(0.09) 2.24(0.12) 9.32(0.97) 8.98(0.79) 10.09(1.08)
Error 3 TP 21.28(2.24) 24.80(0.73) 18.14(2.68) 19.00(2.61) 24.40(1.09) 14.24(2.39)
Mix.L FP 1.48(1.34) 30.64(4.23) 1.42(1.63) 2.04(1.73) 30.20(4.73) 1.18(1.16)
Pred 2.29(0.12) 2.32(0.11) 2.41(0.12) 11.11(1.12) 10.59(0.95) 12.02(1.12)
Error 4 TP 23.80(1.30) 24.93(0.37) 21.80(1.94) 16.20(6.45) 21.83(5.24) 12.53(5.79)
t2 FP 0.53(0.86) 29.47(2.56) 0.20(0.41) 3.73(4.61) 35.77(23.92) 1.93(2.49)
Pred 1.50(0.14) 1.52(0.13) 1.53(0.14) 12.48(6.56) 12.34(7.27) 13.35(6.72)
Error 5 TP 24.33(0.76) 25.00(0.00) 22.93(1.20) 22.93(1.26) 25.00(0.00) 18.00(2.17)
logNor FP 0.26(0.45) 29.00(0.00) 0.13(0.35) 4.30(3.40) 34.80(8.11) 1.23(1.55)
Pred 1.16(0.10) 1.18(0.10) 1.18(0.10) 4.75(1.24) 4.78(1.23) 5.18(1.34)
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Table 4.2: Simulation results in Example 1. (n, q, k, p) = (500, 2, 5, 100). mean(sd) of
true positives (TP), false positives (FP) and prediction errors (Pred) based on 100 replicates.
RBSG RBG RBL BSG BG BL
Error 1 TP 21.87(1.38) 24.67(0.76) 21.97(1.40) 22.93(1.34) 24.93(0.37) 23.07(1.23)
FP 2.63(1.94) 55.33(15.76) 3.07(2.35) 2.43(1.77) 83.47(20.07) 11.20(4.34)
Pred 1.15(0.05) 1.37(0.06) 1.15(0.05) 1.73(0.12) 2.29(0.19) 2.21(0.17)
Error 2 TP 14.48(2.04) 23.06(1.96) 14.42(2.12) 15.18(2.06) 24.02(1.48) 15.48(2.30)
FP 0.64(0.85) 32.26(7.41) 0.74(0.88) 2.20(1.55) 85.78(20.06) 14.06(4.41)
Pred 2.57(0.11) 2.85(0.13) 2.57(0.11) 12.43(1.15) 15.92(1.68) 16.55(1.69)
Error 3 TP 13.74(2.65) 22.52(2.38) 13.80(2.66) 14.30(2.70) 23.92(1.37) 14.62(2.69)
FP 0.68(0.68) 34.24(8.93) 0.80(0.83) 2.74(1.48) 97.40(19.78) 15.96(4.30)
Pred 2.71(0.12) 3.00(0.14) 2.71(0.12) 14.36(1.35) 18.52(1.70) 19.25(1.84)
Error 4 TP 16.90(3.12) 21.83(3.04) 16.90(3.36) 11.70(5.86) 20.70(5.74) 12.07(5.44)
FP 0.33(0.48) 27.97(8.48) 0.27(0.45) 3.10(2.64) 88.50(28.58) 14.83(5.52)
Pred 1.85(0.15) 2.10(0.17) 1.85(0.15) 16.25(9.88) 22.78(17.05) 24.20(18.91)
Error 5 TP 16.26(2.28) 23.42(2.01) 16.42(2.16) 13.80(3.37) 23.24(2.25) 14.24(3.05)
FP 0.32(0.62) 29.38(7.54) 0.32(0.65) 3.00(2.14) 94.72(27.12) 16.26(4.84)
Pred 2.20(0.14) 2.49(0.17) 2.21(0.14) 15.94(4.43) 20.73(5.12) 21.66(5.48)
We have collected the posterior samples from the Gibbs sampler running 15,000 iterations
while discarding the first 7,500 samples as burn-ins. The Bayesian estimates are calculated
using the posterior medians. Simulation results for the gene expression data in Example 1
are tabulated in Table (4.1) and (4.2). We can observe that the performance of methods
that adopt spike–and–slab priors in Table (4.1) is consistently better than methods without
spike–and–slab priors in Table (4.2). Although, methods without spike–and–slab priors
have slightly lower FPs than their counterparts with spike–and–slab priors under some error
distributions, they tend to have much lower TPs and higher prediction errors under all the
error distributions. For example, under Error2, RBSG identifies 14.48(SD 2.04) out of the
25 true positives, much lower than the true positives of 21.66(SD 1.72) from RBSG–SS.
Meanwhile, its false positives 0.64(SD 0.85) is only slightly lower than the FP of RBSG–SS
(1.32(SD 1.33)). The prediction error of RBSG, 2.57 with a SD of 0.11, is also inferior than
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that of the RBSG–SS (2.17(SD 0.10)). Such an advantage can also be observed by comparing
other methods in Table (4.1) with their counterparts (without spike–and–slab priors) from
Table (4.2).
Among all the methods with spike–and–slab priors, as shown in Table (4.1), the proposed
RBSG–SS has the best performance in both identification and prediction in the presence of
data contamination and heavy–tailed errors. Under the mixture Laplace error (Error 3),
RSGB–SS identifies 21.28(SD 2.24) true positives, with a small number of false positives,
1.48(SD 1.34). RBG–SS has a true positive of 24.80(SD 0.73), however, the number of false
positives, 30.64(SD 4.23), is much higher. This is due to the fact that RBG–SS only conducts
group level selection and does not impose the within-group sparsity. Compared to RBSG–
SS, RBL–SS ignores the group structure, leading to fewer true positives of 18.14(SD2.68).
In terms of prediction, RBSG–SS has the smallest L1 error, 2.29(0.12), among all the 3
robust methods with spike–and–slab priors. Although the difference in prediction error
between RBSG–SS and RBG–SS is not distinct, considering the much smaller number of
false positive main and interaction effects, we can fully observe the advantage of RSGB–SS
over RBG–SS in prediction.
Moreover, a cross–comparison between the robust and non–robust methods further demon-
strates the necessity of developing robust Bayesian methods. For instance, under the error
of t distribution with 2 degrees of freedom (Error 4), RBSG–SS has identified 23.80(SD
1.30) true main and interaction effects with only 0.53(SD 0.86) false positives. Its direct
non–robust competitor, BSG–SS, leads to a true positive of 16.20(SD 6.45) with 3.73(SD
4.61) false effects. The superior performance of RBSG–SS over the other two non–robust
methods, BG–SS and BL–SS, is also clear. Although a comparison between the prediction
errors of robust and non–robust methods is not feasible as the two are computed under the
L1 and least square errors, the identification results convincingly suggest the advantage of
robust methods over non-robust ones,
Similar patterns have been observed in Table C.3, C.4, C.5, C.6, C.7 and C.8 for Examples
2, 3 and 4, respectively, in the Appendix. Overall, based on the investigations over all
the methods through comprehensive simulation studies, we can establish the advantage of
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conducting robust Bayesian bi–level selection incorporating spike–and–slab priors.
We demonstrate the sensitivity of RBSG–SS for variable selection to the choice of the
hyper–parameters for pi0, and pi1 in the Appendix. The results are tabulated in Table C.2,
showing that the MPM model is insensitive to different specification of the hyper-parameters.
Following Li et al. Li et al. (2015), we assess the convergence of the MCMC chains by the po-
tential scale reduction factor (PSRF).Brooks and Gelman (1998); Gelman and Rubin (1992)
PSRF values close to 1 indicate that chains converge to the stationary distribution. Gelman
et al. Gelman et al. (2004) recommend using PSRF≤ 1.1 as the cutoff for convergence,
which has been adopted in our study. We compute the PSRF for each parameter and find
all chains converge after the burn-ins. For the purpose of demonstration, Figure C.1 shows
the pattern of PSRF the first five groups of coefficients in Example 1 under Error 2. The
figure clearly shows the convergence of the proposed Gibbs sampler.
4.4 Real Data Analysis
4.4.1 Nurses’ Health Study (NHS) data
Nurses’ Health Study (NHS) is one of the largest investigations into the risk factors for ma-
jor chronic diseases in women. As part of the the Gene Environment Association Studies
initiative (GENEVA), the NHS provides SNP genotypes data as well as detailed information
on dietary and lifestyle variables. Obesity level is one of the most important risk factors
for Type 2 diabetes mellitus (T2D), a chronic disease determined by both genetic and en-
vironmental factors. In this study, we analyze the NHS type 2 diabetes data to identify
genetic factors that are associated with obesity via genetic main effect or gene-environment
interactions. We use weight as the response and focus on SNPs on chromosome 10. We
consider five environment factors, including the total physical activity (act), glycemic load
(gl), cereal fiber intake (ceraf), alcohol intake (alcohol) and a binary indicator of whether an
individual has a history of high cholesterol (chol). All these environmental exposures have
been suggested to be associated with obesity and diabetes (Hu et al. (2001)). In addition,
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we consider three clinical covariates: height, age and a binary indicator of whether an in-
dividual has a history of hypertension (hbp). In NHS study, about half of the subjects are
diagnosed of type 2 diabetes and the other half are controls without the disease. We only
use health subjects in this study. After cleaning the data through matching phenotypes and
genotypes, removing SNPs with minor allele frequency (MAF) less than 0.05 or deviation
from Hardy–Weinberg equilibrium, the working dataset contains 1732 subjects with 35099
SNPs.
For computational convenience prescreening can be conducted to reduce the feature space
to a more attainable size for variable selection. For example, Li et al. Li et al. (2015) use
the single SNP analysis to filter SNPs in a GWA study before downstream analysis. In this
study, we use a marginal linear model with weight as the response variable to evaluate the
penetrance effect of a variant under the environmental exposure. The marginal linear model
use a group of genetic main effect and G×E interactions of a SNP as the predictors, and test
whether this SNP has any effect, main or G×E interaction, at all. The SNPs with p-values
less than a certain cutoff (0.001) for any effect, main or interaction, from the test are kept.
253 SNPs pass the screening.
The proposed approach RBSG-SS identifies 22 main SNP effects and 45 G×E interactions.
The detailed estimation results are provided in Table C.9 in the Appendix. We observe that
the proposed method identifies main and interaction effects of SNPs with important implica-
tions in obesity. For example, two important SNPs, rs6482836 and rs10741150, that located
within gene DOCK1 are identified. DOCK1 (Dedicator Of Cytokinesis 1) has been reported
as a putative candidate for obesity related to adiponectin and triceps skinfold by previous
studies (Kim et al. (2019); Vaughan et al. (2015)). RBSG-SS identifies the main effect of
rs6482836 and its interaction with the E factor act. Physical activity plays an important role
in the prevention of overweight and obese (Wareham et al. (2005)). This result suggests that
the expression level of DOCK1 in an individual may influence the effect of physical activity
in obesity prevention. RBSG-SS also identifies the interaction between rs10741150 and the
E factor chol, suggesting that the effect of cholesterol level can be mediated by DOCK1.
Interestingly, a previous study has shown that the expression level of DOCK5, an important
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paralog of DOCK1, is increased in individuals exposed to a diet high in saturated fatty acids
(El-Sayed Moustafa et al. (2012)). Our results provide more evidence of the importance of
DOCK1 in diet-induced obesity. Another example is the SNP rs11196539, located within
gene NRG3. NRG3(Neuregulin 3) has been found to be associated with both the basal
metabolic rate (BMR) and body mass index (BMI) (Lee et al. (2016)). RBSG-SS identifies
its interaction with the E factors, gl and alcohol. Both glycemic load and alcohol intake are
important dietary variables associated with obesity. The continued intake of high-glycemic
load meals leads to an increased risk of obesity (Brand-Miller et al. (2002)). The increasing
alcohol consumption is associated with a decline in body mass index in women (Nanchahal
et al. (2000)), however, heavy drinking can increase risk of the metabolic syndrome (Baik
and Shin (2008)). Our results suggest that further investigation of NRG3 may help explain
the mechanism of the effects of glycemic load and alcohol intake on obesity. For the environ-
ment main effects, two E factors, chol and gl, have positive coefficients, and the other three,
act, ceraf and alcohol, have negative coefficients, which are consistent with findings in the
previous literature.
In addition to the proposed approach, we also conduct analysis using the alternatives
RBL-SS, BSG-SS and BL-SS. As other alternative methods show inferior performance in
simulation, they are not considered in real data analysis. Detailed estimation results are
provided in Table C.10, C.11 and C.12 in the Appendix. In Table 4.3, we provide the
numbers of main G effects and interactions identified by different approaches and their
overlaps. We can observe that the proposed method identifies different main G effects and
more significantly different interactions from those identified by the alternatives. To further
investigate the biological similarity of the identified genes, we conduct the the Gene Ontology
(GO) analysis. We observe that there is an obvious difference between the proposed method
and the three alternatives. The GO analysis results are provided in Figure C.2.
With real data, it is difficult to objectively evaluate the selection performance. The
prediction performance may provide additional information on the relative performance of
different methods. Following Yan and Huang (2012) and Li et al. (2015), we refit the models
selected by RBSG-SS and RBL-SS by the Robust Bayesian Lasso, and refit the models
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selected by BSG-SS and BL-SS by the Bayesian Lasso. For the comparison between the
robust methods, the prediction mean absolute deviations (PMAD) are computed based on
the posterior median estimates. The PMADs are 8.64 and 8.88 for RBSG-SS and RBL-SS,
respectively. The proposed method outperforms than the competitor. For the comparison
between the non-robust methods, the prediction mean squared errors (PMSE) are computed.
The PMSEs are 128.39 and 137.77 for BSG-SS and BL-SS, respectively. The sparse group
method outperforms than the individual selection method.
4.4.2 TCGA skin cutaneous melanoma data
In this case study, we analyze the Cancer Genome Atlas (TCGA) skin cutaneous melanoma
(SKCM) data. TCGA ia a cancer genomics program organized by the National Cancer
Institute (NCI) and the National Human Genome Research Institute (NHGRI). It publishes
high quality clinical, environmental, and genetic data. For this study, we use the level-3
gene expression data of SKCM downloaded from the cBio Cancer Genomics Portal (Cerami
et al. (2012); Krauthammer et al. (2015)). Our goal is to identify genes that have genetic
main effect or G×E interaction effects on the Breslow’ thickness, an important prognostic
variable for SKCM (Marghoob et al. (2000)). The log-transformed Breslows depth is used as
the response variable and four E factors are considered, age, AJCC pathologic tumor stage,
gender and Clark level. Data are available on 294 subjects and 20,531 gene expressions. We
adopt the same screening method used in the first case study to select 109 genes for further
analysis.
The proposed approach RBSG-SS identifies 16 main SNP effects and 32 G×E interactions.
The detailed estimation results are provided in Table C.13 in the Appendix. One important
gene identified is CXCL6 (C-X-C Motif Chemokine Ligand 6), a chemokine with neutrophil
chemotactic and angiogenic activites. It has been reported that CXCL6 plays an important
role in melanoma growth and metastasis (Verbeke et al. (2011)). RBSG-SS identifies its main
effect and its interactions with E factors, stage and Clark level. This suggests that CXCL6
can have different effects at different stages of melanoma. Another important finding is the
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gene MAGED4, one of member in MAGE(Melanoma-associated antigen) family. MAGE
family contains genes that are highly attractive targets for cancer immunotherapy (Zhang
et al. (2014b)). MAGED4 has been found to be an potential target for glioma immunotherapy
(Sang et al. (2011)). RBSG-SS identifies the main effect of MAGED4 and its interaction
with the E factor tumor stage, suggesting that MAGED4 may also play an important role
in SKCM and its effect may change over different tumor stages. For the main effects of the
E factors, Clark level and tumor stage have positive coefficients, and age and gender have
negative coefficients, which match observations in the literature.
Analysis is further conducted using the three alternatives, and the comparison results
are summarized in Table 4.3. Detailed estimation results are provided in Table C.14, C.15
and C.16 in the Appendix. As for the previous case study, the proposed approach identifies
different sets of main and G×E interaction effects from those identified by the alternatives.
We also investigate the biological similarity of the identified genes by GO analysis (Figure
C.2). The results show that there is an obvious difference between the proposed method
and the three alternatives. Prediction performance is also evaluated. The PMADs are 0.69
and 0.83 for RBSG-SS and RBL-SS, respectively. The proposed approach again has better
prediction performance than RBL-SS. The PMSEs are 0.93 and 1.05 for BSG-SS and BL-
SS, respectively. The sparse group method still outperforms than the individual selection
method.
4.5 Discussion
In this study, we have developed robust Bayesian variable selection methods for gene-
environment interaction studies. The robustness of our methods comes from Bayesian formu-
lation of LAD regression. In G×E studies, the demand for robustness arises in heavy-tailed
distribution/ data contamination in both the response and predictors, as well as model
misspecification. We have focused on the first case, which is frequently encountered in prac-
tice. Investigations of the robust Bayesian methods accommodating the other two cases are
interesting and will be pursued in the future.
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Table 4.3: The numbers of main G effects and interactions identified by different approaches
and their overlaps.
NHS Main G effects Interactions
RBSG-SS RBL-SS BSG-SS BL-SS RBSG-SS RBL-SS BSG-SS BL-SS
RBSG-SS 22 20 16 13 45 21 17 10
RBL-SS 29 20 16 39 14 14
BSG-SS 29 25 34 22
BL-SS 27 42
SKCM Main G effects Interactions
RBSG-SS RBL-SS BSG-SS BL-SS RBSG-SS RBL-SS BSG-SS BL-SS
RBSG-SS 16 10 14 13 32 11 18 10
RBL-SS 17 12 14 33 15 24
BSG-SS 22 15 29 14
BL-SS 20 33
Recently, penalization has emerged as a power tool for dissecting G×E interactions Zhou
et al. (2020a). Our literature review suggests that Bayesian variable selection methods, al-
though tightly related to penalization, has not been fully explored for interaction analyses,
let alone the robust ones. We are among the first to conduct robust G×E analysis within the
Bayesian framework. The proposed Bayesian LAD sparse group LASSO are not only specif-
ically tailored for G×E studies, and but also generally applicable for problems incorporating
the bi-level structure in a broader context, such as simultaneously selection of prognostic
genes and pathways Liu et al. (2019). The spike-and-slab priors have been incorporated to
further improve identification and prediction performances. As a byproduct, the Bayesian
LAD LASSO and group LASSO, both with spike-and-slab priors, have also been investigated
for the first time. The computational feasibility of the Gibbs samplers are guaranteed by
the R package robin, with the core modules of the MCMC algorithms developed in C++.
In G×E studies, the form of interaction effects can be linear, nonlinear, and both linear
and nonlinear, resulting in parametric Wu et al. (2018a); Zhou et al. (2019a,b), nonparamet-
ric Li et al. (2015); Wu et al. (2018c) and semiparametric variable selection methods Ren
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et al. (2020a); Wu et al. (2014, 2015) to dissect G×E interactions, respectively. The proposed
study can be potentially generalized to these studies within robust Bayesian framework. For
example, variable selection for multiple semiparametric G×E studies can be formulated as
a combination of individual and group level selection problem, where the robust Bayesian
methods based on sparse group, group and individual level selection are directly applicable.
The proposed robust Bayesian framework has paved the way for the future investigations.
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Summary
This dissertation focuses on developing penalized variable selection methods, from both fre-
quentist and Bayesian perspectives, to conduct efficient variable selection of high dimensional
omics data with complicated network and interaction structures.
Incorporation of the correlation structure as networks within the framework of penalized
variable selection, can lead to more accurate identification of important omics features and
improved prediction (Li and Li (2008) and Huang et al. (2011)). However, the existing
network–based methods lack robust properties, which are critical to accommodate data
contamination and longtailed distributions in survival time data. In Chapter 2, we develop
a novel robust network-based variable selection method under the AFT model for survival
time in cancer genomic studies. Our method significantly distinguishes from existing ones
in (1) we adopt a weighted LAD objective function to accommodate data contamination,
with Kaplan-Meier weights for censoring; (2) to incorporate the interconnections among gene
expressions, we propose a network-constrained penalty of the “MCP+L1” form, and develop
an efficient algorithm within the coordinate descent framework. The paper associated with
this study is published at the Genetic Epidemiology (Ren et al. (2019a)).
Gene–environment (G×E) interactions plays an important in elucidating the disease eti-
ology for complex diseases, such as cancer, Type 2 Diabetes and asthma. Many studies
have demonstrated the advantages of penalization methods in detecting G×E interactions
from frequentist point of view (Wu et al. (2019)). Bayesian variable selection, however, has
not been widely developed for interaction studies. In Chapter 3, we have proposed a novel
semi-parametric Bayesian variable selection method to simultaneously pinpoint important
G×E interactions in both linear and nonlinear forms while conducting automatic structure
discovery. The superior performance of the proposed method over multiple alternatives has
been demonstrated through extensive simulation studies and a case study. This work is
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published at Statistics in Medicine (Ren et al. (2020a)).
In the last part of the dissertation, we have developed a novel robust Bayesian variable
selection method to dissect G×E interactions in genomic studies. The proposed Bayesian
LAD sparse group method can effectively accommodate heavy-tailed errors and outliers in the
response variable while conducting variable selection by accounting for structural sparsity.
To the best of our knowledge, we are among the first to conduct robust G×E analysis within
the Bayesian framework. The proposed method are not only specifically tailored for G×E
studies, but also generally applicable for problems incorporating the bi-level structure in a
broader context.
To facilitate reproducible research and fast computation, we have developed open source
R packages for each project, which provide highly efficient C++ implementation for all
the proposed and alternative approaches. The R packages regnet (Ren et al. (2019b)) and
spinBayes (Ren et al. (2019c)), associated with the first and second project correspondingly,
are available on CRAN. For the third project, the R package robin is available from GitHub
and will be submitted to CRAN soon.
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Appendix A
Appendices for Chapter 2
A.1 Additional simulation results
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Table A.1: Simulation for gene expression data (n, p) = (300, 505). 50 genes have nonzero
regression coefficients. 5 clinical covariates are not subject to selection. The gene expressions
have Banded.1 (upper panel) or Banded.2 structure (lower panel) with ρ = 0.5. mean(sd) of
true positives (TP) and false positives (FP) based on 100 replicates.
LAD Network LAD MCP LAD LASSO Network MCP LASSO
Banded.1 ρ = 0.5
Error1 TP 41.30(6.26) 36.87(3.16) 32.80(6.73) 35.37(4.41) 27.93(2.35) 45.30(2.38)
FP 13.43(10.74) 8.57(8.39) 105.53(45.21) 8.37(3.65) 8.63(6.67) 85.40(10.19)
Error2 TP 24.93(9.84) 19.77(15.93) 26.93(12.59) 2.00(5.55) 2.47(8.90) 3.17(5.34)
FP 23.00(24.92) 79.87(124.43) 105.27(67.09) 11.93(44.98) 17.97(79.54) 14.10(33.67)
Error3 TP 39.63(9.88) 32.00(4.88) 33.70(6.93) 18.77(10.76) 16.87(9.36) 30.17(14.13)
FP 11.80(9.28) 17.97(31.91) 111.17(46.28) 9.40(6.98) 7.03(4.06) 60.30(32.13)
Error4 TP 36.03(11.87) 30.43(5.37) 30.33(7.91) 12.97(11.78) 11.40(10.67) 22.80(16.40)
FP 11.90(10.46) 21.57(29.67) 109.40(48.10) 8.23(8.18) 6.73(7.25) 52.83(36.92)
Banded.2 ρ = 0.5
Error1 TP 43.63(7.89) 42.43(3.22) 33.53(9.72) 34.20(4.34) 25.20(4.13) 47.40(1.69)
FP 8.07(7.72) 10.83(14.28) 101.17(48.16) 9.17(4.89) 10.07(4.64) 80.93(12.3)
Error2 TP 31.77(11.31) 26.60(10.75) 33.33(5.57) 3.43(8.64) 3.27(7.98) 6.27(8.48)
FP 24.73(43.87) 100.50(119.98)129.90(45.73) 17.00(69.35) 15.03(61.68) 19.40(24.64)
Error3 TP 41.40(8.58) 35.50(5.47) 33.50(7.66) 15.17(11.58) 12.37(8.46) 29.93(15.21)
FP 12.97(27.18) 10.80(17.94) 114.40(54.39) 8.80(8.26) 7.33(5.57) 61.27(30.46)
Error4 TP 37.57(11.66) 32.87(5.69) 34.03(7.3) 14.87(13.23) 11.83(10.39) 26.33(16.11)
FP 9.60(8.62) 19.00(31.61) 113.30(50.56) 9.30(9.34) 7.97(7.45) 55.17(33.04)
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Table A.2: Simulation for gene expression data using correlations calculated from LUSC
data. (n, p) = (300, 505). 50 genes have nonzero regression coefficients. 5 clinical covariates
are not subject to selection. mean(sd) of true positives (TP) and false positives (FP) based
on 100 replicates.
LAD Network LAD MCP LAD LASSO Network MCP LASSO
Error1 TP 46.88(3.61) 46.29(2.89) 40.47(6.29) 45.66(2.21) 43.42(2.38) 48.09(1.18)
FP 1.28(2.00) 3.83(4.83) 1.97(2.69) 1.44(1.92) 1.58(2.20) 13.27(3.66)
Error2 TP 33.65(6.54) 32.59(8.21) 33.69(5.54) 11.02(7.35) 18.25(7.12) 18.14(8.35)
FP 9.92(23.64) 28.03(45.27) 13.27(14.75) 23.94(52.35) 73.50(71.82) 17.14(21.58)
Error3 TP 43.00(6.79) 41.63(5.95) 41.15(6.03) 30.24(11.93) 28.81(8.41) 39.35(9.46)
FP 3.14(3.91) 5.58(6.60) 3.85(6.80) 5.52(12.42) 12.43(29.37) 21.83(11.31)
Error4 TP 40.91(6.53) 40.02(5.67) 39.72(5.82) 22.99(11.13) 23.39(8.16) 35.02(9.72)
FP 3.07(3.41) 8.60(10.37) 3.12(6.07) 7.07(22.44) 18.22(37.61) 26.29(25.11)
Table A.3: Simulation for gene expression data using correlations calculated from NSCLC
data. (n, p) = (300, 505). 50 genes have nonzero regression coefficients. 5 clinical covariates
are not subject to selection. mean(sd) of true positives (TP) and false positives (FP) based
on 100 replicates.
LAD Network LAD MCP LAD LASSO Network MCP LASSO
Error1 TP 43.10(6.57) 43.32(3.41) 41.01(6.91) 47.12(3.08) 39.67(3.12) 45.91(1.65)
FP 1.40(2.00) 3.02(3.77) 5.68(9.65) 0.83(1.44) 1.44(2.27) 23.01(12.09)
Error2 TP 36.44(9.83) 33.73(6.75) 34.46(5.28) 25.23(6.41) 11.27(3.03) 19.72(5.92)
FP 13.80(25.85) 34.36(55.80) 23.14(42.02) 43.94(34.98) 15.86(18.95) 14.23(8.96)
Error3 TP 41.51(8.41) 39.23(6.68) 38.17(6.52) 38.20(10.43) 24.93(9.19) 35.45(8.77)
FP 4.75(6.41) 11.10(12.24) 13.47(20.48) 13.66(37.16) 8.64(34.40) 22.71(21.76)
Error4 TP 42.13(7.50) 38.58(6.86) 39.72(6.14) 34.56(10.60) 19.90(9.03) 30.23(9.58)
FP 7.03(9.27) 13.33(25.09) 16.63(28.77) 30.02(72.28) 13.17(42.50) 19.57(27.40)
111
Table A.4: Simulation for SNP data (n, p) = (300, 505) under AR structures. 50 genes
have nonzero regression coefficients. 5 clinical covariates are not subject to selection. The
SNPs have AR structure with ρ = 0.5 (upper panel) and ρ = 0.8 (lower panel). mean(sd) of
true positives (TP) and false positives (FP) based on 100 replicates.
LAD Network LAD MCP LAD LASSO Network MCP LASSO
AR ρ = 0.5
Error1 TP 39.97(9.05) 39.77(3.54) 34.50(6.24) 33.50(6.60) 29.83(6.88) 46.03(2.30)
FP 8.83(5.80) 9.33(7.71) 106.03(37.94) 9.13(6.26) 8.77(5.17) 84.53(11.25)
Error2 TP 23.23(10.57) 22.43(10.93) 27.43(8.64) 5.17(9.41) 6.93(14.32) 6.10(8.79)
FP 23.93(40.56) 57.97(95.48) 110.17(66.55) 32.03(86.43) 45.67(126.72) 23.67(39.83)
Error3 TP 37.03(10.07) 36.17(4.53) 34.30(6.39) 16.17(11.50) 15.07(10.51) 28.30(16.74)
FP 9.00(6.44) 15.93(26.06) 107.77(43.29) 8.50(5.76) 8.30(5.45) 58.40(34.86)
Error4 TP 38.13(7.35) 34.17(6.01) 34.90(7.04) 10.63(10.55) 9.83(9.89) 19.90(17.49)
FP 10.17(6.86) 27.17(41.85) 109.70(45.23) 6.73(6.10) 6.07(6.49) 40.63(41.16)
AR ρ = 0.8
Error1 TP 46.87(5.11) 45.30(2.87) 42.87(6.06) 48.70(1.42) 26.07(3.49) 48.73(1.01)
FP 3.80(2.96) 3.47(2.66) 104.20(30.42) 10.00(7.89) 6.67(3.39) 60.00(12.99)
Error2 TP 38.80(10.71) 26.17(6.93) 35.93(4.16) 5.97(10.07) 6.10(12.41) 5.70(7.53)
FP 12.20(8.02) 44.20(83.64) 105.40(32.2) 35.30(89.14) 43.57(111.1) 25.77(42.43)
Error3 TP 46.70(6.02) 39.90(5.94) 43.17(3.65) 33.23(16.9) 18.10(9.78) 33.97(15.77)
FP 6.77(5.88) 6.10(10.6) 105.63(28.03) 18.97(16.06) 20.83(65.59) 60.93(29.47)
Error4 TP 42.87(10.92) 36.03(6.83) 42.17(4.47) 25.93(16.99) 13.43(8.39) 29.33(15.39)
FP 5.67(4.56) 10.30(21.71) 120.90(48.61) 19.77(13.39) 7.57(6.82) 50.30(31.1)
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Table A.5: Simulation for SNP data (n, p) = (300, 505) under banded structures. 50
genes have nonzero regression coefficients. 5 clinical covariates are not subject to selection.
The SNPs have Banded.1 (upper panel) or Banded.2 structure (lower panel) with ρ = 0.5.
mean(sd) of true positives (TP) and false positives (FP) based on 100 replicates.
LAD Network LAD MCP LAD LASSO Network MCP LASSO
Banded.1 ρ = 0.5
Error1 TP 39.17(9.57) 36.87(8.19) 30.13(8.40) 31.80(3.95) 26.57(4.39) 43.97(3.18)
FP 9.10(5.92) 13.53(21.54) 91.63(43.74) 8.27(5.30) 8.53(6.22) 81.93(12.6)
Error2 TP 19.17(9.70) 18.30(13.42) 25.43(8.69) 2.83(7.39) 3.60(9.97) 3.17(5.17)
FP 14.93(13.16) 57.30(93.44) 97.63(51.97) 17.30(60.78) 24.20(89.50) 13.10(27.14)
Error3 TP 33.33(10.57) 32.47(4.61) 29.97(8.37) 14.60(13.06) 12.83(11.25) 24.40(17.98)
FP 8.00(4.61) 18.57(38.32) 101.23(52.47) 8.13(7.21) 6.63(6.19) 53.10(37.71)
Error4 TP 33.53(13.54) 29.43(8.05) 31.00(6.77) 11.43(8.63) 10.83(7.73) 24.40(12.76)
FP 16.37(12.94) 18.30(36.76) 108.90(39.14) 7.07(7.91) 6.53(5.78) 56.57(30.96)
Banded.2 ρ = 0.5
Error1 TP 41.23(8.78) 40.57(3.30) 34.23(7.57) 32.23(6.74) 27.77(5.10) 45.93(1.76)
FP 10.83(7.68) 9.17(7.45) 113.63(46.59) 9.63(6.7) 9.30(4.23) 84.00(12.91)
Error2 TP 21.10(7.69) 20.53(13.05) 27.27(8.2) 1.60(1.96) 1.63(2.11) 3.03(4.19)
FP 17.27(10.43) 76.43(122.77) 93.57(49.76) 5.10(10.5) 5.00(10.3) 11.40(15.40)
Error3 TP 35.60(9.11) 34.90(4.48) 34.20(5.11) 15.30(10.17) 14.37(9.68) 28.67(16.14)
FP 10.60(7.02) 15.63(38.21) 117.63(38.53) 9.80(7.23) 9.50(7.10) 66.77(37.00)
Error4 TP 38.50(8.44) 36.47(5.17) 33.20(7.07) 12.43(10.86) 11.80(10.26) 21.80(18.26)
FP 18.77(13.23) 41.57(69.17) 109.73(42.16) 11.13(26.16) 12.90(30.37) 45.90(38.12)
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Table A.6: Simulation for SNP data based on the linkage disequilibrium (LD) structure.
(n, p) = (300, 505). 50 genes have nonzero regression coefficients. 5 clinical covariates are
not subject to selection. mean(sd) of true positives (TP) and false positives (FP) based on
100 replicates.
LAD Network LAD MCP LAD LASSO Network MCP LASSO
Error1 TP 46.47(4.62) 42.94(5.09) 43.10(3.54) 46.25(2.17) 44.94(2.62) 45.93(2.03)
FP 4.30(6.29) 9.43(16.91) 28.10(13.34) 2.59(3.12) 2.85(4.23) 21.52(5.25)
Error2 TP 38.22(7.42) 34.44(7.76) 27.45(4.70) 23.90(5.28) 12.15(9.04) 10.34(9.56)
FP 18.84(18.76) 46.88(69.94) 49.31(16.43) 95.05(59.21) 36.10(82.64) 20.73(22.59)
Error3 TP 45.38(4.71) 40.16(5.59) 39.12(5.01) 26.16(15.89) 27.16(13.09) 33.03(13.71)
FP 5.85(6.66) 11.17(23.56) 35.25(12.73) 10.22(32.97) 25.37(77.51) 36.70(18.09)
Error4 TP 42.65(6.21) 39.28(5.35) 36.40(5.03) 21.66(15.24) 25.14(12.31) 28.30(14.80)
FP 5.99(5.63) 17.00(31.33) 39.82(14.83) 13.95(38.37) 44.58(108.55) 36.91(21.17)
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A.2 Biological similarity analysis
GO enrichment analysis was conducted using the R package GOSim. GO biological processes
that are associated with identified genes are divided into four categories: positive regulation
(P), negative regulation (N), regulation (R, without a well-defined direction) and other (O).
The proportions of genes that involve in the four categories of processes are computed for
each methods. The results are provided in Figure A.1.
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Figure A.1: Gene Ontology (GO) analysis: proportions of genes that have the four cate-
gories of processes with different approaches. Left: NSCLC data. Right: LUSC data. A1:
LAD Network. A4: LAD MCP. A3: LAD LASSO. A4: Network. A5: MCP. A6: LASSO.
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Appendices for Chapter 3
B.1 Hyper-parameters sensitivity analysis
We demonstrate the sensitivity of BSSVC-SI for variable selection to the choice of the hy-
perparameters for piv, pic and pie. We consider five different Beta priors: (1) Beta(0.5, 0.5)
which is a U-shape curve between (0, 1); (2) Beta(1, 1) which is a essentially a uniform
prior; (3) Beta(2, 2) which is a quadratic curve; (4) Beta(1, 5) which is highly right-skewed;
(5) Beta(5, 1) which is highly left-skewed. As a demonstrating example, we use the same
setting of Example 2 to generate data. Table C.2 shows the identification performance of the
median thresholding model (MPM) with different Beta priors. For all choices of Beta priors,
the MPM model is very stable for both the proposed model BSSVC-SI and the alternative
BSSVC. Also BSSVC-SI correctly identifies almost all true effects with low false positives in
all cases. Therefore, we simply use Beta(1, 1) as the prior for piv, pic and pie in this study.
We also evaluate the sensitivity of BSSVC-SI to the choice of the Gamma hyperpriors
on λv, λc and λe. We test the shape parameter of the Gamma prior for five different
values: {0.1, 0.5, 1, 2, 5}. This ranges from highly skewed exponential shape to highly diffuse
unimodal shape. We fix the rate parameter at {1, 2, 5} and test different combinations of
shape and rate parameters on a two-dimensional grid. In Table B.2, we show the simulation
results of some representative cases under the scenarios of Example 2. BSSVC-SI model has
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stable performance with high TP and low FP for different Gamma priors. Similar patterns
are observed for all other cases. In this study, we use Gamma(1, 1) for λv, λc and λe under
all scenarios.
Table B.1: Sensitivity analysis. (n, p, q) = (500, 100, 2). mean(sd) of true positives (TP)
and false positives (FP) based on 100 replicates.
BSSVC-SI BSSVC
Varying Constant Nonzero Varying Constant Nonzero
Beta(0.5, 0.5) TP 3.00(0.00) 5.00(0.00) 5.00(0.00) 3.00(0.00) 0.00(0.00) 5.00(0.00)
FP 0.07(0.25) 0.00(0.00) 0.00(0.00) 5.07(0.25) 0.00(0.00) 0.03(0.18)
Beta(1, 1) TP 3.00(0.00) 5.00(0.00) 5.00(0.00) 3.00(0.00) 0.00(0.00) 5.00(0.00)
FP 0.07(0.25) 0.00(0.00) 0.03(0.18) 5.00(0.00) 0.00(0.00) 0.10(0.31)
Beta(2, 2) TP 3.00(0.00) 4.93(0.25) 5.00(0.00) 3.00(0.00) 0.00(0.00) 5.00(0.00)
FP 0.20(0.48) 0.00(0.00) 0.00(0.00) 4.97(0.18) 0.00(0.00) 0.10(0.31)
Beta(1, 5) TP 3.00(0.00) 4.97(0.18) 5.00(0.00) 3.00(0.00) 0.00(0.00) 5.00(0.00)
FP 0.17(0.46) 0.00(0.00) 0.00(0.00) 5.00(0.00) 0.00(0.00) 0.03(0.18)
Beta(5, 1) TP 3.00(0.00) 5.00(0.00) 5.00(0.00) 3.00(0.00) 0.00(0.00) 5.00(0.00)
FP 0.27(0.52) 0.07(0.25) 0.03(0.18) 5.07(0.25) 0.00(0.00) 0.27(0.58)
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Table B.2: Sensitivity analysis. (n, p, q) = (500, 100, 2). mean(sd) of true positives (TP)
and false positives (FP) based on 100 replicates.
BSSVC-SI BSSVC
Varying Constant Nonzero Varying Constant Nonzero
Gamma(0.1, 1) TP 3.00(0.00) 4.93(0.26) 5.00(0.00) 3.00(0.00) 0.00(0.00) 5.00(0.00)
FP 0.20(0.41) 0.07(0.26) 0.00(0.00) 5.00(0.00) 0.00(0.00) 0.07(0.26)
Gamma(0.5, 2) TP 3.00(0.00) 5.00(0.00) 5.00(0.00) 3.00(0.00) 0.00(0.00) 5.00(0.00)
FP 0.07(0.26) 0.00(0.00) 0.00(0.00) 5.00(0.00) 0.00(0.00) 0.00(0.00)
Gamma(1, 1) TP 3.00(0.00) 5.00(0.00) 5.00(0.00) 3.00(0.00) 0.00(0.00) 5.00(0.00)
FP 0.07(0.25) 0.00(0.00) 0.03(0.18) 5.00(0.00) 0.00(0.00) 0.10(0.31)
Gamma(1, 5) TP 3.00(0.00) 4.93(0.26) 5.00(0.00) 3.00(0.00) 0.00(0.00) 5.00(0.00)
FP 0.07(0.26) 0.00(0.00) 0.07(0.26) 5.00(0.00) 0.00(0.00) 0.07(0.26)
Gamma(2, 5) TP 3.00(0.00) 4.93(0.26) 5.00(0.00) 3.00(0.00) 0.00(0.00) 5.00(0.00)
FP 0.13(0.35) 0.07(0.26) 0.00(0.00) 4.93(0.26) 0.00(0.00) 0.00(0.00)
Gamma(5, 1) TP 3.00(0.00) 5.00(0.00) 5.00(0.00) 3.00(0.00) 0.00(0.00) 5.00(0.00)
FP 0.20(0.41) 0.00(0.00) 0.00(0.00) 5.07(0.26) 0.00(0.00) 0.20(0.41)
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B.2 FDR-based variable selection
The FDR-based variable selection selects variables with posterior inclusion probability larger
than certain threshold that is chosen to control the overall Bayesian FDR rate. Specifically,
a threshold ψα can be determined for flagging the set of predictors Ψψα = {j : pj > ψα}
as significant, for a given overall FDR bound α ∈ (0, 1). The threshold ψα is chosen in
a way that we expect less than 100α% of the predictors in set Ψψα are false positive on
average. To compute threshold ψα, we first sort the {pj, j = 1, . . . , p} in descending order
to obtain {p(j), j = 1, . . . , p}. To compute threshold ψα, we first sort the {pj, j = 1, . . . , p}
in descending order to obtain {p(j), j = 1, . . . , p}. Then ψα = p(ξ) with ξ = max{j∗ :
1
j∗
∑j∗
j=1(1− p(j)) 6 α}. The (1− pj) is interpreted as the estimate of the local FDR (Storey
(2003)) that measures the probability of including the jth predictor when the jth predictor
is not in the true model.
Table B.3: Simulation results for FDR-based variable selection. (n, p, q) = (500, 100, 2).
mean(sd) of true positives (TP) and false positives (FP) based on 100 replicates.
BSSVC-SI BSSVC
Varying Constant Nonzero Varying Constant Nonzero
Example 1 TP 3.00(0.00) 4.93(0.25) 5.00(0.00) 3.00(0.00) 0.00(0.00) 5.00(0.00)
FP 0.17(0.38) 0.07(0.25) 0.00(0.00) 5.20(0.41) 0.00(0.00) 0.13(0.35)
Example 2 TP 3.00(0.00) 5.00(0.00) 5.00(0.00) 3.00(0.00) 0.00(0.00) 5.00(0.00)
FP 0.10(0.31) 0.10(0.31) 0.03(0.18) 5.23(0.50) 0.00(0.00) 0.13(0.35)
Example 3 TP 2.97(0.18) 4.97(0.18) 5.00(0.00) 3.00(0.00) 0.00(0.00) 5.00(0.00)
FP 0.03(0.18) 0.17(0.46) 0.00(0.00) 5.10(0.31) 0.00(0.00) 0.10(0.31)
Example 4 TP 3.00(0.00) 5.00(0.00) 5.00(0.00) 3.00(0.00) 0.00(0.00) 5.00(0.00)
FP 0.07(0.25) 0.00(0.00) 0.07(0.25) 5.13(0.35) 0.00(0.00) 0.20(0.41)
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B.3 Variable selection based on 95% credible interval
Alternatives BVC-SI and BVC lack for the variable selection property. In order to create
sparsity on the coefficients estimated by these three methods, we consider a 95% credible
interval based method used in Li et al. (2015). Specifically, a varying effect is included in the
final model if at least one of its spline coefficients has a two-sided 95% credible interval that
does not cover zero. Similarly, a constant effect is included in the final model if two-sided
95% credible interval od its spline coefficient does not cover zero. The same rule applies to
the linear interaction effects. The results are tabulated in Table B.4.
Table B.4: Simulation results. (n, p, q) = (500, 100, 2). mean(sd) of true positives (TP)
and false positives (FP) based on 100 replicates.
BVC-SI BVC
Varying Constant Nonzero Varying Constant Nonzero
Example 1 TP 2.98(0.15) 4.73(0.45) 5.00(0.00) 3.00(0.00) 0.00(0.00) 5.00(0.00)
FP 1.89(1.40) 0.42(0.69) 4.07(2.27) 6.13(1.18) 0.00(0.00) 3.16(2.02)
Example 2 TP 3.00(0.00) 4.76(0.48) 5.00(0.00) 3.00(0.00) 0.00(0.00) 5.00(0.00)
FP 3.27(2.38) 0.36(0.57) 5.13(2.32) 6.78(1.52) 0.00(0.00) 4.20(2.21)
Example 3 TP 3.00(0.00) 4.78(0.42) 5.00(0.00) 3.00(0.00) 0.00(0.00) 5.00(0.00)
FP 2.09(1.86) 0.24(0.53) 4.33(2.32) 6.04(1.30) 0.00(0.00) 3.42(2.11)
Example 4 TP 3.00(0.00) 4.78(0.52) 5.00(0.00) 3.00(0.00) 0.00(0.00) 5.00(0.00)
FP 3.33(1.98) 0.24(0.43) 6.47(2.66) 6.51(1.36) 0.00(0.00) 5.07(2.61)
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B.4 Sensitivity analysis on smoothness specification
Let O denotes the degree of B spline basis, and K denotes the number of interior knots.
Huang et al. (2002, 2004) show that n1/(2O+3) is the optimal order of the number of spline
knots K. For quadratic and cubic splines corresponding to O = 2 and 3 respectively, We
conduct a sensitivity analysis for the proposed model under the setting of Example 2 for
K ∈ [1, 4]. Table B.5 shows that K = 1 leads to unsatisfactory performance, especially for
prediction. When K ≥ 2, different values of K lead to similar performance under O = 2 and
O = 3. This suggests the model performance is insensitive with respect to the smoothness
specification. We conduct a sensitivity analysis for the proposed model under the setting of
Example 2 given K ∈ [1, 4],
Table B.5: Sensitivity analysis on smoothness specification. (n, p, q) = (500, 100, 2).
mean(sd) of true positives (TP), false positives (FP) and prediction error based on 100
replicates.
O = 2 Varying Constant Nonzero
K TP FP TP FP TP FP Pred.Error
1 2.97(0.18) 0.20(0.55) 4.87(0.35) 0.10(0.31) 4.97(0.18) 0.03(0.18) 1.998(0.152)
2 3.00(0.00) 0.03(0.18) 5.00(0.00) 0.00(0.00) 5.00(0.00) 0.00(0.00) 1.172(0.071)
3 3.00(0.00) 0.00(0.00) 5.00(0.00) 0.03(0.18) 5.00(0.00) 0.13(0.43) 1.140(0.093)
4 3.00(0.00) 0.07(0.25) 4.93(0.25) 0.00(0.00) 5.00(0.00) 0.00(0.00) 1.200(0.118)
O = 3 Varying Constant Nonzero
K TP FP TP FP TP FP Pred.Error
1 3.00(0.00) 0.17(0.38) 4.87(0.35) 0.03(0.18) 5.00(0.00) 0.00(0.00) 1.676(0.159)
2 3.00(0.00) 0.00(0.00) 5.00(0.00) 0.03(0.18) 5.00(0.00) 0.03(0.18) 1.089(0.054)
3 3.00(0.00) 0.00(0.00) 4.97(0.18) 0.03(0.18) 5.00(0.00) 0.00(0.00) 1.185(0.072)
4 3.00(0.00) 0.00(0.00) 5.00(0.00) 0.03(0.18) 5.00(0.00) 0.03(0.18) 1.156(0.078)
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B.5 Additional simulation results
Table B.6: Simulation results in Example 2. SNP genotype data (n, p, q) = (500, 100, 2).
mean(sd) of the integrated median mean squared error (IMSE), median mean squared error
(MSE), total squared errors for all estimates and prediction errors based on 100 replicates.
BSSVC-SI BSSVC BVC-SI BVC BL
IMSE
µ(Z) 0.043(0.013) 0.043(0.012) 0.055(0.024) 0.055(0.022) 200.857(3.626)
β1(Z) 0.042(0.020) 0.021(0.012) 0.069(0.031) 0.085(0.031) 181.351(4.523)
β2(Z) 0.027(0.018) 0.021(0.012) 0.044(0.025) 0.049(0.025) 25.653(10.366)
β3(Z) 0.030(0.026) 0.026(0.022) 0.074(0.034) 0.094(0.038) 136.250(5.223)
MSE
α1 0.011(0.012) 0.012(0.013) 0.022(0.023) 0.022(0.022) 0.065(0.083)
α2 0.003(0.003) 0.003(0.004) 0.007(0.009) 0.007(0.008) 0.023(0.033)
ζ0 0.033(0.025) 0.024(0.019) 0.081(0.057) 0.106(0.062) 135.875(3.861)
ζ1 0.005(0.005) 0.006(0.007) 0.009(0.013) 0.008(0.013) 0.025(0.036)
ζ2 0.008(0.009) 0.006(0.008) 0.019(0.023) 0.019(0.022) 0.065(0.104)
ζ3 0.009(0.015) 0.009(0.013) 0.017(0.023) 0.019(0.025) 0.065(0.070)
ζ4 0.009(0.014) 0.011(0.019) 0.011(0.015) 0.010(0.014) 0.045(0.080)
ζ5 0.006(0.007) 0.006(0.008) 0.020(0.028) 0.024(0.030) 0.065(0.086)
Total 0.227(0.083) 0.253(0.104) 2.020(0.260) 1.931(0.228) 548.430(13.003)
Pred.
Error 1.160(0.071) 1.169(0.064) 2.196(0.180) 2.155(0.154) 7.870(0.445)
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Table B.7: Simulation results in Example 3. SNP genotype data based on the linkage
disequilibrium (LD) structure (n, p, q) = (500, 100, 2). mean(sd) of the integrated median
mean squared error (IMSE), median mean squared error (MSE), total squared errors for all
estimates and prediction errors based on 100 replicates.
BSSVC-SI BSSVC BVC-SI BVC BL
IMSE
µ(Z) 0.046(0.015) 0.045(0.014) 0.060(0.023) 0.058(0.022) 200.784(3.630)
β1(Z) 0.059(0.025) 0.025(0.013) 0.112(0.045) 0.120(0.045) 182.705(6.130)
β2(Z) 0.035(0.018) 0.023(0.017) 0.051(0.024) 0.054(0.025) 28.617(12.114)
β3(Z) 0.032(0.019) 0.027(0.018) 0.083(0.049) 0.105(0.051) 142.424(15.015)
MSE
α1 0.003(0.005) 0.003(0.004) 0.006(0.009) 0.006(0.009) 0.017(0.020)
α2 0.005(0.006) 0.004(0.006) 0.010(0.015) 0.009(0.013) 0.024(0.026)
ζ0 0.010(0.013) 0.008(0.011) 0.024(0.034) 0.023(0.033) 0.075(0.095)
ζ1 0.008(0.014) 0.008(0.015) 0.012(0.016) 0.011(0.014) 0.051(0.093)
ζ2 0.010(0.014) 0.008(0.012) 0.024(0.035) 0.025(0.035) 0.088(0.092)
ζ3 0.009(0.008) 0.010(0.009) 0.024(0.034) 0.024(0.032) 0.102(0.114)
ζ4 0.013(0.017) 0.022(0.022) 0.026(0.034) 0.023(0.030) 0.064(0.090)
ζ5 0.017(0.026) 0.038(0.034) 0.032(0.039) 0.030(0.036) 0.050(0.065)
Total 0.307(0.107) 0.407(0.141) 2.176(0.219) 2.015(0.207) 559.260(24.011)
Pred.
Error 1.203(0.064) 1.209(0.068) 2.164(0.137) 2.088(0.132) 7.683(0.424)
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Table B.8: Simulation results in Example 4. SNP genotype from T2D data (n, p, q) =
(500, 100, 2). mean(sd) of the integrated median mean squared error (IMSE), median mean
squared error (MSE), total squared errors for all estimates and prediction errors based on
100 replicates.
BSSVC-SI BSSVC BVC-SI BVC BL
IMSE
µ(Z) 0.051(0.019) 0.051(0.019) 0.066(0.021) 0.064(0.020) 202.409(4.069)
β1(Z) 0.032(0.015) 0.018(0.011) 0.052(0.027) 0.068(0.030) 181.747(6.418)
β2(Z) 0.015(0.010) 0.014(0.009) 0.029(0.021) 0.033(0.020) 24.012(3.920)
β3(Z) 0.023(0.018) 0.019(0.013) 0.051(0.027) 0.066(0.030) 137.823(6.639)
MSE
α1 0.003(0.003) 0.003(0.004) 0.007(0.013) 0.007(0.013) 0.021(0.031)
α2 0.003(0.004) 0.003(0.005) 0.005(0.005) 0.005(0.004) 0.013(0.016)
ζ0 0.007(0.014) 0.007(0.016) 0.015(0.015) 0.014(0.014) 0.098(0.157)
ζ1 0.004(0.006) 0.004(0.005) 0.008(0.013) 0.008(0.011) 0.050(0.086)
ζ2 0.009(0.009) 0.006(0.007) 0.019(0.022) 0.018(0.020) 0.030(0.044)
ζ3 0.007(0.010) 0.007(0.009) 0.012(0.018) 0.012(0.021) 0.040(0.057)
ζ4 0.004(0.004) 0.004(0.004) 0.006(0.008) 0.006(0.008) 0.026(0.033)
ζ5 0.003(0.003) 0.003(0.004) 0.013(0.014) 0.014(0.014) 0.043(0.059)
Total 0.178(0.052) 0.194(0.049) 1.751(0.194) 1.648(0.157) 550.070(12.987)
Pred.
Error 1.141(0.073) 1.147(0.064) 2.164(0.134) 2.109(0.125) 8.575(0.458)
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B.6 Computational cost
Table B.9: Computational cost analysis for BSSVC-SI under the setting of Example 1. p:
number of genes. time: CPU time (in seconds) for 10,000 MCMC iterations. The number of
regression coefficients to be estimated after basis expansion is approximately qnp + p, where
qn is the number of basis function. In this study, qn = 5.
n = 500 n = 1500 n = 3000
# of genes time # of genes time # of genes time
p = 100 11.707 p = 300 121.396 p = 600 552.043
p = 200 24.878 p = 600 236.571 p = 900 834.645
p = 300 36.372 p = 900 341.366 p = 1200 988.939
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B.7 The estimated varying coefficient functions
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Figure B.1: Simulation study in Example 1 for the proposed method (BSSVC-SI). Red line:
true parameter values. Black line: median estimates of varying coefficients for BSSVC-SI.
Blue dashed lines: 95% credible intervals for the estimated varying coefficients.
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B.8 Assessment of the convergence of MCMC chains
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Figure B.2: Potential scale reduction factor (PSRF) against iterations for varying coeffi-
cient functions in Figure B.1. Black line: the PSRF. Red line: the threshold of 1.1. The γˆj1
to γˆj5, (j = 0, . . . , 3), represent the five estimated spline coefficients for the varying coefficient
function βj, respectively.
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B.9 Additional results for real data analysis
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Figure B.3: Real data analysis for the proposed method (BSSVC-SI). Black line: median
estimates of varying coefficients for BSSVC-SI. Blue dashed lines: 95% credible intervals for
the estimated varying coefficients.
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B.10 Posterior inference for the BSSVC-SI method
B.10.1 Priors
Y |η, γ11, . . . , γp1,γ1∗, . . . , γp∗, α1, . . . , αq, ζ0, ζ1, . . . , ζp, σ2
∝ (σ2)−n2 exp
{
− 1
2σ2
(Y − µ)>(Y − µ)
}
η ∼ Nqn(0, Ση0)
α ∼ Nq(0, Σα0)
ζ0 ∼ N(0, σ2ζ0)
γj1|pic, τ 2cj, σ2 ∼ picN(0, σ2τ 2cj) + (1− pic)δ0(γj1), j = 1, . . . , p
τ 2cj|λc ∼
λ2c
2
exp(−λ
2
cτ
2
cj
2
), j = 1, . . . , p
γj∗|piv, τ 2vj, σ2 ∼ pivNL(0, Diag(σ2τ 2vj, . . . , σ2τ 2vj)) + (1− piv)δ0(γj∗), j = 1, . . . , p
τ 2vj|λv ∼ Gamma(
L+ 1
2
,
Lλ2v
2
), j = 1, . . . , p
ζj|pie, τ 2ej, σ2 ∼ pieN(0, σ2τ 2ej) + (1− pie)δ0(ζj), j = 1, . . . , p
τ 2ej|λe ∼
λ2e
2
exp(−λ
2
eτ
2
ej
2
), j = 1, . . . , p
σ2 ∼ (σ2)−s−1 exp(− h
σ2
)
Consider the following conjugate gamma priors for λ2c , λ
2
v and λ
2
e
λ2c ∼ Gamma(ac, bc), λ2v ∼ Gamma(av, bv) and λ2e ∼ Gamma(ae, be)
and conjugate beta priors for pic, piv and pie
pic ∼ Beta(rc, wc), piv ∼ Beta(rv, wv) and pie ∼ Beta(re, we)
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B.10.2 Gibbs Sampler
pi(η|rest)
∝ pi(η)pi(y|·)
∝ exp
(
− 1
2
η>Σ−1η0 η
)
exp
(
− 1
2σ2
(Y − µ)>(Y − µ)
)
∝ exp
(
− 1
2
η>Σ−1η0 η −
1
2σ2
(Y −B0η − µ(−η))>(Y −B0η − µ(−η))
)
∝ exp
(
η>Σ−1η0 η +
1
σ2
η>B>0 B0η −
2
σ2
(Y − µ(−η))>(B0η)
)
∝ exp
(
η>
(
Σ−1η0 +
1
σ2
B>0 B0
)
η − 2
σ2
(Y − µ(−η))>B0η
)
where B0 = (B0(Z1), . . . , B0(Zn))
>. Hence, the full conditional distribution of η is multi-
variate normal with mean
µη =
(
Σ−1η0 +
1
σ2
B>0 B0
)−1( 1
σ2
(Y − µ(−η))>B0
)>
and variance
Ση =
(
Σ−1η0 +
1
σ2
B>0 B0
)−1
Similarly, the full conditional distribution of α is N(µα,Σα) with
µα =
(
Σ−1α0 +
1
σ2
W>W
)−1( 1
σ2
(Y − µ(−α))>W
)>
and variance
Σα =
(
Σ−1α0 +
1
σ2
W>W
)−1
where W = (W1, . . . ,Wn)
>. And the full conditional distribution of ζ0 is N(µζ0 ,Σζ0) with
µζ0 =
(
1/σ2ζ0 +
1
σ2
n∑
i=1
E2i
)−1( 1
σ2
n∑
i=1
(yi − µ(−ζ0))Ei
)
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and variance
Σζ0 =
(
1/σ2ζ0 +
1
σ2
n∑
i=1
E2i
)−1
The full conditional distribution of γj∗
pi(γj∗|rest)
∝ pi(γj∗|τ 2vj, σ2)pi(y|·)
∝ (σ2)−n2 exp
(
− 1
2σ2
(Y − Ujγj∗ − µ(−γj∗))>(Y − Ujγj∗ − µ(−γj∗))
)
×
(
piv(2piσ
2τ 2vj)
−L
2 exp
(
− 1
2σ2τ 2vj
γ>j∗γj∗
)
I{γj∗ 6=0} + (1− piv)δ0(γj∗)
)
(B.1)
where Uj = (U1j, . . . , Unj)
> is a n× L matrix.
lvj = pi(γj∗ 6= 0|rest)
=
piv
piv + (1− piv)(τ 2vj)
L
2 |Σγj∗|−
1
2 exp
(
− 1
2σ2
‖Σ
1
2
γj∗U
>
j (Y − µ(−γj∗))‖22
)
Hence, the full conditional distribution of γj∗ is a spike and slab distribution
γj∗|rest ∼ lvjN(µγj∗ , σ2Σγj∗) + (1− lvj)δ0(γj∗)
with mean
µγj∗ = Σγj∗U
>
j (Y − µ(−γj∗))
This posterior distribution is a mixture of a multivariate normal and a point mass at 0. To
sample from this posterior distribution at the gth iteration, we follow the steps:
• Generate u from Unif[0,1]
• If u ≤ lvj
– Generate t from N(µγj∗ , σ
2Σγj∗)
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– set γ
(g)
j∗ = t and φ
(g)
vj = 1
• If u > lvj
– set γ
(g)
j∗ = 0 and φ
(g)
vj = 0
Note that, when we sample γ
(g)
j∗ , we also compute the value of φ
(g)
vj . The full conditional
distribution of γj1 can be expressed as
pi(γj1|rest)
∝ pi(γj1|τ 2cj, σ2)pi(y|·)
∝ (σ2)−n2 exp
(
− 1
2σ2
(Y −Xjγj1 − µ(−γj1))>(Y −Xjγj1 − µ(−γj1))
)
×
(
pic(2piσ
2τ 2cj)
− 1
2 exp
(
− 1
2σ2τ 2cj
γ2j1
)
I{γj1 6=0} + (1− pic)δ0(γj1)
)
Let Σγj1 = (X
>
j Xj +
1
τ2cj
)−1, we have
lcj = pi(γj1 6= 0|rest)
=
pic
pic + (1− pic)(τ 2cj)
1
2 (Σγj1)
− 1
2 exp
(
− Σγj1
2σ2
‖(Y − µ(−γj1))>Xj‖22
)
Hence, the full conditional distribution of γj1 is a spike and slab distribution
γj1|rest ∼ lcjN(µγj1 , σ2Σγj1) + (1− lcj)δ0(γj1)
with mean
µγj1 = Σγj1X
>
j (Y − µ(−γj1))
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The full conditional distribution of ζj, j = 1, . . . , p
pi(ζj|rest)
∝ pi(ζj|τ 2j , σ2)pi(y|·)
∝ (σ2)−n2 exp
(
− 1
2σ2
(Y − Tjζj − µ(−ζj))>(Y − Tjζj − µ(−ζj))
)
×
(
pie(2piσ
2τ 2ej)
− 1
2 exp
(
− 1
2σ2τ 2ej
ζ2j
)
I{ζj 6=0} + (1− pie)δ0(ζj)
)
Let Σζj = (T
>
j Tj +
1
τ2ej
)−1, we have
lej = pi(ζj 6= 0|rest)
=
pie
pie + (1− pie)(τ 2ej)
1
2 (Σζj)
− 1
2 exp
(
− Σζj
2σ2
‖(Y − µ(−ζj))>Tj‖22
)
Hence, the full conditional distribution of ζj is a spike and slab distribution
ζj|rest ∼ lejN(µζj , σ2Σζj) + (1− lej)δ0(ζj)
where
µζj = ΣζjT
>
j (Y − µ(−ζj))
Now, we derive the full conditional distribution for τ 2vj, τ
2
cj and τ
2
ej.
pi(τ 2vj|rest)
∝ pi(τ 2vj|λv)pi(γj∗|τ 2vj, σ2)
∝ (τ 2vj)
L+1
2
−1 exp
(
− τ 2vj
Lλ2v
2
)
×
(
piv(2piσ
2τ 2vj)
−L
2 exp
(
− 1
2σ2τ 2vj
γ>j∗γj∗
)
I{γj∗ 6=0} + (1− piv)δ0(γj∗)
)
(B.2)
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When γj∗ = 0, B.2 is equal to
(1− piv)(τ 2vj)
L+1
2
−1 exp
(
− τ 2vj
Lλ2v
2
)
Therefore, when γj∗ = 0, the posterior distribution for (τ 2vj)
−1 is Inverse-Gamma(L+1
2
, Lλ
2
v
2
).
When γj∗ 6= 0, B.2 is equal to
pi(τ 2vj|rest)
∝ (1− piv)(2piσ2τ 2vj)−
L
2 (τ 2vj)
L+1
2
−1 exp
(
− τ 2vj
Lλ2v
2
)
exp
(
− 1
2σ2τ 2vj
γ>j∗γj∗
)
∝ (1− piv)(2piσ2)−L2 (τ 2vj)−
1
2 exp
(
− τ 2vj
Lλ2v
2
− ‖γj∗‖
2
2
2σ2τ 2vj
)
Therefore, when γj∗ 6= 0, the posterior distribution for (τ 2vj)−1 is Inverse-Gaussian(Lλ2v,√
Lλ2vσ
2
‖γj∗‖22 ). Together
(τ 2vj)
−1|rest ∼

Inverse-Gamma(L+1
2
, Lλ
2
v
2
) if γj∗ = 0
Inverse-Gaussian(Lλ2v,
√
Lλ2vσ
2
‖γj∗‖22 ) if γj∗ 6= 0
Similarly, the posterior distribution for (τ 2cj)
−1 is
pi(τ 2cj|rest)
∝ pi(τ 2cj|λc)pi(γj1|τ 2cj, σ2)
∝ λ
2
c
2
exp
(
− τ 2cj
λ2c
2
)
×
(
pic(2piσ
2τ 2cj)
− 1
2 exp
(
− 1
2σ2τ 2cj
γ2j1
)
I{γj1 6=0} + (1− pic)δ0(γj1)
)
(B.3)
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When γj1 = 0, B.3 is equal to
(1− pic)λ
2
c
2
exp
(
− τ 2cj
λ2c
2
)
Therefore, when γj1 = 0, the posterior distribution for (τ
2
cj)
−1 is Inverse-Gamma(1, λ
2
c
2
).
When γj1 6= 0, B.3 is equal to
pi(τ 2cj|rest)
∝ (1− pic)(2piσ2τ 2cj)−
1
2
λ2c
2
exp
(
− τ 2cj
λ2c
2
)
exp
(
− 1
2σ2τ 2cj
γ2j1
)
∝ (τ 2cj)−
1
2 exp
(
− τ 2cj
λ2c
2
− γ
2
j1
2σ2τ 2cj
)
Therefore, when γj1 6= 0, the posterior distribution for (τ 2cj)−1 is Inverse-Gaussian(λ2c ,
√
λ2cσ
2
γ2j1
).
Together
(τ 2cj)
−1|rest ∼

Inverse-Gamma(1, λ
2
c
2
) if γj1 = 0
Inverse-Gaussian(λ2c ,
√
λ2cσ
2
γ2j1
) if γj1 6= 0
The posterior distribution (τ 2ej)
−1
pi(τ 2ej|rest)
∝ pi(τ 2ej|λe)pi(ζj|τ 2ej, σ2)
∝ λ
2
e
2
exp
(
− τ 2ej
λ2e
2
)
×
(
pie(2piσ
2τ 2ej)
− 1
2 exp
(
− 1
2σ2τ 2ej
ζ2j
)
I{ζj 6=0} + (1− pie)δ0(ζj)
)
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Following the similar arguments, we have
(τ 2ej)
−1|rest ∼

Inverse-Gamma(1, λ
2
e
2
) if ζj = 0
Inverse-Gaussian(λ2e,
√
λ2eσ
2
ζ2j
) if ζj 6= 0
Now, we derive the full conditional distribution for λ2v and τ
2
cj. The posterior distribution
for λ2v:
pi(λ2v|rest)
∝ pi(λ2v)
p∏
j=1
pi(τ 2vj|λ2v)
∝ (λ2v)av−1 exp(−bvλ2v)
p∏
j=1
(
Lλ2v
2
)L+1
2
exp
(
− Lλ
2
v
2
τ 2vj
)
∝ (λ2v)av+
p(L+1)
2
−1 exp
(
− (bv +
L
∑p
j=1 τ
2
vj
2
)λ2v
)
the posterior distribution for λ2v is Gamma(av +
p(L+1)
2
, bv +
L
∑p
j=1 τ
2
vj
2
).
pi(λ2c |rest)
∝ pi(λ2c)
p∏
j=1
pi(τ 2cj|λ2c)
∝ (λ2c)ac−1 exp(−bcλ2c)
p∏
j=1
λ2c
2
exp
(
− λ
2
c
2
τ 2cj
)
∝ (λ2c)ac+p−1 exp
(
− (bc +
∑p
j=1 τ
2
cj
2
)λ2c
)
the posterior distribution for λ2c is Gamma(ac+p, bc+
∑p
j=1 τ
2
cj
2
). Similarly, the full conditional
distribution for λ2e is Gamma(ae + p, be +
∑p
j=1 τ
2
ej
2
).
Next, we derive the full conditional distribution for piv, pic and pie. The posterior distri-
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bution for piv
pi(piv|rest)
∝ pi(piv)
p∏
j=1
pi(γ2j∗|piv, τ 2vj, σ2)
∝ pirv−1v (1− piv)wv−1
×
p∏
j=1
(
piv(2piσ
2τ 2vj)
−L
2 exp
(
− 1
2σ2τ 2vj
γ>j∗γj∗
)
I{γj∗ 6=0} + (1− piv)δ0(γj∗)
)
∝ pirv+
∑p
j=1 I{γj∗6=0}−1
v (1− piv)wv+
∑p
j=1 δ0(γj∗)−1
the posterior distribution for piv is Beta(rv +
∑p
j=1 I{γj∗ 6=0}, wv +
∑p
j=1 δ0(γj∗)).
pi(pic|rest)
∝ pi(pic)
p∏
j=1
pi(γ2j1|pic, τ 2cj, σ2)
∝ pirc−1c (1− pic)wc−1
×
p∏
j=1
(
pic(2piσ
2τ 2cj)
− 1
2 exp
(
− 1
2σ2τ 2cj
γ2j1
)
I{γj1 6=0} + (1− pic)δ0(γj1)
)
∝ pirc+
∑p
j=1 I{γj1 6=0}−1
c (1− pic)wc+
∑p
j=1(δ0(γj1))−1
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the posterior distribution for pic is Beta(rc +
∑p
j=1 I{γj1 6=0}, wc +
∑p
j=1 δ0(γj1)).
pi(pie|rest)
∝ pi(pie)
p∏
j=1
pi(ζ2j |pie, τ 2ej, σ2)
∝ pire−1e (1− pie)we−1
×
p∏
j=1
(
pie(2piσ
2τ 2ej)
− 1
2 exp
(
− 1
2σ2τ 2ej
ζ2j
)
I{ζj 6=0} + (1− pie)δ0(ζj)
)
∝ pire+
∑p
j=1 I{ζj 6=0}−1
e (1− pie)we+
∑p
j=1(δ0(ζj))−1
the posterior distribution for pie is Beta(re +
∑p
j=1 I{ζj 6=0}, we +
∑p
j=1 δ0(ζj)). Last, the full
conditional distribution for σ2
pi(σ2|rest)
∝pi(σ2)pi(y|·)
p∏
j=1
pi(γj1|pic, τ 2cj, σ2)pi(γj∗|piv, τ 2vj, σ2)pi(ζj|pie, τ 2j , σ2)
∝(σ2)−s−1 exp(− h
σ2
)(σ2)−
n
2 exp
(
− 1
2σ2
(Y − µ)>(Y − µ)
)
×
p∑
j=1
(
pic(2piσ
2τ 2cj)
− 1
2 exp
(
− 1
2σ2τ 2cj
γ2j1
)
I{γj1 6=0} + (1− pic)δ0(γj1)
)
×
p∑
j=1
(
piv(2piσ
2τ 2vj)
−L
2 exp
(
− 1
2σ2τ 2vj
γ>j∗γj∗
)
I{γj∗ 6=0} + (1− piv)δ0(γj∗)
)
×
p∑
j=1
(
pie(2piσ
2τ 2ej)
− 1
2 exp
(
− 1
2σ2τ 2ej
ζ2j
)
I{ζj 6=0} + (1− pie)δ0(ζj)
)
∝(σ2)−(s+
n+L
∑
I{γj∗6=0}+
∑
I{ζj 6=0}+
∑
I{γj1 6=0}
2
)−1
× exp
(
− 1
σ2
(
h+
(Y − µ)>(Y − µ) +∑pj=1(τ 2cj)−1γ2j1 + (τ 2vj)−1γ>j∗γj∗ + (τ 2j )−1ζ2j
2
))
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the posterior distribution for σ2 is Inverse-Gamma(µσ2 , Σσ2) where
µσ2 = s+
n+ L
∑p
j=1 I{γj∗ 6=0} +
∑p
j=1 I{ζj 6=0} +
∑p
j=1 I{γj1 6=0}
2
Σσ2 = h+
(Y − µ)>(Y − µ) +∑pj=1(τ 2cj)−1γ2j1 + (τ 2vj)−1γ>j∗γj∗ + (τ 2j )−1ζ2j
2
B.11 Posterior inference for the BSSVC method
B.11.1 Priors
Y |η, γ1, . . . , γp,α1, . . . , αq, ζ0, ζ1, . . . , ζp, σ2
∝ (σ2)−n2 exp
{
− 1
2σ2
(Y − µ)>(Y − µ)
}
η ∼ Nqn(0, Ση0)
α ∼ Nq(0, Σα0)
ζ0 ∼ N(0, σ2ζ0)
γj|pic, τ 2vj, σ2 ∼ pivNqn(0, Diag(σ2τ 2vj, . . . , σ2τ 2vj)) + (1− piv)δ0(γj), j = 1, . . . , p
τ 2vj|λv ∼ Gamma(
qn + 1
2
,
qnλ
2
v
2
), j = 1, . . . , p
ζj|pie, τ 2ej, σ2 ∼ pieN(0, σ2τ 2ej) + (1− pie)δ0(ζj), j = 1, . . . , p
τ 2ej|λe ∼
λ2e
2
exp(−λ
2
eτ
2
ej
2
), j = 1, . . . , p
σ2 ∼ (σ2)−s−1 exp(− h
σ2
)
Consider the following conjugate gamma priors for λ2v and λ
2
e
λ2v ∼ Gamma(av, bv) and λ2e ∼ Gamma(ae, be)
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and conjugate beta priors for piv and pie
piv ∼ Beta(rv, wv) and pie ∼ Beta(re, we)
B.11.2 Posterior distribution
pi(η|rest) ∼ Nqn(µη, Ση) where
µη =
(
Σ−1η0 +
1
σ2
B>0 B0
)−1( 1
σ2
(Y − µ(−η))>B0
)>
Ση =
(
Σ−1η0 +
1
σ2
B>0 B0
)−1
pi(α|rest) ∼ Nq(µα,Σα) where
µα =
(
Σ−1α0 +
1
σ2
W>W
)−1( 1
σ2
(Y − µ(−α))>W
)>
Σα =
(
Σ−1α0 +
1
σ2
W>W
)−1
pi(ζ0|rest) ∼ N(µζ0 ,Σζ0) where
µζ0 =
(
σ−1ζ0 +
1
σ2
n∑
i=1
E2i
)−1( 1
σ2
n∑
i=1
(yi − µ(−ζ0))Ei
)
Σζ0 =
(
1/σ2ζ0 +
1
σ2
n∑
i=1
E2i
)−1
γj|rest ∼ lvjN(µγj , σ2Σγj) + (1− lvj)δ0(γj) where
µγj = ΣγjU
>
j (Y − µ(−γj))
Σγj = (U
>
j Uj +
1
τ 2vj
Iqn)
−1
lvj =
piv
piv + (1− piv)(τ 2vj)
qn
2 |Σγj |−
1
2 exp
(
− 1
2σ2
‖Σ
1
2
γjU
>
j (Y − µ(−γj))‖22
)
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ζj|rest ∼ lejN(µζj , σ2Σζj) + (1− lej)δ0(ζj) where
µζj = ΣζjT
>
j (Y − µ(−ζj))
Σζj = (T
>
j Tj +
1
τ 2ej
)−1
lej =
pie
pie + (1− pie)(τ 2ej)
1
2 (Σζj)
− 1
2 exp
(
− Σζj
2σ2
‖(Y − µ(−ζj))>Tj‖22
)
At the gth iteration, the values of φ
(g)
vj and φ
(g)
ej can be determined by whether the γ
(g)
j and
ζ
(g)
j are set to 0 or not, respectively.
(τ 2vj)
−1|rest ∼

Inverse-Gamma( qn+1
2
, qnλ
2
v
2
) if γj = 0
Inverse-Gaussian(qnλ
2
v,
√
qnλ2vσ
2
‖γj‖22 ) if γj 6= 0
(τ 2ej)
−1|rest ∼

Inverse-Gamma(1, λ
2
e
2
) if ζj = 0
Inverse-Gaussian(λ2e,
√
λ2eσ
2
ζ2j
) if ζj 6= 0
λv and λe all have Gamma posterior distributions
λ2v ∼ Gamma(av +
p(qn + 1)
2
, bv +
qn
∑p
j=1 τ
2
vj
2
)
λ2e ∼ Gamma(ae + p, be +
∑p
j=1 τ
2
ej
2
)
piv and pie have beta posterior distributions
piv ∼ Beta(rv +
p∑
j=1
I{γj 6=0}, wv +
p∑
j=1
δ0(γj))
pie ∼ Beta(re +
p∑
j=1
I{ζj 6=0}, we +
p∑
j=1
δ0(ζj))
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σ2 ∼ Inverse-Gamma(µσ2 ,Σσ2) where
µσ2 = s+
n+ qn
∑p
j=1 I{γj 6=0} +
∑p
j=1 I{ζj 6=0}
2
Σσ2 = h+
(Y − µ)>(Y − µ) +∑pj=1(τ 2vj)−1γ>j γj + (τ 2cj)−1ζ2j
2
B.12 Posterior inference for the BVC-SI method
B.12.1 Priors
Y |η, γ11, . . . , γp1,γ1∗, . . . , γp∗, α1, . . . , αq, ζ0, ζ1, . . . , ζp, σ2
∝ (σ2)−n2 exp
{
− 1
2σ2
(Y − µ)>(Y − µ)
}
η ∼ Nqn(0,Ση0)
α ∼ Nq(0,Σα0)
ζ0 ∼ N(0, σ2ζ0)
γj1|τ 2cj, σ2 ∼ N(0, σ2τ 2cj), j = 1, . . . , p
τ 2cj|λc ∼
λ2c
2
exp(−λ
2
cτ
2
cj
2
), j = 1, . . . , p
γj∗|τ 2vj, σ2 ∼ NL(0, diag(σ2τ 2vj, . . . , σ2τ 2vj)), j = 1, . . . , p
τ 2vj|λv ∼ Gamma(
L+ 1
2
,
Lλ2v
2
), j = 1, . . . , p
ζj|τ 2ej, σ2 ∼ N(0, σ2τ 2ej), j = 1, . . . , p
τ 2ej|λ ∼
λ2e
2
exp(−λ
2
eτ
2
ej
2
), j = 1, . . . , p
σ2 ∼ (σ2)−s−1 exp(− h
σ2
)
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Consider the following conjugate gamma priors for λ2c , λ
2
v and λ
2
e
λ2c ∼ Gamma(ac, bc), λ2v ∼ Gamma(av, bv) and λ2e ∼ Gamma(ae, be)
B.12.2 Gibbs Sampler
pi(η|rest) ∼ Nqn(µη, Ση) where
µη =
(
Σ−1η0 +
1
σ2
B>0 B0
)−1( 1
σ2
(Y − µ(−η))>B0
)>
Ση =
(
Σ−1η0 +
1
σ2
B>0 B0
)−1
pi(α|rest) ∼ Nq(µα,Σα) where
µα =
(
Σ−1α0 +
1
σ2
W>W
)−1( 1
σ2
(Y − µ(−α))>W
)>
Σα =
(
Σ−1α0 +
1
σ2
W>W
)−1
pi(ζ0|rest) ∼ N(µζ0 ,Σζ0) where
µζ0 =
(
1/σ2ζ0 +
1
σ2
n∑
i=1
E2i
)−1( 1
σ2
n∑
i=1
(yi − µ(−ζ0))Ei
)
Σζ0 =
(
1/σ2ζ0 +
1
σ2
n∑
i=1
E2i
)−1
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The full conditional distribution of γj
pi(γj∗|rest)
∝ pi(γj∗|τ 2vj, σ2)pi(y|·)
∝ exp
(
− 1
2
(σ2τ 2vj)
−1γ>j∗γj∗ −
1
2σ2
(Y − Ujγj∗ − µ(−γj∗))>(Y − Ujγj∗ − µ(−γj∗))
)
∝ exp
(
− 1
2σ2
(
(τ 2vj)
−1γ>j∗γj∗ + γ
>
j∗U
>
j Ujγj∗ − 2(Y − µ(−γj∗))>(Ujγj∗)
))
∝ exp
(
− 1
2σ2
(
γ>j∗
(
(τ 2vj)
−1 + U>j Uj
)
γj∗ − 2(Y − µ(−γj∗))>Ujγj∗
))
where Uj = (U1j, . . . , Unj)
>. Hence, the full conditional distribution of γj∗ is multivariate
normal with mean
µγj∗ =
(
(τ 2vj)
−1IL + U>j Uj
)−1(
(Y − µ(−γj∗))>Uj
)>
and variance
Σγj∗ = σ
2
(
(τ 2vj)
−1IL + U>j Uj
)−1
Similarly, the full conditional distribution of γj1 is normal distribution with mean
µγj1 =
(
(τ 2cj)
−1 +X>j Xj
)−1(
(yi − µ(−γj1))>Xj
)
and variance
Σγj1 = σ
2
(
(τ 2cj)
−1 +X>j Xj
)−1
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Let Dτe = diag(τ
2
e1, . . . , τ
2
ep). The full conditional distribution of ζ = (ζ1, . . . , ζp)
>
pi(ζ|rest)
∝ pi(ζ|τ 2e1, . . . , τ 2ep, σ2)pi(y|·)
∝ exp
(
− 1
2
(σ2Dτe)
−1ζ>ζ − 1
2σ2
(Y − Tζ − µ(−ζ))>(Y − Tζ − µ(−ζ))
)
∝ exp
(
− 1
2σ2
(
D−1τe ζ
>ζ + ζ>T>Tζ − 2(Y − µ(−ζ))>Tζ
))
∝ exp
(
− 1
2σ2
(
ζ>(D−1τe + T
>T )ζ − 2(Y − µ(−ζ))>Tζ
))
where T = (T1, . . . , Tn)
>. The full conditional is Np(µζ , σ2Σζ) with
µζ =
(
D−1τe + T
>T
)−1(
(Y − µ(−ζ))>T
)>
and variance
Σζ =
(
D−1τe + T
>T
)−1
Now, we derive the full conditional distribution for τ 2ej and λ
2
e.
pi(τ 2vj|rest)
∝ pi(τ 2vj|λv)pi(γj∗|τ 2vj, σ2)
∝ (τ 2vj)
L+1
2
−1 exp
(
− τ 2vj
Lλ2v
2
)
(τ 2vj)
−L
2 exp
(
− 1
2
(σ2τ 2vj)
−1γ>j∗γj∗
)
∝ (τ 2vj)−
1
2 exp
(
− τ 2vj
Lλ2v
2
− ||γj∗||
2
2
2σ2τ 2vj
)
the posterior distribution for (τ 2vj)
−1 is Inverse-Gaussian(Lλ2v,
√
Lλ2vσ
2
||γj∗||22 ). Similarly, the pos-
terior distribution for (τ 2cj)
−1 is Inverse-Gaussian(λ2c ,
√
λ2cσ
2
γ2j1
), and the posterior distribution
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for (τ 2ej)
−1 is Inverse-Gaussian(λ2e,
√
λ2eσ
2
ζ2j
).
pi(λ2v|rest)
∝ pi(λ2v)
p∏
j=1
pi(τ 2vj|λ2v)
∝ (λ2v)av−1 exp(−bvλ2v)
p∏
j=1
(
Lλ2v
2
)L+1
2
exp
(
− Lλ
2
v
2
τ 2vj
)
∝ (λ2v)av+
p(L+1)
2
−1 exp
(
− (bv +
L
∑p
j=1 τ
2
vj
2
)λ2v
)
the posterior distribution for λ2c is Gamma(ac+p, bc+
∑p
j=1 τ
2
cj
2
). Similarly, the full conditional
distribution for λ2e is Gamma(ae + p, be +
∑p
j=1 τ
2
ej
2
). Last, the full conditional distribution for
σ2
pi(σ2|rest)
∝ pi(σ2)pi(y|·)
p∏
j=1
pi(γj1|pic, τ 2cj, σ2)pi(γj∗|piv, τ 2vj, σ2)pi(ζj|pie, τ 2ej, σ2)
∝ (σ2)−s−1 exp(− h
σ2
)(σ2)−
n
2 exp
(
− 1
2σ2
(Y − µ)>(Y − µ)
)
× (σ2)− p2 exp
(
− 1
2σ2
p∑
j=1
(τ 2cj)
−1γ2j1
)
× (σ2)− pL2 exp
(
− 1
2σ2
p∑
j=1
(τ 2vj)
−1γ>j∗γj∗
)
× (σ2)− p2 exp
(
− 1
2σ2
p∑
j=1
(τ 2ej)
−1ζ2j
)
∝ (σ2)−(s+n+2p+pL2 )−1
× exp
(
− 1
σ2
(
h+
(Y − µ)>(Y − µ) +∑pj=1(τ 2cj)−1γ2j1 + (τ 2vj)−1γ>j∗γj∗ + (τ 2ej)−1ζ2j
2
))
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the posterior distribution for σ2 is Inverse-Gamma(µσ2 , Σσ2) where
µσ2 = s+
n+ 2p+ pL
2
Σσ2 = h+
(Y − µ)>(Y − µ) +∑pj=1(τ 2cj)−1γ2j1 + (τ 2vj)−1γ>j∗γj∗ + (τ 2ej)−1ζ2j
2
B.13 Posterior inference for the BVC method
B.13.1 Priors
Y |η, γ1, . . . , γp, α1, . . . , αq, ζ0, ζ1, . . . , ζp, σ2 ∝ (σ2)−n2 exp
{
− 1
2σ2
(Y − µ)>(Y − µ)
}
η ∼ Nqn(0,Ση0)
α ∼ Nq(0,Σα0)
ζ0 ∼ N(0, σ2ζ0)
γj|τ 2vj, σ2 ∼ Nqn(0, diag(σ2τ 2vj, . . . , σ2τ 2vj)), j = 1, . . . , p
τ 2vj|λv ∼ Gamma(
qn + 1
2
,
qnλ
2
v
2
), j = 1, . . . , p
ζj|τ 2ej, σ2 ∼ N(0, σ2τ 2ej), j = 1, . . . , p
τ 2ej|λe ∼
λ2e
2
exp(−λ
2
eτ
2
ej
2
), j = 1, . . . , p
σ2 ∼ (σ2)−s−1 exp(− h
σ2
)
Consider the following conjugate gamma priors for λ2v and λ
2
e
λ2v ∼ Gamma(av, bv) and λ2e ∼ Gamma(ae, be)
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B.13.2 Gibbs Sampler
pi(η|rest) ∼ Nqn(µη, Ση) where
µη =
(
Σ−1η0 +
1
σ2
B>0 B0
)−1( 1
σ2
(Y − µ(−η))>B0
)>
Ση =
(
Σ−1η0 +
1
σ2
B>0 B0
)−1
pi(α|rest) ∼ Nq(µα,Σα) where
µα =
(
Σ−1α0 +
1
σ2
W>W
)−1( 1
σ2
(Y − µ(−α))>W
)>
Σα =
(
Σ−1α0 +
1
σ2
W>W
)−1
pi(ζ0|rest) ∼ N(µζ0 ,Σζ0) where
µζ0 =
(
1/σ2ζ0 +
1
σ2
n∑
i=1
E2i
)−1( 1
σ2
n∑
i=1
(yi − µ(−ζ0))Ei
)
Σζ0 =
(
1/σ2ζ0 +
1
σ2
n∑
i=1
E2i
)−1
γj|rest ∼ Nqn(µγj , σ2Σγj) where
µγj = ΣγjU
>
j (Y − µ(−γj))
Σγj = (U
>
j Uj +
1
τ 2vj
Iqn)
−1
ζj|rest ∼ N(µζj , σ2Σζj) where
µζj = ΣζjT
>
j (Y − µ(−ζj))
Σζj = (T
>
j Tj +
1
τ 2ej
)−1
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The posterior distribution for (τ 2vj)
−1 is Inverse-Gaussian(qnλ2v,
√
qnλ2vσ
2
||γj ||22 ). Similarly, the
posterior distribution for (τ 2ej)
−1 is Inverse-Gaussian(λ2e,
√
λ2eσ
2
ζ2j
). λv and λe all have Gamma
posterior distributions
λ2v ∼ Gamma(av +
p(qn + 1)
2
, bv +
qn
∑p
j=1 τ
2
vj
2
)
λ2e ∼ Gamma(ae + p, be +
∑p
j=1 τ
2
ej
2
)
σ2 ∼ Inverse-Gamma(µσ2 ,Σσ2) where
µσ2 = s+
n+ p+ pqn
2
Σσ2 = h+
1
2
(
(Y − µ)>(Y − µ) +
p∑
j=1
(τ 2vj)
−1γ>j γj + (τ
2
ej)
−1ζ2j
)
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Appendix C
Appendices for Chapter 4
C.1 Summary of methods.
Table C.1: Summary of the proposed and alternative methods.
Methods Reference
Robust
RBSG-SS Robust Bayesian sparse group selection
with spike–and–slab priors
proposed for the first time
RBG-SS Robust Bayesian group selection with
spike–and–slab priors
proposed for the first time
RBL-SS Robust Bayesian Lasso with spike–and–slab
priors
proposed for the first time
RBSG Robust Bayesian sparse group selection proposed for the first time
RBG Robust Bayesian group Lasso Li et al. (2010)
RBL Robust Bayesian Lasso Li et al. (2010)
Non-robust
BSG-SS Bayesian sparse group Lasso with
spike–and–slab priors
Xu and Ghosh (2015)
BG-SS Bayesian group Lasso with spike–and–slab
priors
Xu and Ghosh (2015);
Zhang et al. (2014a)
BL-SS Bayesian Lasso with spike–and–slab priors Xu and Ghosh (2015);
Zhang et al. (2014a)
BSG Bayesian sparse group Lasso Xu and Ghosh (2015)
BG Bayesian group Lasso Kyung et al. (2010)
BL Bayesian Lasso Park and Casella (2008)
Note: We constructed the models that can be applied to G×E settings based on the references.
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C.2 Hyper-parameters sensitivity analysis
We demonstrate the sensitivity of RBSG-SS for variable selection to the choice of the hyper-
parameters for pi0, and pi1. We consider five different Beta priors: (1) Beta(0.5, 0.5) which
is a U-shape curve between (0, 1); (2) Beta(1, 1) which is a essentially a uniform prior; (3)
Beta(2, 2) which is a quadratic curve; (4) Beta(1, 5) which is highly right-skewed; (5) Beta(5,
1) which is highly left-skewed. As a demonstrating example, we use the same setting of Ex-
ample 1 to generate data under the Error 2. Table C.2 shows the identification performance
of the median thresholding model (MPM) with different Beta priors. For all choices of Beta
priors, the MPM model is very stable. Also RBSG-SS correctly identifies most of the true
effects with low false positives in all cases. Therefore, we simply use Beta(1, 1) as the prior
for pi0, and pi1 in this study.
Table C.2: Sensitivity analysis for RBSG-SS using Example 1. mean(sd) of true positives
(TP), false positives (FP) and prediction errors (Pred) based on 100 replicates.
TP FP Pred
Beta(0.5, 0.5) 21.31(1.67) 1.71(1.50) 2.19(0.11)
Beta(1, 1) 21.66(1.72) 1.32(1.33) 2.17(0.10)
Beta(2, 2) 21.13(2.10) 1.47(1.16) 2.18(0.10)
Beta(1, 5) 20.82(1.71) 1.38(1.30) 2.17(0.10)
Beta(5, 1) 21.58(1.75) 2.22(1.52) 2.19(0.09)
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C.3 Assessment of the convergence of MCMC chains
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Figure C.1: Potential scale reduction factor (PSRF) against iterations for the first five
groups of coefficients in Example 1. Black line: the PSRF. Red line: the threshold of 1.1.
The βˆj1 to βˆj6 represent the six estimated coefficients for the main and interaction effects in
the jth group, (j = 0, . . . , 5), respectively.
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C.4 Additional simulation results
Table C.3: Simulation results in Example 2. (n, q, k, p) = (500, 2, 5, 100). mean(sd) of
true positives (TP), false positives (FP)and prediction errors (Pred) based on 100 replicates.
RBSG-SS RBG-SS RBL-SS BSG-SS BG-SS BL-SS
Error 1 TP 24.87(0.35) 25.00(0.00) 24.53(0.51) 24.83(0.38) 25.00(0.00) 24.53(0.51)
N FP 1.63(1.16) 31.40(3.38) 2.30(1.86) 1.13(1.04) 29.20(1.10) 0.60(0.85)
Pred 0.85(0.03) 0.86(0.03) 0.86(0.03) 1.09(0.06) 1.13(0.06) 1.10(0.07)
Error 2 TP 22.23(1.76) 24.67(0.76) 19.23(1.72) 19.97(1.63) 24.47(0.90) 15.27(1.91)
L FP 1.90(1.30) 35.73(7.83) 2.10(1.40) 2.33(1.42) 34.13(7.44) 1.73(1.39)
Pred 2.24(0.14) 2.18(0.11) 2.38(0.16) 10.21(1.27) 9.13(0.94) 11.30(1.83)
Error 3 TP 21.50(1.48) 25.00(0.00) 17.43(2.13) 18.73(2.02) 25.00(0.00) 13.10(1.54)
Mix.L FP 2.13(1.14) 35.20(6.77) 1.90(1.37) 2.90(1.71) 34.00(6.88) 1.37(0.96)
Pred 2.39(0.18) 2.29(0.11) 2.52(0.22) 12.46(1.67) 10.40(0.94) 13.04(1.35)
Error 4 TP 23.58(1.49) 25.00(0.00) 21.04(2.29) 15.94(5.34) 23.18(3.50) 12.08(4.60)
t2 FP 0.80(0.93) 30.32(3.27) 0.78(1.07) 7.46(27.02) 53.50(58.05) 3.56(8.91)
Pred 1.85(0.16) 1.82(0.13) 1.92(0.17) 25.65(55.13) 25.63(67.60) 30.67(87.77)
Error 5 TP 24.12(1.00) 25.00(0.00) 21.82(1.90) 18.04(3.64) 24.24(1.88) 13.12(2.99)
logNor FP 0.90(1.02) 29.48(1.64) 0.82(0.90) 2.72(1.75) 36.12(12.21) 1.48(1.25)
Pred 1.81(0.13) 1.82(0.12) 1.89(0.15) 14.85(6.53) 12.87(5.94) 15.19(6.43)
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Table C.4: Simulation results in Example 2. (n, q, k, p) = (500, 2, 5, 100). mean(sd) of
true positives (TP), false positives (FP) and prediction errors (Pred) based on 100 replicates.
RBSG RBG RBL BSG BG BL
Error 1 TP 24.20(0.61) 25.00(0.00) 24.23(0.57) 24.33(0.61) 25.00(0.00) 24.30(0.60)
N FP 2.93(1.86) 54.80(17.34) 3.30(1.97) 1.87(1.61) 56.20(10.30) 5.77(2.56)
Pred 1.14(0.05) 1.32(0.06) 1.15(0.05) 1.74(0.12) 2.13(0.14) 2.01(0.15)
Error 2 TP 14.00(2.27) 22.20(2.33) 13.63(2.66) 13.70(2.29) 23.63(1.61) 14.20(1.97)
L FP 0.60(0.85) 31.40(12.07) 0.83(1.05) 1.33(1.18) 62.77(24.90) 8.80(4.54)
Pred 2.57(0.13) 2.77(0.14) 2.58(0.14) 12.18(1.15) 14.42(1.40) 14.91(1.43)
Error 3 TP 12.40(2.03) 22.47(1.17) 12.27(1.87) 12.43(1.77) 23.20(1.49) 13.37(2.13)
Mix.L FP 0.57(0.77) 29.33(5.54) 0.60(0.93) 1.47(1.31) 59.80(13.17) 8.17(3.04)
Pred 2.69(0.11) 2.86(0.11) 2.69(0.10) 13.59(1.05) 16.32(1.46) 16.93(1.60)
Error 4 TP 15.98(2.92) 23.04(2.78) 16.10(3.12) 10.20(5.31) 20.52(5.81) 11.08(5.00)
t2 FP 0.26(0.53) 27.36(6.21) 0.30(0.65) 2.34(3.56) 65.04(30.70) 9.38(6.26)
Pred 2.19(0.16) 2.35(0.16) 2.21(0.17) 26.27(53.26) 34.08(78.47) 34.95(79.04)
Error 5 TP 16.48(2.69) 23.48(1.58) 16.30(2.63) 11.96(3.66) 22.26(3.70) 12.70(3.50)
logNor FP 0.32(0.59) 28.72(5.89) 0.34(0.59) 1.40(1.21) 62.34(20.52) 8.34(3.77)
Pred 2.20(0.14) 2.41(0.14) 2.20(0.13) 15.79(5.97) 18.90(6.61) 19.53(6.65)
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Table C.5: Simulation results in Example 3. (n, q, k, p) = (500, 2, 5, 100). mean(sd) of
true positives (TP), false positives (FP)and prediction errors (Pred) based on 100 replicates.
RBSG-SS RBG-SS RBL-SS BSG-SS BG-SS BL-SS
Error 1 TP 24.00(0.91) 25.00(0.00) 22.13(1.57) 24.33(0.66) 25.00(0.00) 22.83(1.37)
N FP 1.85(1.46) 33.40(5.21) 1.87(1.36) 1.27(1.34) 29.60(1.83) 0.77(1.04)
Pred 0.86(0.03) 0.86(0.03) 0.89(0.03) 1.11(0.07) 1.13(0.07) 1.17(0.10)
Error 2 TP 17.63(2.37) 24.73(0.69) 14.37(2.54) 15.00(2.32) 23.73(1.46) 11.00(1.95)
L FP 2.50(1.41) 33.27(5.14) 2.67(1.99) 2.60(1.43) 30.67(6.69) 1.87(1.53)
Pred 2.33(0.12) 2.15(0.10) 2.40(0.17) 10.37(1.01) 9.01(0.81) 10.71(0.94)
Error 3 TP 17.23(1.77) 24.80(0.61) 14.47(2.21) 15.10(2.29) 23.67(1.77) 11.03(1.38)
Mix.L FP 2.27(1.78) 32.20(6.94) 1.63(1.43) 2.13(1.70) 30.93(5.48) 1.17(1.34)
Pred 2.39(0.13) 2.24(0.10) 2.45(0.13) 11.98(1.45) 10.32(1.04) 12.37(1.41)
Error 4 TP 23.63(1.19) 24.67(0.92) 20.13(2.19) 15.07(4.69) 22.67(3.68) 11.40(4.01)
t2 FP 1.30(1.12) 29.13(2.67) 1.17(0.95) 3.37(1.88) 29.93(9.48) 2.37(1.97)
Pred 1.48(0.13) 1.45(0.11) 1.55(0.14) 12.66(12.40) 10.10(8.77) 12.75(11.83)
Error 5 TP 24.80(0.48) 25.00(0.00) 23.57(1.43) 20.30(2.83) 24.87(0.51) 15.87(2.32)
logNor FP 0.33(0.55) 29.60(1.83) 0.40(1.04) 3.00(1.66) 32.93(5.86) 2.33(1.63)
Pred 1.19(0.10) 1.21(0.10) 1.21(0.11) 6.055(1.77) 5.47(1.73) 6.54(1.75)
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Table C.6: Simulation results in Example 3. (n, q, k, p) = (500, 2, 5, 100). mean(sd) of
true positives (TP), false positives (FP) and prediction errors (Pred) based on 100 replicates.
RBSG RBG RBL BSG BG BL
Error 1 TP 21.27(1.17) 25.00(0.00) 21.30(1.06) 22.23(0.94) 25.00(0.00) 22.13(1.28)
N FP 1.97(1.56) 45.40(11.68) 2.03(1.56) 1.23(1.33) 43.60(10.41) 3.37(2.03)
Pred 1.08(0.04) 1.21(0.05) 1.07(0.04) 1.57(0.12) 1.87(0.13) 1.79(0.13)
Error 2 TP 17.63(2.37) 24.73(0.69) 14.37(2.54) 15.00(2.32) 23.73(1.46) 11.00(1.95)
L FP 2.50(1.41) 33.27(5.14) 2.67(1.99) 2.60(1.43) 30.67(6.69) 1.87(1.53)
Pred 2.33(0.12) 2.15(0.10) 2.40(0.17) 10.37(1.01) 9.01(0.81) 10.71(0.94)
Error 3 TP 8.43(2.18) 16.70(3.29) 8.70(2.00) 7.97(2.04) 18.60(3.07) 8.27(1.78)
Mix.L FP 0.33(0.71) 17.70(4.60) 0.43(0.73) 0.60(0.72) 33.60(10.63) 3.70(2.34)
Pred 2.54(0.11) 2.69(0.12) 2.55(0.11) 12.33(1.15) 14.30(1.40) 14.55(1.40)
Error 4 TP 13.77(2.18) 21.20(2.06) 13.67(2.04) 9.67(3.74) 20.60(4.79) 9.77(3.76)
t2 FP 0.43(0.63) 22.80(3.98) 0.57(0.63) 1.03(1.13) 38.00(12.21) 4.47(2.50)
Pred 1.73(0.12) 1.85(0.13) 1.73(0.13) 11.78(9.05) 13.94(11.84) 14.22(12.41)
Error 5 TP 19.10(1.86) 24.87(0.73) 19.10(1.60) 15.27(2.94) 24.07(1.70) 15.07(2.88)
logNor FP 0.20(0.48) 31.13(5.96) 0.23(0.57) 1.10(1.16) 43.93(11.82) 3.83(2.21)
Pred 1.45(0.08) 1.61(0.09) 1.46(0.08) 6.13(1.13) 7.19(1.24) 7.16(1.29)
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Table C.7: Simulation results in Example 4. (n, q, k, p) = (500, 2, 5, 100). mean(sd) of
true positives (TP), false positives (FP) and prediction errors (Pred) based on 100 replicates.
RBSG-SS RBG-SS RBL-SS BSG-SS BG-SS BL-SS
Error 1 TP 24.93(0.37) 25.00(0.00) 24.93(0.25) 25.00(0.00) 25.00(0.00) 24.90(0.31)
N FP 1.33(0.99) 30.60(3.84) 1.47(1.25) 1.00(1.02) 29.20(1.10) 0.33(0.61)
Pred 0.84(0.02) 0.88(0.02) 0.85(0.03) 1.10(0.04) 1.20(0.06) 1.11(0.05)
Error 2 TP 20.80(2.65) 23.60(1.47) 17.24(2.96) 18.58(3.46) 23.04(1.64) 14.08(3.26)
L FP 1.32(1.22) 30.76(4.93) 1.66(1.29) 1.98(1.53) 27.72(5.49) 1.42(1.25)
Pred 2.25(0.11) 2.22(0.08) 2.37(0.12) 10.32(1.25) 9.53(0.75) 11.43(1.20)
Error 3 TP 20.56(2.73) 23.69(1.38) 16.53(3.20) 17.56(3.49) 22.80(1.65) 12.67(3.39)
Mix.L FP 1.40(1.30) 30.04(5.46) 1.78(1.82) 1.76(1.28) 27.60(5.24) 1.22(1.43)
Pred 2.38(0.13) 2.35(0.10) 2.51(0.16) 12.04(1.40) 11.12(0.96) 13.32(1.44)
Error 4 TP 24.60(0.93) 24.67(0.92) 23.77(1.57) 20.10(6.38) 22.27(5.10) 15.63(6.69)
t2 FP 0.40(0.56) 29.13(2.97) 0.47(0.73) 1.83(1.90) 28.13(9.22) 1.17(1.15)
Pred 1.48(0.09) 1.52(0.09) 1.51(0.11) 11.54(6.94) 11.33(6.95) 12.64(6.74)
Error 5 TP 23.16(1.68) 24.96(0.28) 19.60(2.14) 15.64(3.76) 23.44(1.83) 11.60(2.75)
logNor FP 1.08(1.16) 29.16(1.33) 0.72(0.83) 2.20(1.83) 30.56(7.43) 1.48(1.43)
Pred 1.56(0.14) 1.53(0.13) 1.63(0.15) 10.98(5.80) 9.45(5.38) 11.38(6.03)
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Table C.8: Simulation results in Example 4. (n, q, k, p) = (500, 2, 5, 100). mean(sd) of
true positives (TP), false positives (FP) and prediction errors (Pred) based on 100 replicates.
RBSG RBG RBL BSG BG BL
Error 1 TP 21.47(1.87) 24.40(1.07) 21.67(1.81) 22.70(1.64) 24.87(0.51) 22.53(1.85)
N FP 3.17(2.51) 56.00(20.03) 3.33(2.59) 2.30(1.66) 66.33(14.04) 6.57(2.62)
Pred 1.26(0.06) 1.44(0.07) 1.27(0.06) 2.40(0.27) 2.83(0.24) 2.75(0.30)
Error 2 TP 9.08(2.54) 19.38(3.12) 9.20(2.60) 9.68(2.41) 20.82(2.93) 10.80(2.65)
L FP 0.78(0.86) 30.30(10.26) 0.84(0.89) 2.18(1.48) 65.94(19.60) 8.62(3.38)
Pred 2.67(0.08) 2.89(0.09) 2.67(0.09) 13.54(0.87) 16.38(1.19) 16.87(1.27)
Error 3 TP 8.51(2.31) 18.71(3.37) 8.62(2.33) 9.02(2.33) 20.60(2.76) 10.58(2.50)
Mix.L FP 0.56(0.69) 25.29(7.94) 0.56(0.66) 1.87(1.36) 56.87(15.55) 7.38(2.91)
Pred 2.79(0.11) 3.00(0.12) 2.79(0.12) 15.34(1.29) 18.66(1.69) 19.30(1.88)
Error 4 TP 13.30(3.32) 21.93(2.72) 13.47(3.33) 10.93(4.30) 20.97(4.76) 11.97(4.43)
t2 FP 0.50(0.57) 29.07(9.28) 0.40(0.50) 1.70(1.39) 60.03(20.56) 7.90(3.92)
Pred 2.03(0.12) 2.22(0.12) 2.03(0.12) 15.20(7.98) 18.61(12.19) 19.41(13.39)
Error 5 TP 14.38(2.64) 22.36(2.22) 14.40(2.70) 10.12(3.53) 20.84(3.74) 10.56(3.39)
logNor FP 0.30(0.58) 25.16(4.36) 0.22(0.46) 0.88(1.12) 36.52(12.60) 3.70(2.57)
Pred 1.84(0.15) 1.99(0.17) 1.84(0.15) 11.23(5.54) 13.02(5.80) 13.18(5.90)
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C.5 Estimation results for data analysis
Table C.9: Analysis of the NHS T2D data using RBSG-
SS.
SNP Gene chol act gl ceraf alcohol
3.503 -3.447 0.752 -3.364 -2.639
rs10741150 DOCK1 -0.948
rs10765059 TCERG1L -0.531 0.877
rs10786611 RF00019 0.668 0.723 0.530
rs10884466 RNA5SP326 -0.466 0.643
rs10885423 NRG3 -0.715
rs10886442 GRK5 0.805
rs11196539 NRG3 -0.608 -0.801
rs11198590 CACUL1 -0.494 0.994 -0.687
rs11259039 FRMD4A 1.016
rs1194657 THAP12P3 0.798
rs1219508 RPS15AP5 -0.742
rs12265854 SLC16A12 0.397
rs12414552 TCERG1L 0.667 0.470 0.585 -0.690
rs12767723 SLC25A18P1 0.820 -0.515
rs12772559 TACR2 0.938 0.510
rs12774333 LRMDA -0.599
rs12775160 FOXI2 -0.651 -0.501 0.647
rs16916794 SLC39A12 -0.552 0.511 0.455
rs16920092 PLXDC2 -0.843
rs17094114 GFRA1 -0.615
Continued on the next page
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Table C.9: Continued from the previous page.
SNP Gene chol act gl ceraf alcohol
rs2492664 OR6L1P 0.695 -0.737
rs2784767 PLAC9 -0.540
rs2814322 GRID1 -0.830
rs3740063 ABCC2 -0.966
rs3763722 LARP4B 0.332 -1.156 0.866
rs4411238 PRKG1 0.537
rs4578341 CHST15 -0.822 0.602
rs4747517 ITIH5 -1.468 0.920
rs4749926 IL2RA -0.840 -0.815
rs4917817 PYROXD2 -0.624 0.594
rs4918904 XRCC6P1 0.997
rs6482836 DOCK1 -0.957 1.067
rs7070789 GPAM -1.245 -0.791
rs7072255 ANTXRLP1 0.800
rs7077721 SNRPD2P1 0.858 0.774
rs7896554 NACAP2 0.840 -0.630 -0.565
rs7897847 LGI1 0.962
rs870753 CFAP58 -0.783
rs881726 GFRA1 1.001
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Table C.10: Analysis of the NHS T2D data using RBL-
SS.
SNP Gene chol act gl ceraf alcohol
1.354 -0.430 -0.778 -2.424 -4.000
rs1041168 PLPP4 0.463
rs10741150 DOCK1 -1.126
rs10786611 RF00019 0.632
rs10794069 ADAM12 0.524
rs10824802 MBL2 0.553
rs10884466 RNA5SP326 -0.439 0.503
rs10885423 NRG3 -1.060
rs10886047 MIR3663HG -0.410
rs10886442 GRK5 1.087
rs10998780 ATP5MC1P7 0.150
rs11003665 RNA5SP318 0.632
rs11013740 KIAA1217 0.852
rs11196539 NRG3 -0.624
rs11198590 CACUL1 -0.628
rs11202221 BMPR1A 0.815
rs11259039 FRMD4A 1.021
rs11595123 AKR1E2 1.079
rs11813505 KIAA1217 1.301
rs1194657 THAP12P3 0.663
rs1219508 RPS15AP5 -0.886
rs12265854 SLC16A12 0.596
Continued on the next page
161
Table C.10: Continued from the previous page.
SNP Gene chol act gl ceraf alcohol
rs12269237 RF00017 0.884
rs12414552 TCERG1L 0.594
rs12414627 PNLIPRP1 -0.551
rs12767723 SLC25A18P1 0.962
rs12772559 TACR2 0.906
rs12774333 LRMDA -0.449
rs12775160 FOXI2 -0.560
rs1573137 SORCS3 0.615
rs16916794 SLC39A12 -0.803 0.528
rs16920092 PLXDC2 -0.655
rs17094114 GFRA1 -0.563
rs2291314 PLPP4 0.536
rs2420979 TACC2 -1.091
rs2492664 OR6L1P 0.655 -0.363
rs2664339 RNU6-543P -0.501
rs2666236 IATPR 0.689
rs2784767 PLAC9 -0.452 0.730
rs2814322 GRID1 -0.806
rs2842129 DYNC1I2P1 -0.662
rs2900814 SNRPD2P1 -0.643
rs3740063 ABCC2 -0.885
rs3763722 LARP4B 1.036
rs4411238 PRKG1 0.399
Continued on the next page
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Table C.10: Continued from the previous page.
SNP Gene chol act gl ceraf alcohol
rs4578341 CHST15 -0.582 0.479
rs4747009 LRRC20 0.710
rs4747517 ITIH5 -0.905
rs4749926 IL2RA -0.607
rs4752432 PLPP4 0.725
rs4917817 PYROXD2 -0.506
rs4934762 PCAT5 -0.560
rs6482836 DOCK1 -0.709
rs7070789 GPAM -0.820
rs7072255 ANTXRLP1 0.811
rs7077721 SNRPD2P1 0.702
rs7894809 PCGF5 0.501
rs7896554 NACAP2 0.850 -0.953
rs7897847 LGI1 0.929
rs7903853 FRMD4A -1.185
rs7920351 TCERG1L -0.713
rs881726 GFRA1 0.675
rs943213 DOCK1 -0.939
Table C.11: Analysis of the NHS T2D data using BSG-
SS.
SNP Gene chol act gl ceraf alcohol
2.045 -2.049 -2.204 -1.796 -4.436
Continued on the next page
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Table C.11: Continued from the previous page.
SNP Gene chol act gl ceraf alcohol
rs1041168 PLPP4 0.638
rs10765059 TCERG1L 0.709
rs10786611 RF00019 0.773 0.556
rs10829671 EBF3 -0.505
rs10884466 RNA5SP326 -0.563 0.625
rs10886442 GRK5 1.038
rs10998780 ATP5MC1P7 0.704
rs11017821 TCERG1L 0.665
rs11198590 CACUL1 -0.698 0.905 0.568
rs11200996 CCSER2 0.508
rs11259039 FRMD4A 1.174
rs1219508 RPS15AP5 -0.787
rs12265854 SLC16A12 0.681 -0.494
rs12269237 RF00017 0.684
rs12414552 TCERG1L 0.480
rs12764378 ARID5B -0.420
rs12767723 SLC25A18P1 0.638 -0.559
rs12775160 FOXI2 -0.762 0.893
rs1361709 PCDH15 -0.852
rs1395465 RN7SL63P 0.292
rs16916794 SLC39A12 -0.614 0.580 0.622
rs16920092 PLXDC2 -0.692
rs17094114 GFRA1 -0.676
Continued on the next page
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Table C.11: Continued from the previous page.
SNP Gene chol act gl ceraf alcohol
rs17469499 KIAA1217 -0.527
rs2472737 RET 0.629
rs2577356 GFRA1 0.875
rs2784767 PLAC9 -0.569 0.537
rs2792708 GPAM 0.488
rs2900814 SNRPD2P1 -0.460
rs2926458 RNU6-463P -0.680
rs3763722 LARP4B -1.251 1.186
rs4411238 PRKG1 0.619
rs4747517 ITIH5 -1.257
rs4752432 PLPP4 0.956
rs4917817 PYROXD2 -0.626 0.630
rs4922535 GDF10 -0.601 -0.649
rs4934762 PCAT5 -0.640
rs4934858 NRP1 0.281
rs6482836 DOCK1 -0.773
rs7070789 GPAM -0.642
rs7072255 ANTXRLP1 0.723
rs7085788 RHOBTB1 -0.720
rs7086058 RN7SKP143 -0.507
rs716168 VTI1A -0.570
rs7894809 PCGF5 0.642
rs7895870 RN7SKP167 -0.867
Continued on the next page
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Table C.11: Continued from the previous page.
SNP Gene chol act gl ceraf alcohol
rs7896554 NACAP2 1.097 -0.477
rs7917422 HTR7 0.794
rs881726 GFRA1 0.933
Table C.12: Analysis of the NHS T2D data using BL-SS.
SNP Gene chol act gl ceraf alcohol
3.095 -2.406 -2.373 -1.716 -3.721
rs1041168 PLPP4 0.670
rs10508670 KIAA1217 0.773
rs10765059 TCERG1L 0.445
rs10829671 EBF3 -0.717
rs10884466 RNA5SP326 -0.528
rs10998780 ATP5MC1P7 1.195
rs11017821 TCERG1L 0.307
rs11198590 CACUL1 1.273
rs11200996 CCSER2 0.509
rs11202221 BMPR1A 0.954
rs11259039 FRMD4A 1.020
rs11594070 ATE1-AS1 -0.401
rs1194657 THAP12P3 0.681
rs12248205 CDH23 -0.938
rs12256982 ZMIZ1 0.152
rs12265854 SLC16A12 0.661 -0.830
Continued on the next page
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Table C.12: Continued from the previous page.
SNP Gene chol act gl ceraf alcohol
rs12269237 RF00017 0.864
rs12412976 RPLP1P10 0.592 -0.590
rs12414552 TCERG1L 0.549
rs12414627 PNLIPRP1 -0.572
rs12764378 ARID5B -0.564
rs12767723 SLC25A18P1 1.062
rs12775160 FOXI2 -0.636
rs1361709 PCDH15 -0.729
rs1395465 RN7SL63P 0.562
rs1573137 SORCS3 0.869
rs16916794 SLC39A12 -0.430 0.862
rs16920092 PLXDC2 -0.508
rs17094114 GFRA1 -0.734
rs17469499 KIAA1217 -0.680
rs2384105 SNRPEP8 -0.738
rs2420979 TACC2 -0.629
rs2472737 RET 0.553
rs2577356 GFRA1 0.739
rs2784767 PLAC9 -0.593 0.576
rs2792708 GPAM 0.568
rs2900814 SNRPD2P1 -0.157
rs2926458 RNU6-463P -0.527
rs3763722 LARP4B -1.002 1.151
Continued on the next page
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Table C.12: Continued from the previous page.
SNP Gene chol act gl ceraf alcohol
rs4411238 PRKG1 0.461
rs4747009 LRRC20 1.016
rs4747517 ITIH5 -1.695
rs4752432 PLPP4 0.787
rs4917817 PYROXD2 -0.637 0.751
rs4934762 PCAT5 -0.771
rs4934858 NRP1 0.496
rs6482836 DOCK1 -0.899
rs7069001 WDFY4 -0.942
rs7070789 GPAM -1.154 -0.771
rs7077718 DNMBP -0.661
rs7085788 RHOBTB1 -0.721
rs7086058 RN7SKP143 -0.872
rs716168 VTI1A -0.662
rs7894809 PCGF5 0.828
rs7895870 RN7SKP167 -1.295
rs7896554 NACAP2 0.989
rs7917422 HTR7 0.663 1.306
rs7920351 TCERG1L -1.059
rs809836 LYZL1 1.109
rs881726 GFRA1 0.922
rs915216 DUSP5 1.102
168
Table C.13: Analysis of the TCGA SKCM data using
RBSG-SS.
Gene clark stage age gender
0.834 0.228 -0.116 -0.183
AHNAKRS 0.107
ANKRD28 0.134 0.138
ASH2L -0.297
BTD -0.312
C1ORF140 -0.002 0.246 -0.083 -0.022 0.092
CD44 0.070
CHP1 0.107 0.045
CXCL6 0.126 -0.120 -0.095
DLG6 0.113 -0.015 0.067 0.185 -0.142
DOK5 -0.066
ETNK2 0.152
FILIP1 -0.030
JADE1 -0.147
JPH4 0.115
KBF2 -0.032 0.182 0.034 -0.026
LRRN2 -0.061
MAGED4 -0.098 -0.020
NHSL2 -0.088
PITPNA 0.151 -0.051 -0.012 -0.033 0.008
SOX8 0.088 -0.212
TMEM145 0.048
Continued on the next page
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Table C.13: Continued from the previous page.
Gene clark stage age gender
TMEM159 0.160 -0.121 -0.042 0.189
WBSCR27 0.070 0.126
Table C.14: Analysis of the TCGA SKCM data using
RBL-SS.
Gene clark stage age gender
0.926 -0.062 -0.011 0.388
AHNAKRS 0.084
ANKRD28 0.191 0.207
ASH2L -0.258
BAIAP2 0.043
BTD -0.309 -0.255
C1ORF140 0.129
C1ORF54 -0.102
CHP1 0.081 -0.111
CPXM1 0.005
CSNK2A2 -0.003
CYP1B1-AS1 0.104
DAP 0.036 -0.116
DLG6 0.242
ETNK2 0.109
FHL5 0.220
FILIP1 -0.016
Continued on the next page
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Table C.14: Continued from the previous page.
Gene clark stage age gender
GAMT 0.082
IL11RA -0.087
IQCK -0.090
JADE1 -0.161
JPH4 0.159
KDM6B -0.142
LRFN2 0.096
MAGED4 -0.130
MAPE -0.191
MPD1 -0.078
NHSL2 -0.144 -0.306
PAX1 0.171 0.217
PBX2 0.141 0.130
PITPNA 0.161 -0.056
RNPEPL1 0.052
SLC12A5 -0.081
SOX8 0.140 -0.091
STPG1 0.184
TMEM145 0.222
TMEM159 0.123
TNFAIP1 0.283
TP53TG1 0.102 -0.063
WBSCR27 0.090 0.126
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Table C.15: Analysis of the TCGA SKCM data using
BSG-SS.
Gene clark stage age gender
0.487 0.163 0.048 0.087
AHNAKRS 0.120
ANKRD28 0.138
ARMC9 0.008
ASH2L 0.019 -0.194 -0.107
BTD -0.303 -0.138
C14ORF2 0.251
C1ORF140 0.100 0.024 0.029
CD44 0.125
CHP1 0.123
CPXM1 -0.047
CXCL6 0.032
DLG6 0.093 0.204 -0.061
DOK5 -0.052
ETNK2 0.094
FILIP1 -0.049
GAMT -0.004
IL11RA -0.045
JADE1 -0.149
JPH4 0.110
KBF2 -0.077
LRRN2 -0.073
Continued on the next page
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Table C.15: Continued from the previous page.
Gene clark stage age gender
MAGED4 -0.122
MAPE -0.217
NHSL2 -0.026
PBX2 0.133 0.155
PHP1B -0.076
PITPNA 0.150 0.077 0.038 -0.039
SOX8 0.103 -0.148
STPG1 0.197
TMEM145 0.015 -0.045 0.147
TMEM159 0.140 0.113
TNFRSF4 0.077
TP53TG1 0.072
WBSCR27 0.015 0.092
ZFP62 -0.010
Table C.16: Analysis of the TCGA SKCM data using
BL-SS.
Gene clark stage age gender
0.545 0.308 0.080 0.047
AHNAKRS 0.102
ANKRD28 0.180 0.134
ASH2L -0.185
BTD -0.386
Continued on the next page
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Table C.16: Continued from the previous page.
Gene clark stage age gender
C14ORF2 0.126
C1ORF140 0.199
CELSR2 0.112
CHP1 0.080
CPXM1 -0.067
CSNK2A2 -0.026
CYP1B1-AS1 0.104
DAP -0.139
DLG6 0.088 0.236
ETNK2 0.206 -0.089
FHL5 0.076
FILIP1 -0.062
GAMT 0.058
IL11RA -0.056
IQCK -0.098
JADE1 -0.203
JPH4 0.101
KBF2 -0.089
KDM6B -0.173
LRFN2 0.109
LRRN2 -0.091
MAGED4 -0.113
MAPE -0.114
Continued on the next page
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Table C.16: Continued from the previous page.
Gene clark stage age gender
MPD1 -0.100
NHSL2 -0.035
PAX1 0.050
PBX2 0.126 0.072
PHP1B -0.054
PIP4K2C -0.101
PITPNA 0.193
PTP4A3 -0.138
RNPEPL1 0.171
SAA2 0.021 -0.058
SLC12A5 -0.112
SOX8 0.132 -0.084
TIE1 -0.093
TMEM145 0.188
TMEM159 0.174 0.181
TP53TG1 0.156 -0.030
WBSCR27 0.048 0.105
C.6 Biological similarity analysis
We carried out an examination of the Gene Ontology (GO) biological processes which provide
us with a deeper insight on the differences of the markers identified by different methods. We
totally identified 77 unique genes using our proposed method along with three other methods
for the NHS data. We conducted the GO enrichment analysis using the R package GOSim
and found these genes involve in a total of 158 GO biological processes, the p-values of which
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are smaller than 0.1 in the GO enrichment analysis. Then we divided the 158 processes into
four categories: positive regulation (P), negative regulation (N), regulation (R, without a
well-defined direction) and other (O). We computed the proportions of genes that involve in
the four categories of processes for each of the four methods. Similarly for the TCGA SKCM
data, 109 genes were identified by our method along with three other alternative methods.
GO enrichment analysis showed that they involve in 183 biological processes, with p-values
smaller than 0.1. The results for NHS and TCGA SKCM are provided in Figure C.2, which
shows an obvious difference between our proposed method and the three alternatives in both
datasets.
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Figure C.2: Gene Ontology (GO) analysis: proportions of genes that have the four cate-
gories of processes with different approaches. Left: NHS data. Right: TCGA SKCM data.
176
C.7 Posterior inference
C.7.1 RBG-SS
Hierarchical model specification
yi = W
>
i α + E
>
i θ + U
>
i β + ν
− 1
2κ
√
uizi i = 1, . . . , n
ui|ν ind∼ ν exp (−νui) i = 1, . . . , n
zi
ind∼ N(0, 1) i = 1, . . . , n
ν ∼ Gamma (c1, c2)
α ∼ Nq(0, Σα0)
θ ∼ Nk(0, Σθ0)
βj|φj, sj ind∼ φj NL (0, sjIL) + (1− φj)δ0(βj) j = 1, . . . , p
φj|pi0 ind∼ Bernoulli(pi0) j = 1, . . . , p
pi0 ∼ Beta (a0, b0)
sj|η ∼ Gamma
(
L+ 1
2
,
η
2
)
j = 1, . . . , p
η ∼ Gamma (d1, d2)
Gibbs Sampler
• ui|rest ∼ Inverse-Gaussian(µui , λui), where the shape parameter λui = 2ν, mean pa-
rameter µui =
√
2κ2
(yi−y˜i)2 and y˜i = yi −W>i α− E>i θ − U>i β.
• ν|rest ∼ Gamma (sν , rν), where the shape parameter sν = c1 + 3n2 and the rate param-
eter rν = c2 +
∑n
i=1 ui + (2κ
2)−1
∑n
i=1 u
−1
i y˜i
2.
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• α|rest ∼ N(µα, Σα), where
µα = Σανκ
−2
n∑
i=1
u−1i Wi(yi − E>i θ − U>i β)
Σα =
(
νκ−2
n∑
i=1
u−1i WiW
>
i + Σ
−1
α0
)−1
• θ|rest ∼ N(µθ, Σθ), where
µθ = Σθνκ
−2
n∑
i=1
u−1i Ei(yi −W>i α− U>i β)
Σθ =
(
νκ−2
n∑
i=1
u−1i EiE
>
i + Σ
−1
θ0
)−1
• βj|rest ∼ ljN(µβj , Σβj) + (1− lj)δ0(βj) where
µβj = Σβjνκ
−2
n∑
i=1
u−1i Uij y˜ij
Σβj =
(
νκ−2
n∑
i=1
u−1i UijU
>
ij +
1
sj
IL
)−1
lj =
pi0
pi0 + (1− pi0)s
L
2
j |Σβj |−
1
2 exp
{
−1
2
‖Σ
1
2
βj
νκ−2
∑n
i=1 u
−1
i Uij y˜ij‖22
}
and y˜ij is defined as y˜ij = yi −W>i α− E>i θ − U>(j)β(j).
• The posterior of sj is
s−1j |rest ∼

Inverse-Gamma(L+1
2
, η
2
) if βj = 0
Inverse-Gaussian(η,
√
η
‖βj‖22 ) if βj 6= 0
• pi0|rest ∼ Beta
(
a0 +
∑p
j=1 I{βj 6=0}, b0 +
∑p
j=1 I{βj=0}
)
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• η|rest ∼ Gamma (sη, rη), where sη = p+p×L2 +d1 and the rate parameter rη =
∑p
j=1 sj
2
+
d2.
C.7.2 RBL-SS
Hierarchical model specification
yi = W
>
i α + E
>
i θ + U
>
i β + ν
− 1
2κ
√
uizi
ui|ν ind∼ ν exp (−νui)
zi
ind∼ N(0, 1)
ν ∼ Gamma (c1, c2)
α ∼ Nq(0, Σα0)
θ ∼ Nk(0, Σθ0)
βjl|φjl, sjl ind∼ φjl N (0, sjl) + (1− φjl)δ0(βjl) j = 1, . . . , p; l = 1, . . . , L
φjl|pi1 ind∼ Bernoulli(pi1) j = 1, . . . , p; l = 1, . . . , L
sjl|η ∼ Gamma
(
1,
η
2
)
j = 1, . . . , p; l = 1, . . . , L
pi1 ∼ Beta (a1, b1)
η ∼ Gamma (d1, d2)
Gibbs Sampler
• ui|rest ∼ Inverse-Gaussian(µui , λui), where the shape parameter λui = 2ν, mean pa-
rameter µui =
√
2κ2
(Yi−y˜i)2 and y˜i = yi −W>i α− E>i θ − U>i β.
• ν|rest ∼ Gamma (sν , rν), where the shape parameter sν = c1 + 3n2 and the rate param-
eter rν = c2 +
∑n
i=1 ui + (2κ
2)−1
∑n
i=1 u
−1
i y˜i
2.
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• α|rest ∼ N(µα, Σα), where
µα = Σανκ
−2
n∑
i=1
u−1i Wi(Yi − E>i θ − U>i β)
Σα =
(
νκ−2
n∑
i=1
u−1i WiW
>
i + Σ
−1
α0
)−1
• θ|rest ∼ N(µθ, Σθ), where
µθ = Σθνκ
−2
n∑
i=1
u−1i Ei(Yi −W>i α− U>i β)
Σθ =
(
νκ−2
n∑
i=1
u−1i EiE
>
i + Σ
−1
θ0
)−1
• βjl|rest ∼ ljlN(µβjl , σ2βjl) + (1− ljl)δ0(βjl) where
µβjl = σ
2
βjl
νκ−2
n∑
i=1
u−1i Uijly˜ijl
σ2βjl =
(
νκ−2
n∑
i=1
u−1i U
2
ijl +
1
sjl
)−1
ljl =
pi1
pi1 + (1− pi1)s
1
2
jl(σ
2
βjl
)−
1
2 exp
{
−1
2
σ2βjl(νκ
−2∑n
i=1 u
−1
i Uijly˜ijl)
2
}
and y˜ijl is defined as y˜ijl = yi −W>i α− E>i θ − U>(jl)β(jl).
• The posterior of sjl is
s−1jl |rest ∼

Inverse-Gamma(1, η
2
) if βjl = 0
Inverse-Gaussian(η,
√
η
β2jl
) if βjl 6= 0
• pi1|rest ∼ Beta
(
a1 +
∑
j,l I{βjl 6=0}, b1 +
∑
j,l I{βjl=0}
)
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• η|rest ∼ Gamma (sη, rη), where sη = p×L+d1 and the rate parameter rη =
∑
j,l sjl
2
+d2.
C.7.3 RBSG
Hierarchical model specification
yi = W
>
i α + E
>
i θ + U
>
i β + ν
− 1
2κ
√
uizi
ui|ν ind∼ ν exp (−νui)
zi
ind∼ N(0, 1)
ν ∼ Gamma (c1, c2)
α ∼ Nq(0, Σα0)
θ ∼ Nk(0, Σθ0)
βj|rj, ωjl ind∼ NL(0, Vj), where Vj = diag
{( 1
rj
+
1
ωjl
)−1
, l = 1, 2, . . . , L
}
rj, ωj1, . . . , ωjL|η1, η2 ∝
L∏
l=1
[
(ωjl)
− 1
2
(
1
rj
+
1
ωjl
)− 1
2
]
(rj)
− 1
2 exp
(
−η1
2
rj − η2
2
L∑
l=1
ωjl
)
η1, η2 ∝ η
p
2
1 η
pL
2 exp {−d1η1 − d2η2}
σ2 ∼ 1/σ2
Gibbs Sampler
• ui|rest ∼ Inverse-Gaussian(µui , λui), where the shape parameter λui = 2ν, mean pa-
rameter µui =
√
2κ2
(Yi−y˜i)2 and y˜i = yi −W>i α− E>i θ − U>i β.
• ν|rest ∼ Gamma (sν , rν), where the shape parameter sν = c1 + 3n2 and the rate param-
eter rν = c2 +
∑n
i=1 ui + (2κ
2)−1
∑n
i=1 u
−1
i y˜i
2.
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• α|rest ∼ N(µα, Σα), where
µα = Σανκ
−2
n∑
i=1
u−1i Wi(Yi − E>i θ − U>i β)
Σα =
(
νκ−2
n∑
i=1
u−1i WiW
>
i + Σ
−1
α0
)−1
• θ|rest ∼ N(µθ, Σθ), where
µθ = Σθνκ
−2
n∑
i=1
u−1i Ei(Yi −W>i α− U>i β)
Σθ =
(
νκ−2
n∑
i=1
u−1i EiE
>
i + Σ
−1
θ0
)−1
• βj|rest ∼ N(µβj , Σβj) where
µβj = Σβjνκ
−2
n∑
i=1
u−1i Uij y˜ij
Σβj =
(
νκ−2
n∑
i=1
u−1i UijU
>
ij + V
−1
j
)−1
and y˜ij is defined as y˜ij = yi −W>i α− E>i θ − U>(j)β(j).
• r−1j |rest ∼ Inv-Gaussian(η1,
√
η1σ2
‖βj‖22 )
• ω−1jl |rest ∼ Inv-Gaussian(η2,
√
η2σ2
β2jl
)
• η1|rest ∼ Gamma (sη1 , rη1), where sη1 = p2 +1 and the rate parameter rη1 =
∑p
j=1 rj
2
+d1.
• η2|rest ∼ Gamma (sη2 , rη2), where sη2 = p × L + 1 and the rate parameter rη2 =∑
j,l ωjl
2
+ d2.
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C.7.4 RBG
Hierarchical model specification
yi = W
>
i α + E
>
i θ + U
>
i β + ν
− 1
2κ
√
uizi i = 1, . . . , n
ui|ν ind∼ ν exp (−νui) i = 1, . . . , n
zi
ind∼ N(0, 1) i = 1, . . . , n
ν ∼ Gamma (c1, c2)
α ∼ Nq(0, Σα0)
θ ∼ Nk(0, Σθ0)
βj|sj ind∼ NL (0, sjIL) j = 1, . . . , p
sj|η ∼ Gamma
(
L+ 1
2
,
η
2
)
j = 1, . . . , p
η ∼ Gamma (d1, d2)
Gibbs Sampler
• ui|rest ∼ Inverse-Gaussian(µui , λui), where the shape parameter λui = 2ν, mean pa-
rameter µui =
√
2κ2
(yi−y˜i)2 and y˜i = yi −W>i α− E>i θ − U>i β.
• ν|rest ∼ Gamma (sν , rν), where the shape parameter sν = c1 + 3n2 and the rate param-
eter rν = c2 +
∑n
i=1 ui + (2κ
2)−1
∑n
i=1 u
−1
i y˜i
2.
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• α|rest ∼ N(µα, Σα), where
µα = Σανκ
−2
n∑
i=1
u−1i Wi(yi − E>i θ − U>i β)
Σα =
(
νκ−2
n∑
i=1
u−1i WiW
>
i + Σ
−1
α0
)−1
• θ|rest ∼ N(µθ, Σθ), where
µθ = Σθνκ
−2
n∑
i=1
u−1i Ei(yi −W>i α− U>i β)
Σθ =
(
νκ−2
n∑
i=1
u−1i EiE
>
i + Σ
−1
θ0
)−1
• βj|rest ∼ N(µβj , Σβj) where
µβj = Σβjνκ
−2
n∑
i=1
u−1i Uij y˜ij
Σβj =
(
νκ−2
n∑
i=1
u−1i UijU
>
ij +
1
sj
IL
)−1
and y˜ij is defined as y˜ij = yi −W>i α− E>i θ − U>(j)β(j).
• s−1j |rest ∼ Inverse-Gaussian(η,
√
η
‖βj‖22 )
• η|rest ∼ Gamma (sη, rη), where sη = p+p×L2 +d1 and the rate parameter rη =
∑p
j=1 sj
2
+
d2.
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C.7.5 RBL
Hierarchical model specification
yi = W
>
i α + E
>
i θ + U
>
i β + ν
− 1
2κ
√
uizi
ui|ν ind∼ ν exp (−νui)
zi
ind∼ N(0, 1)
ν ∼ Gamma (c1, c2)
α ∼ Nq(0, Σα0)
θ ∼ Nk(0, Σθ0)
βjl|sjl ind∼ N (0, sjl) j = 1, . . . , p; l = 1, . . . , L
sjl|η ∼ Gamma
(
1,
η
2
)
j = 1, . . . , p; l = 1, . . . , L
η ∼ Gamma (d1, d2)
Gibbs Sampler
• ui|rest ∼ Inverse-Gaussian(µui , λui), where the shape parameter λui = 2ν, mean pa-
rameter µui =
√
2κ2
(Yi−y˜i)2 and y˜i = yi −W>i α− E>i θ − U>i β.
• ν|rest ∼ Gamma (sν , rν), where the shape parameter sν = c1 + 3n2 and the rate param-
eter rν = c2 +
∑n
i=1 ui + (2κ
2)−1
∑n
i=1 u
−1
i y˜i
2.
• α|rest ∼ N(µα, Σα), where
µα = Σανκ
−2
n∑
i=1
u−1i Wi(Yi − E>i θ − U>i β)
Σα =
(
νκ−2
n∑
i=1
u−1i WiW
>
i + Σ
−1
α0
)−1
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• θ|rest ∼ N(µθ, Σθ), where
µθ = Σθνκ
−2
n∑
i=1
u−1i Ei(Yi −W>i α− U>i β)
Σθ =
(
νκ−2
n∑
i=1
u−1i EiE
>
i + Σ
−1
θ0
)−1
• βjl|rest ∼ N(µβjl , σ2βjl) where
µβjl = σ
2
βjl
νκ−2
n∑
i=1
u−1i Uijly˜ijl
σ2βjl =
(
νκ−2
n∑
i=1
u−1i U
2
ijl +
1
sjl
)−1
and y˜ijl is defined as y˜ijl = yi −W>i α− E>i θ − U>(jl)β(jl).
• s−1j |rest ∼ Inverse-Gaussian(η,
√
η
β2jl
)
• η|rest ∼ Gamma (sη, rη), where sη = p×L+d1 and the rate parameter rη =
∑
j,l sjl
2
+d2.
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C.7.6 BSG-SS
Hierarchical model specification
Y ∝ (σ2)−n2 exp
{
− 1
2σ2
n∑
i=1
(yi −W>i α− E>i θ − U>i β)2
}
α ∼ Nq(0, Σα0)
θ ∼ Nk(0, Σθ0)
βj = V
1
2
j bj, where V
1
2
j = diag{ωj1, . . . , ωjL}
bj|φbj ind∼ φbj NL (0, IL) + (1− φbj)δ0(bj)
φbj|pi0 ind∼ Bernoulli(pi0)
pi0 ∼ Beta (a0, b0)
ωjl|φwjl ind∼ φwjl N+
(
0, s2
)
+ (1− φwjl)δ0(ωjl)
φwjl|pi1 ind∼ Bernoulli(pi1)
pi1 ∼ Beta (a1, b1)
s2 ∼ Inverse-Gamma (1, η)
σ2 ∼ 1/σ2
Gibbs Sampler
• α|rest ∼ N(µα, Σα), where
µα = Σα(σ
2)−1
n∑
i=1
Wi(yi − E>i θ − U>i β)
Σα =
(
1
σ2
n∑
i=1
WiW
>
i + Σ
−1
α0
)−1
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• θ|rest ∼ N(µθ, Σθ), where
µθ = Σθ(σ
2)−1
n∑
i=1
Ei(yi −W>i α− U>i β)
Σθ =
(
1
σ2
n∑
i=1
EiE
>
i + Σ
−1
θ0
)−1
• bj|rest ∼ ljN(µbj , Σbj) + (1− lj)δ0(bj) where
µbj = Σbj(σ
2)−1
n∑
i=1
V
1
2
j Uij y˜ij
Σbj =
(
1
σ2
n∑
i=1
V
1
2
j UijU
>
ijV
1
2
j + IL
)−1
lbj =
pi0
pi0 + (1− pi0)|Σbj |−
1
2 exp
{
− 1
2σ4
‖Σ
1
2
bj
∑n
i=1 V
1
2
j Uij y˜ij‖22
}
and y˜ij is defined as y˜ij = yi −W>i α− E>i θ − U>(j)β(j).
• ωjl|rest ∼ lwjl N+(µωjl , σ2ωjl) + (1− lwjl)δ0(ωjl) where
µωjl = σ
2
ωjl
(σ2)−1
n∑
i=1
bjlUijly˜ijl
σ2ωjl =
(
1
σ2
n∑
i=1
U2ijlb
2
jl +
1
s2
)−1
lwjl =
pi1
pi1 + (1− pi1)12s(σ2ωjl)−
1
2 exp
{
−σ
2
ωjl
2σ4
(
∑n
i=1 bjlUijly˜ijl)
2
}[
Φ
(
µωjl
σωjl
)]−1
and y˜ijl is defined as y˜ijl = yi −W>i α− E>i θ − U>(jl)β(jl).
• s2|rest ∼ Inv-Gamma
(
1 + 1
2
∑
j,l I{ωjl 6=0}, η +
1
2
∑
j,l ω
2
jl
)
• pi0|rest ∼ Beta
(
a0 +
∑p
j=1 I{βj 6=0}, b0 +
∑p
j=1 I{βj=0}
)
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• pi1|rest ∼ Beta
(
a1 +
∑
j,l I{ωjl 6=0}, b1 +
∑
j,l I{ωjl=0}
)
• η is estimated with the EM approach used in the proposed method. For the gth EM
update η(g) = 1
E
η(g−1) [
1
s2
|Y ] .
• σ2|rest ∼ Inv-Gamma(n
2
,
∑n
i=1 y˜i
2
2
), where y˜i = yi −W>i α− E>i θ − U>i β.
C.7.7 BGL-SS
Hierarchical model specification
Y ∝ (σ2)−n2 exp
{
− 1
2σ2
n∑
i=1
(yi −W>i α− E>i θ − U>i β)2
}
α ∼ Nq(0, Σα0)
θ ∼ Nk(0, Σθ0)
βj|φj, σ2, sj ind∼ φj NL
(
0, σ2sjIL
)
+ (1− φj)δ0(βj) j = 1, . . . , p
φj|pi0 ind∼ Bernoulli(pi0) j = 1, . . . , p
pi0 ∼ Beta (a0, b0)
sj|η ind∼ Gamma
(
L+ 1
2
,
η
2
)
j = 1, . . . , p
η ∼ Gamma (d1, d2)
σ2 ∼ 1/σ2
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Gibbs Sampler
• α|rest ∼ N(µα, Σα), where
µα = Σα(σ
2)−1
n∑
i=1
Wi(yi − E>i θ − U>i β)
Σα =
(
1
σ2
n∑
i=1
WiW
>
i + Σ
−1
α0
)−1
• θ|rest ∼ N(µθ, Σθ), where
µθ = Σθ(σ
2)−1
n∑
i=1
Ei(yi −W>i α− U>i β)
Σθ =
(
1
σ2
n∑
i=1
EiE
>
i + Σ
−1
θ0
)−1
• βj|rest ∼ ljN(µβj , σ2Σβj) + (1− lj)δ0(βj) where
µβj = Σβj
n∑
i=1
Uij y˜ij
Σβj =
(
n∑
i=1
UijU
>
ij +
1
sj
IL
)−1
lj =
pi0
pi0 + (1− pi0)s
L
2
j |Σβj |−
1
2 exp
{
− 1
2σ2
‖Σ
1
2
βj
∑n
i=1 Uij y˜ij‖22
}
and y˜ij is defined as y˜ij = yi −W>i α− E>i θ − U>(j)β(j).
• The posterior of sj is
s−1j |rest ∼

Inverse-Gamma(L+1
2
, η
2
) if βj = 0
Inverse-Gaussian(η,
√
ησ2
‖βj‖22 ) if βj 6= 0
190
• pi0|rest ∼ Beta
(
a0 +
∑p
j=1 I{βj 6=0}, b0 +
∑p
j=1 I{βj=0}
)
• η|rest ∼ Gamma (sη, rη), where sη = p+p×L2 +d1 and the rate parameter rη =
∑p
j=1 sj
2
+
d2.
• σ2|rest ∼ Inv-Gamma(n+L
∑p
j=1 I{βj 6=0}
2
,
∑n
i=1 y˜i
2+
∑p
j=1(sj)
−1β>j βj
2
), where y˜i = yi−W>i α−
E>i θ − U>i β.
C.7.8 BL-SS
Hierarchical model specification
Y ∝ (σ2)−n2 exp
{
− 1
2σ2
n∑
i=1
(yi −W>i α− E>i θ − U>i β)2
}
α ∼ Nq(0, Σα0)
θ ∼ Nk(0, Σθ0)
βjl|φjl, σ2, sjl ind∼ φjl N
(
0, σ2sjl
)
+ (1− φjl)δ0(βjl) j = 1, . . . , p; l = 1, . . . , L
φjl|pi1 ind∼ Bernoulli(pi1) j = 1, . . . , p; l = 1, . . . , L
sjl|η ind∼ Gamma
(
1,
η
2
)
j = 1, . . . , p; l = 1, . . . , L
pi1 ∼ Beta (a1, b1)
η ∼ Gamma (d1, d2)
σ2 ∼ 1/σ2
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Gibbs Sampler
• α|rest ∼ N(µα, Σα), where
µα = Σα(σ
2)−1
n∑
i=1
Wi(yi − E>i θ − U>i β)
Σα =
(
1
σ2
n∑
i=1
WiW
>
i + Σ
−1
α0
)−1
• θ|rest ∼ N(µθ, Σθ), where
µθ = Σθ(σ
2)−1
n∑
i=1
Ei(yi −W>i α− U>i β)
Σθ =
(
1
σ2
n∑
i=1
EiE
>
i + Σ
−1
θ0
)−1
• βjl|rest ∼ ljlN(µβjl , σ2βjl) + (1− ljl)δ0(βjl) where
µβjl = σ
2
βjl
(σ2)−1
n∑
i=1
Uijly˜ijl
σ2βjl = σ
2
(
n∑
i=1
U2ijl +
1
sjl
)−1
ljl =
pi0
pi0 + (1− pi0)s
1
2
jl(σ
2
βjl
)−
1
2 (σ2)−
1
2 exp
{
−σ
2
βjl
2σ4
(
∑n
i=1 Uijly˜ijl)
2
}
and y˜ijl is defined as y˜ijl = yi −W>i α− E>i θ − U>(jl)β(jl).
• The posterior of sjl is
s−1jl |rest ∼

Inverse-Gamma(1, η
2
) if βjl = 0
Inverse-Gaussian(η,
√
ησ2
β2jl
) if βjl 6= 0
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• pi1|rest ∼ Beta
(
a1 +
∑
j,l I{βjl 6=0}, b1 +
∑
j,l I{βjl=0}
)
• η|rest ∼ Gamma (sη, rη), where sη = p×L+d1 and the rate parameter rη =
∑
j,l sjl
2
+d2.
• σ2|rest ∼ Inv-Gamma(n+
∑
j,l I{βjl 6=0}
2
,
∑n
i=1 y˜i
2+
∑
j,l(s
−1
jl )β
2
jl
2
), where y˜i = yi−W>i α−E>i θ−
U>i β.
C.7.9 BSG
Hierarchical model specification
Y |α, θ, β, σ2 ∝ (σ2)−n2 exp
{
− 1
2σ2
n∑
i=1
(yi −W>i α− E>i θ − U>i β)2
}
α ∼ Nq(0, Σα0)
θ ∼ Nk(0, Σθ0)
βj|ωjl, rj ind∼ NL(0, σ2Vj), where Vj = diag
{( 1
rj
+
1
ωjl
)−1
, l = 1, 2, . . . , L
}
rj, ωj1, . . . , ωjL|η1, η2 ∝
L∏
l=1
[
(ωjl)
− 1
2
(
1
rj
+
1
ωjl
)− 1
2
]
(rj)
− 1
2 exp
(
−η1
2
rj − η2
2
L∑
l=1
ωjl
)
η1, η2 ∝ η
p
2
1 η
pL
2 exp {−d1η1 − d2η2}
σ2 ∼ 1/σ2
Gibbs Sampler
• α|rest ∼ N(µα, Σα), where
µα = Σα(σ
2)−1
n∑
i=1
Wi(yi − E>i θ − U>i β)
Σα =
(
1
σ2
n∑
i=1
WiW
>
i + Σ
−1
α0
)−1
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• θ|rest ∼ N(µθ, Σθ), where
µθ = Σθ(σ
2)−1
n∑
i=1
Ei(yi −W>i α− U>i β)
Σθ =
(
1
σ2
n∑
i=1
EiE
>
i + Σ
−1
θ0
)−1
• βj|rest ∼ N(µβj , Σβj) where
µβj = Σβj(σ
2)−1
n∑
i=1
Uij y˜ij
Σβj = σ
2
(
n∑
i=1
UijU
>
ij + V
−1
j
)−1
and y˜ij is defined as y˜ij = yi −W>i α− E>i θ − U>(j)β(j).
• r−1j |rest ∼ Inv-Gaussian(η1,
√
η1σ2
‖βj‖22 )
• ω−1jl |rest ∼ Inv-Gaussian(η2,
√
η2σ2
β2jl
)
• η1|rest ∼ Gamma (sη1 , rη1), where sη1 = p2 +1 and the rate parameter rη1 =
∑p
j=1 rj
2
+d1.
• η2|rest ∼ Gamma (sη2 , rη2), where sη2 = p × L + 1 and the rate parameter rη2 =∑
j,l ωj
2
+ d2.
• σ2|rest ∼ Inv-Gamma(n+p×L
2
,
∑n
i=1 y˜i
2+
∑p
j=1 β
>
j V
−1
j βj
2
), where y˜i = yi −W>i α − E>i θ −
U>i β.
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C.7.10 BGL
Hierarchical model specification
Y ∝ (σ2)−n2 exp
{
− 1
2σ2
n∑
i=1
(yi −W>i α− E>i θ − U>i β)2
}
α ∼ Nq(0, Σα0)
θ ∼ Nk(0, Σθ0)
βj|σ2, sj ind∼ NL
(
0, σ2sjIL
)
j = 1, . . . , p
sj|η ind∼ Gamma
(
L+ 1
2
,
η
2
)
j = 1, . . . , p
η ∼ Gamma (d1, d2)
σ2 ∼ 1/σ2
Gibbs Sampler
• α|rest ∼ N(µα, Σα), where
µα = Σα(σ
2)−1
n∑
i=1
Wi(yi − E>i θ − U>i β)
Σα =
(
1
σ2
n∑
i=1
WiW
>
i + Σ
−1
α0
)−1
• θ|rest ∼ N(µθ, Σθ), where
µθ = Σθ(σ
2)−1
n∑
i=1
Ei(yi −W>i α− U>i β)
Σθ =
(
1
σ2
n∑
i=1
EiE
>
i + Σ
−1
θ0
)−1
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• βj|rest ∼ N(µβj , σ2Σβj) where
µβj = Σβj
n∑
i=1
Uij y˜ij
Σβj =
(
n∑
i=1
UijU
>
ij +
1
sj
IL
)−1
and y˜ij is defined as y˜ij = yi −W>i α− E>i θ − U>(j)β(j).
• s−1j |rest ∼ Inverse-Gaussian(η,
√
ησ2
‖βj‖22 )
• η|rest ∼ Gamma (sη, rη), where sη = p+p×L2 +d1 and the rate parameter rη =
∑p
j=1 sj
2
+
d2.
• σ2|rest ∼ Inv-Gamma(n+p×L
2
,
∑n
i=1 y˜i
2+
∑p
j=1(sj)
−1β>j βj
2
), where y˜i = yi −W>i α − E>i θ −
U>i β.
C.7.11 BL
Hierarchical model specification
Y ∝ (σ2)−n2 exp
{
− 1
2σ2
n∑
i=1
(yi −W>i α− E>i θ − U>i β)2
}
α ∼ Nq(0, Σα0)
θ ∼ Nk(0, Σθ0)
βjl|σ2, sjl ind∼ N
(
0, σ2sjl
)
j = 1, . . . , p; l = 1, . . . , L
sjl|η ind∼ Gamma
(
1,
η
2
)
j = 1, . . . , p; l = 1, . . . , L
η ∼ Gamma (d1, d2)
σ2 ∼ 1/σ2
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Gibbs Sampler
• α|rest ∼ N(µα, Σα), where
µα = Σα(σ
2)−1
n∑
i=1
Wi(yi − E>i θ − U>i β)
Σα =
(
1
σ2
n∑
i=1
WiW
>
i + Σ
−1
α0
)−1
• θ|rest ∼ N(µθ, Σθ), where
µθ = Σθ(σ
2)−1
n∑
i=1
Ei(yi −W>i α− U>i β)
Σθ =
(
1
σ2
n∑
i=1
EiE
>
i + Σ
−1
θ0
)−1
• βjl|rest ∼ N(µβjl , σ2βjl) where
µβjl = σ
2
βjl
(σ2)−1
n∑
i=1
Uijly˜ijl
σ2βjl = σ
2
(
n∑
i=1
U2ijl +
1
sjl
)−1
and y˜ijl is defined as y˜ijl = yi −W>i α− E>i θ − U>(jl)β(jl).
• s−1j |rest ∼ Inverse-Gaussian(η,
√
ησ2
β2jl
)
• η|rest ∼ Gamma (sη, rη), where sη = p×L+d1 and the rate parameter rη =
∑
j,l sjl
2
+d2.
• σ2|rest ∼ Inv-Gamma(n+p×L
2
,
∑n
i=1 y˜i
2+
∑
j,l s
−1
jl β
2
jl
2
), where y˜i = yi −W>i α−E>i θ−U>i β.
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